# EDGAR Filing Document

**Accession Number:** 0000884525
**File Stem:** 0001193125-26-156867
**Filing Date:** 2026-4
**Character Count:** 456742
**Document Hash:** c0f532d171da6dce0af9c34b771a1f9e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-156867.hdr.sgml**: 20260415

**ACCESSION NUMBER**: 0001193125-26-156867

**CONFORMED SUBMISSION TYPE**: N-VPFS

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260415

**DATE AS OF CHANGE**: 20260415

**EFFECTIVENESS DATE**: 20260415

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A
- **CENTRAL INDEX KEY:** 0000884525

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-VPFS
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-06584
- **FILM NUMBER:** 26863941

**BUSINESS ADDRESS:**
- **STREET 1:** 100 SUMMIT LAKE DRIVE
- **STREET 2:** SECOND FLOOR
- **CITY:** VALHALLA
- **STATE:** NY
- **ZIP:** 10595
- **BUSINESS PHONE:** 6172666008

**MAIL ADDRESS:**
- **STREET 1:** 100 SUMMIT LAKE DRIVE
- **STREET 2:** SECOND FLOOR
- **CITY:** VAHALLA
- **STATE:** NY
- **ZIP:** 10595

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** JOHN HANCOCK INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A
- **DATE OF NAME CHANGE:** 20050103

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MANUFACTURERS LIFE INSURANCE CO OF NEW YORK SEP ACCOUNT A
- **DATE OF NAME CHANGE:** 19971022

## Series and Classes Contracts Data

### JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A (Series ID: S000002860)

| Class ID   | Class Name                                    | Ticker Symbol   |
|:---|:---|:---|
| C000007850 | Venture and Wealthmark Variable Annuity       |  |
| C000007851 | Ven 9 and NY Wealthmark                       |  |
| C000007852 | Venture III and Wealthmark ML3                |  |
| C000007853 | NYVison                                       |  |
| C000043113 | NYVantage                                     |  |
| C000043114 | NYVision 2007                                 |  |
| C000051223 | AnnuityNote Series 1 A Share                  |  |
| C000051224 | AnnuityNote Series 1 NAV                      |  |
| C000056588 | Venture Opportunity A Share                   |  |
| C000057093 | Venture Opportunity B Share                   |  |
| C000063738 | GIFL Rollover                                 |  |
| C000078687 | AnnuityNote Series 2                          |  |
| C000081725 | Venture 4                                     |  |
| C000088468 | AnnuityNote Portfolios C Share                |  |
| C000090858 | GIFL Select                                   |  |
| C000091146 | AnnuityNote Portfolios A Share                |  |
| C000091147 | AnnuityNote Portfolios ADV                    |  |
| C000095073 | Venture Frontier                              |  |
| C000100452 | Venture 4 Series Variable Annuity             |  |
| C000100453 | Venture 7 Series Variable Annuity             |  |
| C000106098 | Venture Opportunity A-Series Variable Annuity |  |
| C000106099 | Venture Opportunity O-Series Variable Annuity |  |

##### [**Table of Contents**](#toc)
AUDITED STATUTORY-BASIS FINANCIAL STATEMENTS

John Hancock Life Insurance Company of New York

For the Years Ended December 31, 2025, 2024 and 2023

With Report of Independent Auditors

------

##### [**Table of Contents**](#toc)
**AUDITED STATUTORY-BASIS FINANCIAL STATEMENTS** 

**John Hancock Life Insurance Company of New York** 

**YEARS ENDED DECEMBER 31, 2025, 2024 and 2023** 

**Contents** 

---

| | |
|:---|:---|
|  [Report of Independent Auditors](#fny65097_1) | 1 |
|  Statutory-Basis Financial Statements |  |
|  [Statutory-Basis Balance Sheets](#fny65097_2) | 3 |
|  [Statutory-Basis Statements of Operations](#fny65097_3) | 5 |
|  [Statutory-Basis Statements of Changes in Capital and Surplus](#fny65097_4) | 6 |
|  [Statutory-Basis Statements of Cash Flow](#fny65097_5) | 7 |
|  [Notes to Statutory-Basis Financial Statements](#fny65097_6) | 8 |

---

------

##### [**Table of Contents**](#toc)
Report of Independent Auditors

The Board of Directors and Stockholder

John Hancock Life Insurance Company of New York

**Opinion** 

We have audited the statutory-basis financial statements of John Hancock Life Insurance Company of New York (the Company), which comprise the balance sheets as of December 31, 2025 and 2024, and the related statements of operations, changes in capital and surplus and cash flow for each of the three years in the period ended December 31, 2025, and the related notes to the financial statements (collectively referred to as the "financial statements").

*Unmodified Opinion on Statutory Basis of Accounting* 

In our opinion, the accompanying financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, on the basis of accounting described in Note 2.

*Adverse Opinion on U.S. Generally Accepted Accounting Principles* 

In our opinion, because of the significance of the matter described in the Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles section of our report, the financial statements do not present fairly, in accordance with accounting principles generally accepted in the United States of America, the financial position of the Company at December 31, 2025 and 2024, or the results of its operations or its cash flows for each of the three years in the period ended December 31, 2025.

**Basis for Opinion** 

We conducted our audits in accordance with auditing standards generally accepted in the United States of America (GAAS). Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Financial Statements section of our report. We are required to be independent of the Company and to meet our other ethical responsibilities in accordance with the relevant ethical requirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinions.

*Basis for Adverse Opinion on U.S. Generally Accepted Accounting Principles* 

As described in Note 2 to the financial statements, the Company prepared these financial statements using accounting practices prescribed or permitted by the New York State Department of Financial Services, which is a basis of accounting other than accounting principles generally accepted in the United States of America. The effects on the financial statements of the variances between these statutory accounting practices described in Note 2 and accounting principles generally accepted in the United States of America, although not reasonably determinable, are presumed to be material and pervasive.

**Responsibilities of Management for the Financial Statements** 

Management is responsible for the preparation and fair presentation of the financial statements in accordance with the accounting practices prescribed or permitted by the New York State Department of Financial Services. Management is also responsible for the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of financial statements that are free from material misstatement, whether due to fraud or error.

------

##### [**Table of Contents**](#toc)
In preparing the financial statements, management is required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern for one year after the date that the financial statements are issued.

**Auditor's Responsibilities for the Audit of the Financial Statements** 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not a guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when it exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Misstatements are considered material if there is a substantial likelihood that, individually or in the aggregate, they would influence the judgment made by a reasonable user based on the financial statements.

In performing an audit in accordance with GAAS, we:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Exercise professional judgment and maintain professional skepticism throughout the audit.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or
error, and design and perform audit procedures responsive to those risks. Such procedures include examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are
appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control. Accordingly, no such opinion is expressed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Evaluate the appropriateness of accounting policies used and the reasonableness of significant accounting
estimates made by management, as well as evaluate the overall presentation of the financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Conclude whether, in our judgment, there are conditions or events, considered in the aggregate that raise
substantial doubt about the Company's ability to continue as a going concern for a reasonable period of time.

We are required to communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit, significant audit findings, and certain internal control-related matters that we identified during the audit.

---

| |
|:---|
|  /s/ Ernst & Young LLP |
|  Boston, Massachusetts |
|  April 8, 2026 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**STATUTORY-BASIS BALANCE SHEETS** 

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions)** | | |
|  **Admitted assets** |  |  |
|  Cash and invested assets: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds | $**6363** | $6284 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stocks: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stocks | **—** | 15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stocks | **24** | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans on real estate | **517** | 546 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment properties | **103** | 163 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash, cash equivalents and short-term investments | **803** | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy loans | **234** | 217 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives | **329** | 353 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivable for collateral on derivatives | **9** | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Receivable for securities | **—** | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other invested assets | **509** | 629 |
|  Total cash and invested assets | **8891** | 8269 |
|  Investment income due and accrued | **78** | 81 |
|  Premiums due | **4** | 5 |
|  Amounts recoverable from reinsurers | **29** | 33 |
|  Funds held by or deposited with reinsured companies | **649** | 678 |
|  Net deferred tax asset | **90** | 94 |
|  Other reinsurance receivable | **18** | 21 |
|  Amounts due from affiliates | **45** | 469 |
|  Other assets | **5** | 15 |
|  Assets held in separate accounts | **8677** | 8460 |
|  Total admitted assets | $**18486** | $18125 |

---

The accompanying notes are an integral part of the statutory-basis financial statements.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**STATUTORY-BASIS BALANCE SHEETS** 

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions)** | | |
|  **Liabilities and capital and surplus** |  |  |
|  Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy and contract obligations: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy reserves | $**6549** | $6426 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholders' and beneficiaries' funds | **183** | 190 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividends payable to policyholders | **14** | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy benefits in process of payment | **29** | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other amount payable on reinsurance | **53** | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other policy obligations | **1** | 1 |
|  Total policy and contract obligations | **6829** | 6704 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payable to parent and affiliates | **124** | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers to (from) separate account due or accrued, net | **(9)** | (12) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset valuation reserve | **82** | 89 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reinsurance in unauthorized companies | **18** | 91 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Funds withheld from unauthorized reinsurers | **261** | 284 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest maintenance reserve | **481** | 507 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Current federal income taxes payable | **5** | 31 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives | **235** | 250 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payables for collateral on derivatives | **50** | 66 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payables for securities | **—** | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other general account obligations | **187** | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Obligations related to separate accounts | **8677** | 8460 |
|  Total liabilities | **16940** | 16568 |
|  Capital and surplus: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stock (par value $1; 3,000,000 shares authorized; 2,000,003 shares issued and outstanding at December 31, 2025 and 2024) | **2** | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other than special surplus funds | **63** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Paid-in surplus | **913** | 913 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unassigned surplus | **568** | 642 |
|  Total capital and surplus | **1546** | 1557 |
|  Total liabilities and capital and surplus | $**18486** | $18125 |

---

The accompanying notes are an integral part of the statutory-basis financial statements.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**STATUTORY-BASIS STATEMENTS OF OPERATIONS** 

---

| | | | |
|:---|:---|:---|:---|
|  | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums and other revenues: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Life and annuity premiums, net | $**877** | $907 | $919 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consideration for supplementary contracts with life contingencies | **5** | 16 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net investment income | **351** | 358 | 332 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Amortization of interest maintenance reserve | **23** | 22 | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commissions and expense allowance on reinsurance ceded | **25** | 27 | 28 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reserve adjustment on reinsurance ceded | **(142)** | (146) | (116) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Separate account administrative and contract fees | **100** | 98 | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other revenue | **21** | 24 | 29 |
|  Total premiums and other revenues | **1260** | 1306 | 1323 |
|  Benefits paid or provided: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Death, surrender and other contract benefits, net | **1788** | 1359 | 1357 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annuity benefits | **106** | 96 | 94 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Disability benefits | **1** | 2 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest and adjustments on policy or deposit-type funds | **5** | 5 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Payments on supplementary contracts with life contingencies | **10** | 9 | 7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increase (decrease) in life and annuity reserves | **125** | (110) | (64) |
|  Total benefits paid or provided | **2035** | 1361 | 1398 |
|  Insurance expenses and other deductions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Commissions and expense allowance on reinsurance assumed | **48** | 49 | 49 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; General expenses | **39** | 35 | 39 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Insurance taxes, licenses and fees | **10** | 12 | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net transfers to (from) separate accounts | **(922)** | (537) | (426) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment income ceded | **42** | 32 | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other (income) deductions | **(77)** | (67) | (102) |
|  Total insurance expenses and other deductions | **(860)** | (476) | (378) |
|  Income (loss) from operations before dividends to policyholders, federal income taxes and net realized capital gains (losses) | **85** | 421 | 303 |
|  Dividends to policyholders | **15** | 15 | 14 |
|  Income (loss) from operations before federal income taxes and net realized capital gains (losses) | **70** | 406 | 289 |
|  Federal income tax expense (benefit) | **2** | 11 | (32) |
|  Income (loss) from operations before net realized capital gains (losses) | **68** | 395 | 321 |
|  Net realized capital gains (losses) | **(2)** | (94) | (22) |
|  Net income (loss) | $**66** | $301 | $299 |

---

The accompanying notes are an integral part of the statutory-basis financial statements.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**STATUTORY-BASIS STATEMENTS OF CHANGES IN CAPITAL AND SURPLUS** 

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Common<br>Stock** | **Other than<br>special<br>surplus<br>funds** | **Paid-in<br>Surplus** | **Unassigned<br>Surplus<br>(Deficit)** | **Total Capital**<br>**and Surplus** |
| **(in millions)** | | | | | |
|  Balances at January 1, 2023 | $2 |  | $913 | $306 | 1221 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income (loss) |  |  |  | 299 | 299 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized capital gains (losses) |  |  |  | (40) | (40) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net deferred income tax |  |  |  | (38) | (38) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease (increase) in non-admitted assets |  |  |  | (3) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in liability for reinsurance in unauthorized companies |  |  |  | 70 | 70 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease (increase) in asset valuation reserves |  |  |  | 8 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend paid to Parent |  |  |  | (100) | (100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in surplus as a result of reinsurance |  |  |  | (6) | (6) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other adjustments, net |  |  |  |  |  |
|  Balances at December 31, 2023 | 2 |  | 913 | 496 | $1411 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income (loss) |  |  |  | 301 | 301 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized capital gains (losses) |  |  |  | (71) | (71) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net deferred income tax |  |  |  | (14) | (14) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease (increase) in non-admitted assets |  |  |  | (3) | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in liability for reinsurance in unauthorized companies |  |  |  | (51) | (51) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease (increase) in asset valuation reserves |  |  |  | 90 | 90 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend paid to Parent |  |  |  | (100) | (100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in surplus as a result of reinsurance |  |  |  | (6) | (6) |
|  Balances at December 31, 2024 | 2 |  | 913 | 642 | 1557 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net income (loss) |  |  |  | **66** | **66** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net unrealized capital gains (losses) |  |  |  | **(39)** | **(39)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in net deferred income tax |  |  |  | **(11)** | **(11)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease (increase) in non-admitted assets |  |  |  | **(2)** | **(2)** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change in liability for reinsurance in unauthorized companies |  |  |  | **73** | **73** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Decrease (increase) in asset valuation reserves |  |  |  | **7** | **7** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other than special surplus funds |  | 63 |  | **(63)** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend paid to Parent |  |  |  | **(100)** | **(100)** |
|  Change in surplus as a result of reinsurance |  |  |  | **(5)** | **(5)** |
|  Balances at December 31, 2025 | $2 | $63 | $913 | $568 | $1546 |

---

The accompanying notes are an integral part of the statutory-basis financial statements.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**STATUTORY-BASIS STATEMENTS OF CASH FLOW** 

---

| | | | |
|:---|:---|:---|:---|
|  | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  **Operations** |  |  |  |
|  Premiums and other considerations collected, net of reinsurance | $**883** | $922 | $936 |
|  Net investment income received | **358** | 360 | 330 |
|  Separate account fees | **100** | 98 | 94 |
|  Commissions and expenses allowance on reinsurance ceded | **20** | 21 | 22 |
|  Miscellaneous income | **50** | 50 | 43 |
|  Benefits and losses paid | **(2043)** | (1621) | (1595) |
|  Net transfers from (to) separate accounts | **925** | 539 | 428 |
|  Commissions and expenses (paid) recovered | **(60)** | (56) | (14) |
|  Dividends paid to policyholders | **(14)** | (12) | (9) |
|  Federal and foreign income and capital gain taxes (paid) recovered | **(36)** | (9) | (15) |
|  Net cash provided by operating activities | **183** | 292 | 220 |
|  **Investment activities** |  |  |  |
|  Proceeds from sales, maturities, or repayments of investments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds | **605** | 270 | 482 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stocks | **—** | 52 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans on real estate | **47** | 71 | 56 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate | **62** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other invested assets | **119** | 93 | 73 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives | **—** |  | 11 |
|  Total investment proceeds | **833** | 486 | 632 |
|  Cost of investments acquired: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds | **685** | 441 | 436 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Stocks | **—** | 4 | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans on real estate | **19** | 32 | 21 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate | **7** | 10 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other invested assets | **12** | 20 | 50 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives | **1** |  |  |
|  Total cost of investments acquired | **724** | 507 | 541 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net increase (decrease) in receivable/payable for securities and collateral on derivatives | **(33)** | 11 | (48) |
|  Net (increase) decrease in policy loans | **(17)** | (23) | (56) |
|  Net cash provided by (used in) investment activities | **59** | (33) | (13) |
|  **Financing and miscellaneous activities** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net deposits (withdrawals) on deposit-type contracts | **(7)** | (7) | (12) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Repurchase Agreements | **(16)** | (16) | (31) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend paid to parent | **(100)** | (100) | (100) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other cash provided (applied) | **656** | (162) | (83) |
|  Net cash provided by (used in) financing and miscellaneous activities | **533** | (285) | (226) |
|  Net increase (decrease) in cash, cash equivalents and short-term investments | **775** | (26) | (19) |
|  Cash, cash equivalents and short-term investments at beginning of year | **28** | 54 | 73 |
|  Cash, cash equivalents and short-term investments at end of year | $**803** | $28 | $54 |

---

The accompanying notes are an integral part of the statutory-basis financial statements.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**1. Organization and Nature of Operations** 

John Hancock Life Insurance Company of New York (the "Company") is a life insurance company organized on February 10, 1992 under the laws of the State of New York. The New York State Department of Financial Services (the "Insurance Department") granted the Company a license to operate on July 22, 1992. The Company is a wholly-owned subsidiary of John Hancock Life Insurance Company (U.S.A.) ("JHUSA"). JHUSA is a wholly-owned subsidiary of The Manufacturers Investment Corporation ("MIC"). MIC is a wholly-owned subsidiary of John Hancock Financial Corporation ("JHFC"), which is an indirect, wholly-owned subsidiary of The Manufacturers Life Insurance Company ("MLI"). MLI, in turn, is a wholly-owned subsidiary of Manulife Financial Corporation ("MFC"), a Canadian-based, publicly traded financial services holding company.

The Company provides a wide range of financial protection and wealth management products and services to both individual and institutional customers. Through its insurance operations, the Company offers a variety of individual life insurance products that are distributed through multiple distribution channels, including insurance agents, brokers, banks, and financial planners. The Company also offers a variety of retirement products to retirement plans. The Company distributes these products through multiple distribution channels, including insurance agents and affiliated brokers, securities brokerage firms, financial planners, pension plan sponsors, pension plan consultants, and banks.

Under a distribution agreement with the Company, John Hancock Distributors LLC ("JHD"), a registered broker dealer and wholly-owned subsidiary of JHUSA, acts as the principal underwriter of variable life contracts and other products issued by the Company.

**2. Significant Accounting Policies** 

**Use of Estimates** 

The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Such estimates and assumptions could change in the future as more information becomes known and may impact the amounts reported and disclosed herein.

**Basis of Presentation** 

These financial statements have been prepared in conformity with accounting practices prescribed or permitted by the Insurance Department. The National Association of Insurance Commissioners' ("NAIC") *Accounting Practices and Procedures Manual*("NAIC SAP") has been adopted as a component of practices prescribed or permitted by the State of New York. The New York Superintendent of the Insurance Department (the "Superintendent") has the authority to prescribe or permit other specific practices that deviate from prescribed practices. NAIC SAP practices differ from accounting principles generally accepted in the United States ("GAAP") as described below.

*Investments:* Investments in bonds not backed by other loans are principally stated at amortized cost using the constant yield (interest) method. Bonds can also be stated at the lesser of amortized cost or fair value based on their NAIC designated rating. Under revised NAIC guidance, bonds are classified as either issuer credit obligations or asset-backed securities. Residual or first-loss interests without substantive credit enhancement are excluded from bond status and reported under Statement of Statutory Accounting Principles ("SSAP") No. 21R - Other Invested Assets.

Perpetual preferred stocks are valued at fair value, not to exceed any currently effective call price. Redeemable preferred stocks, which have characteristics of debt securities and are rated as medium quality or better, are reported at cost or amortized cost. All other redeemable preferred stocks are reported at the lower of cost, amortized cost, or fair value.

For bonds other than asset-backed securities, the Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. The Company recognizes other-than-temporary impairment losses on bonds with unrealized losses when the entity does not have the intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. Declines in value due to credit difficulties are also considered other-than-temporary when the Company does not have the intent and ability to hold the security for a period of time sufficient to allow for any anticipated recovery in value. The entire difference between amortized cost and fair value on such bonds with credit difficulties is recognized as an impairment loss in income.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

Asset-backed securities (e.g., collateralized mortgage obligations) are adjusted for changes in prepayment assumptions on the related accretion of discounts or amortization of premiums using either the retrospective or prospective methods. The retrospective adjustment method is used to value all such securities, except principal-only and interest-only securities and those with NAIC designations of 3-6, which are valued using the prospective method. If a decline in fair value is determined to be other-than-temporary, the cost basis of the security is written down to the present value of estimated future cash flows using the original effective interest rate inherent in the security.

Common stocks are primarily reported at fair value based on quoted market prices and the related net unrealized capital gains (losses) are reported in unassigned surplus, net of any adjustment for federal income taxes. There are no restrictions on common and preferred stocks.

Non-insurance subsidiaries, with significant ongoing operations other than for the benefit of the Company and its affiliates, are reported based on the underlying audited GAAP equity. Non-insurance subsidiaries, with no significant ongoing operations other than for the benefit of the Company and its affiliates, are reported based on the underlying audited GAAP equity, including the admitted portion of goodwill. Dividends from subsidiaries are included in net investment income. The remaining net change in the subsidiaries' equity is included in the change in net unrealized capital gains (losses).

Realized capital gains (losses) on sales of securities are recognized using the first-in, first-out ("FIFO") method. The cost basis of bonds, common and preferred stocks, and other invested assets is adjusted for impairments in value deemed to be other-than-temporary and such adjustments are reported as a component of net realized capital gains (losses).

Mortgage loans on real estate are reported at unpaid principal balances, less an allowance for impairments. Valuation allowances, if necessary, are established for mortgage loans on real estate based on the difference between the net value of the collateral, determined as the fair value of the collateral less estimated costs to obtain and sell, and the recorded investment in the mortgage loan. The initial valuation allowance and subsequent changes in the allowance for mortgage loans are charged or credited directly to unassigned surplus. A mortgage loan is considered impaired when, based on current information and events, it is probable that the Company will be unable to collect all principal and interest amounts due according to the contractual terms of the mortgage agreement. When management determines foreclosure is probable and the impairment is other-than-temporary, the mortgage loan is written down and a realized loss is recognized.

Real estate held for the production of income is reported at depreciated cost, net of related obligations. Real estate the Company intends to sell is reported at the lower of depreciated cost or fair value, net of related obligations. Depreciation is calculated on a straight-line basis over the estimated useful lives of the properties.

Cash equivalents are short-term highly liquid investments with original maturities of three months or less and are principally stated at amortized cost. Short-term investments include investments with maturities of one year or less and greater than three months at the date of acquisition and are principally stated at amortized cost.

Policy loans are reported at unpaid principal balances.

Derivative instruments that meet hedge accounting criteria are accounted for consistently with the item hedged (i.e., amortized cost or fair value with the related net unrealized capital gains (losses) reported in unassigned surplus along with any adjustment for federal income taxes). Derivative instruments entered into for other hedging purposes, known as economic hedges, do not meet the criteria to qualify for hedge accounting. These derivative instruments are accounted for at fair value, and the related changes in fair value are recognized as net unrealized capital gains (losses) reported in unassigned surplus, net of any adjustments for federal income taxes. Embedded derivatives are not accounted for separately from the host contract.

Other invested assets consist of ownership interests in partnerships and limited liability companies ("LLCs") carried based on the underlying audited GAAP equity, except for affordable housing tax credit properties, which are carried at amortized cost. The related net unrealized capital gains (losses) are reported in unassigned surplus, net of any adjustments for federal income taxes. The Company records its share of income using the most recent financial information available, generally on a three-month lag.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

*Interest Maintenance and Asset Valuation Reserves:* Under a formula prescribed by the NAIC, the Company defers the portion of realized capital gains (losses) on sales of fixed income investments, principally bonds and mortgage loans, and interest-related hedging activities attributable to changes in the general level of interest rates and amortizes those deferrals over the remaining period to maturity based on groupings of individual securities sold in five-year bands. That net deferral is reported as the interest maintenance reserve ("IMR") in the accompanying Balance Sheets. Realized capital gains (losses) are reported in income, net of federal income tax and transferred to the IMR. Interest rate swaps and swaptions supporting our Variable Annuities dynamic hedging program are not in an accounting hedge relationship and any realized capital gains (losses) on these sold interest rate swaps and swaptions are not deferred to IMR. Net Negative (Disallowed) IMR limitation is determined by an NAIC prescribed formula with nonadmitted changes reflected directly in special surplus funds. The asset valuation reserve ("AVR") provides a valuation allowance for invested assets. The AVR is determined by an NAIC prescribed formula with changes reflected directly in unassigned surplus.

*Goodwill:* Goodwill is admitted subject to an aggregate limitation of 10% of the capital and surplus in the most recently filed quarterly statement, excluding electronic data processing ("EDP") equipment, operating system software, net deferred tax assets, and net positive goodwill. Goodwill is amortized over the period the Company benefits economically, not to exceed 10 years. Goodwill is reported in other invested assets in the Balance Sheets.

*Separate Accounts:* Separate account assets and liabilities reported in the accompanying Balance Sheets represent funds that are separately administered, principally for annuity contracts and variable life insurance policies, and for which the contract holder, rather than the Company, bears the investment risk. Separate account obligations are intended to be satisfied from separate account assets and not from assets of the general account. Separate accounts are generally reported at fair value. The operations of the separate accounts are not included in the Statements of Operations; however, income earned on amounts initially invested by the Company in the formation of new separate accounts is included in other revenue. Fees charged to contract holders, principally mortality, policy administration, and surrender charges are included in separate account administrative and contract fees. The assets in the separate accounts are not pledged to others as collateral or otherwise restricted. For the years ended December 31, 2025, 2024 and 2023, there were no gains (losses) on transfers of assets from the general account to the separate account.

*Nonadmitted Assets:* Certain assets designated as nonadmitted, principally deferred income taxes, the Company's investment in John Hancock Variable Trust Advisers LLC ("JHVTA") (formerly John Hancock Investment Management Services, LLC), an affiliated company, other invested assets, furniture and equipment, prepaid expenses, and other assets not specifically identified as admitted assets within the NAIC SAP are excluded from the accompanying Balance Sheets and are charged directly to unassigned surplus.

*Policy Reserves:* Reserves for life, annuity, and deposit-type contracts are developed by actuarial methods prescribed by the NAIC that will provide, in the aggregate, reserves that are greater than or equal to the maximum of guaranteed policy cash values or the amounts required by the Superintendent of Financial Services.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• At December 31, 2025 and 2024, the Company held reserves of $475 million and $400 million,
respectively, as a result of asset adequacy testing ("AAT").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reserves for most individual life insurance policies, written prior to 2021, are determined based on prescribed
interest rates, mortality tables and valuation methods.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reserves for individual life insurance policies, written since January 1, 2021, and as well as certain term
policies written prior to that date, and reserves for all variable annuities are determined using principle-base reserve ("PBR") methods and assumptions as defined in NY Insurance Regulation 213 ("Reg 213").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reserves for other annuity and supplementary contracts with life contingency, are determined based on prescribed
interest rates, mortality tables and valuation methods.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Liabilities related to policyholder funds left on deposit with the Company are generally equal to fund balances.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For life insurance, the calendar year exact method is used to calculate the reserve at December 31, 2025 and
2024. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Tabular interest, tabular less actual reserve released, and tabular costs have been determined by formula.
Tabular interest on funds not involving life contingencies is calculated as one percent of the product of such valuation rate of interest times the mean of the amount of funds subject to such valuation rate of interest held at the beginning and end
of the valuation year.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• From time to time, the Company finds it appropriate to modify certain required policy reserves because of changes
in actuarial assumptions. Reserve modifications resulting from such determinations are recorded directly to unassigned surplus.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reserves for variable deferred annuity contracts are calculated in accordance with NY DFS Reg 213
§103.6.

*Reinsurance:* Reinsurance ceded contracts do not relieve the Company from its obligations to policyholders. The Company remains liable to its policyholders for the portion reinsured to the extent that any reinsurer does not meet its obligations for reinsurance ceded to it under the reinsurance agreements. Failure of the reinsurers to honor their obligations could result in losses to the Company; consequently, estimates are established for amounts deemed or estimated to be uncollectible. To minimize its exposure to significant losses from reinsurance insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentration of credit risk arising from similar characteristics of the insurer.

*Funds held by or deposited with reinsured companies:* Under certain reinsurance agreements, the Company allows the ceding insurer to retain funds that would otherwise be remitted to the Company. These arrangements are designed to secure the ceding company's obligations. Interest accrues on the funds held by or deposited with reinsurer at rates specified in the reinsurance contracts and is recognized as Other (income) deductions in the Company's Statements Operations. The Company assesses the creditworthiness of ceding insurers and monitors the collectability of these assets, establishing guidance based on admissibility for uncollectible amounts when necessary.

*Funds held under coinsurance: Under* certain reinsurance agreements, the Company retains funds that would otherwise be remitted to the reinsurer. These arrangements allow the Company to secure obligations due from the reinsurer. Interest accrues on the funds held under coinsurance in the reinsurance contracts and is recognized as Other (income) deductions in the Company's Statements of Operations. The Company evaluates the creditworthiness of reinsurers and assesses the collectability of any associated receivables, establishing guidance based on admissibility for uncollectible amounts when necessary.

Premiums, commissions, expense reimbursements, benefits, and reserves related to reinsured business are accounted for on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. Premiums ceded to other companies have been reported as a reduction of premium income. Amounts applicable to reinsurance ceded for future policy benefits, unearned premium reserves, and claim liabilities have been reported as reductions of these items.

The Company records a liability for unsecured policy reserves ceded to reinsurers not authorized in the State of New York to assume such business. Changes to those amounts are credited or charged directly to unassigned surplus. Policy and contract liabilities ceded to reinsurers have been reported as reductions of the related reserves. Commissions and expense allowances allowed by reinsurers on business ceded are reported as income when received. Investment income ceded includes separate account fee income, net investment income and realized investment and other gains (losses), which were ceded to the affiliated reinsurers. NAIC SAP prescribes that no gain be recognized upon inception of a reinsurance treaty. The initial gain is recorded directly to other than special surplus funds and released into income over the life of the treaty.

*Federal Income Taxes:* Total federal income taxes are based upon the Company's best estimate of its current and deferred tax assets or liabilities. Current tax expense is reported in the Statements of Operations as federal income tax expense if resulting from operations and within net realized capital gains (losses) if resulting from capital transactions. Changes in the balances of deferred taxes, which provide for book versus tax temporary differences, are subject to limitations and are reported within various lines within surplus. The provision for federal and foreign income taxes incurred in the Statements of Operations is different from that which would be obtained by applying the statutory federal income tax rate to income before income tax (including realized capital gains). For additional information, see the Federal Income Taxes Note for reconciliation of the effective tax rate.

*Participating Insurance and Policyholder Dividends:* Participating business which is assumed from JHUSA, represented approximately 11% and 13% of the Company's aggregate reserve for group fixed annuity and life contracts at December 31, 2025 and 2024, respectively. The amount of policyholders' dividends to be paid is approved annually by JHUSA's Board of Directors. Policyholder dividends are recognized when declared rather than over the term of the related policies. The determination of the amount of policyholders' dividends is complex and varies by policy type. In general, the aggregate amount of policyholders' dividends is calculated based upon actual interest, mortality, morbidity, persistency, and expense experience for the year, as well as management's judgment as to the appropriate level of statutory surplus to be retained by the Company.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

*Statements of Cash Flow:* Cash, cash equivalents and short-term investments in the Statements of Cash Flow represent movements of cash and highly liquid debt investments with initial maturities of one year or less. Cash flows associated with derivative instruments are presented in the statement of cash flows based on the nature of the related activity. Cash flows related to derivative purchases, sales, settlements, and changes in derivative-related collateral or other balances are presented within investing activities, consistent with the Company's statement of cash flow presentation. Related gains and losses are reflected in net investment income or net realized/unrealized capital gains (losses), as applicable, based on the derivative's designation and accounting treatment.

*Premiums and Benefits:* Premiums for whole life, term life, universal life, annuity policies, and group annuity contracts with any mortality and morbidity risk are recognized as revenue when due. Revenues for universal life and annuity policies with mortality or morbidity risk consist of the entire premium received. Premiums received for variable universal life, as well as annuity policies and group annuity contracts without mortality or morbidity risk are recorded using deposit accounting and are credited directly to an appropriate policy reserve account, without recognizing premium revenue. Benefits incurred represent the total of death benefits paid, annuity benefits paid and the change in policy reserves.

*Premium deficiency reserves:* The Company does not utilize anticipated investment income as a factor in its premium deficiency calculation. The Company did not record a premium deficiency reserve for the years ended December 31, 2025 and 2024.

*Policy and Contract Claims:* Policy and contract claims are determined on an individual-case basis for reported losses. Estimates of incurred but not reported losses are developed based on past experience.

*Guaranty Fund Assessments:* Guaranty fund assessments are accrued when the Company receives knowledge of an insurance insolvency.

*Variances Between NAIC SAP and GAAP:* The more significant variances in GAAP are: (a) bonds would generally be reported at fair value; (b) changes in the fair value of derivative financial instruments would generally be reported in income unless deemed an effective hedge; (c) embedded derivatives would be bifurcated from the underlying contract or security and accounted for separately at fair value; (d) income recognition on partnerships and LLCs, which are accounted for under the equity method, would not be limited to the amount of cash distribution; (e) majority-owned noninsurance subsidiaries, variable interest entities where the Company is the primary beneficiary, and certain other controlled entities would be consolidated; (f) changes in the balances of deferred income taxes would generally be included in net income; (g) market value adjusted ("MVA") annuity products would be reported in the general account of the Company; (h) all assets, subject to valuation allowances, would be recognized; (i) under U.S. GAAP, long duration targeted improvements ("LDTI") applies, with liabilities measured using current best-estimate cash flow assumptions and updated discount rates, with certain changes recognized through OCI. Under NAIC SAP, reserving follows SSAP No. 54R and the Valuation Manual, including prescribed disabled-life, active-life and incurred but not reported ("IBNR") methodologies where applicable; (j) reserves ceded under reinsurance contracts, unearned ceded premium and unpaid ceded claims would be reported as an asset; (k) AVR and the IMR would not be recorded; (l) under the Current Expected Credit Loss ("CECL") model, expected credit losses for financial assets, including mortgage loans, real estate, policy loans, and receivables, are estimated over the life of the assets and reported in income, requiring consideration of historical experience, current conditions, and reasonable forecasts; (m) for held-to-maturity bonds, the entire expected credit loss is recognized through earnings and the allowance for credit losses ("ACL"), while available for sale bonds, credit losses are recognized through earnings and ACL, limited to the difference between the bond's amortized cost and its fair value, with non-credit losses reflected in other comprehensive income; (n) surplus notes would be reported as liabilities; (o) premiums received in excess of policy charges for universal life and annuity policies would not be recognized as premium revenue and benefits would represent the excess of benefits paid over the policy account value and interest credited to the account values; (p) certain acquisition costs, such as commissions and other variable costs, directly related to acquiring new business are charged to current operations as incurred under NAIC SAP and would generally be capitalized under U.S. GAAP and amortized on a constant-level basis over the expected term of the related contracts; (q) changes in unrealized capital gains (losses) and foreign currency translations would be presented as other comprehensive income; (r) lease liabilities would be recognized for future cash flows of leases, with offsetting right-of-use assets; and (s) effective January 1, 2025, the NAIC's principles-based bond definition applies only under SAP, requiring classification as issuer credit obligations or asset-backed securities and excluding residual interests from bond treatment, whereas GAAP does not impose these requirements.

The effects of the foregoing variances from GAAP on the accompanying statutory-basis financial statements have not been determined, but are presumed to be material.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**3. Permitted or Prescribed Statutory Accounting Practices** 

The financial statements of the Company are presented in conformity with accounting practices prescribed or permitted by the Insurance Department.

For determining the Company's solvency under the State of New York's insurance laws and regulations, the Insurance Department recognizes only statutory accounting practices prescribed or permitted by the State of New York for determining and reporting the financial condition and results of operations of the Company. NAIC SAP has been adopted as a component of practices prescribed or permitted by the State of New York. The Superintendent has the authority to prescribe or permit other specific practices that deviate from prescribed practices. As of December 31, 2025 and 2024, the Superintendent had not prescribed or permitted the Company to use any accounting practices that would result in the Company's income or financial position to deviate from NAIC SAP.

**4. Accounting Changes** 

Accounting changes adopted to conform to the provisions of NAIC SAP are reported as changes in accounting principles. The cumulative effect of changes in accounting principles is reported as an adjustment to unassigned surplus in the period of the change in accounting principle. The cumulative effect is the difference between the amount of unassigned surplus at the beginning of the year and the amount of unassigned surplus that would have been reported at that date if the new accounting principle had been applied retrospectively.

**Adoption of New Accounting Standards** 

On August 11, 2025, the NAIC adopted clarifications to Statement of Statutory Accounting Principles ("SSAP") No. 61R and Appendix A-791 requiring that risk transfer for combination reinsurance contracts with interdependent features (e.g., coinsurance paired with yearly renewable term) be assessed on a combined basis rather than separately by component. This clarification was intended to prevent structures that achieve favorable accounting treatment without transferring sufficient risk. The clarification is effective immediately for new or newly amended contracts, with a transition period for existing contracts through December 31, 2026. The Company did not enter into any material new or newly amended reinsurance contracts during the period that are subject to this clarified guidance. For existing contracts, the Company is continuing to evaluate the impact of this clarification during the transition period. Based on the Company's evaluation to date, this clarification did not have a material impact on the Company's financial position or results of operations.

Effective January 1, 2025, the Company implemented amendments to SSAP No. 26R - *Bonds***,** and SSAP No. 43R – *Loan-Backed and Structured Securities***,** and related revisions to SSAP No. 21R - *Other Invested Assets* as part of its multi-year principles-based bond definition ("PBBD") project.*.* This project was initiated to address inconsistencies in bond classification and improve transparency in statutory reporting. PBBD does not permit grandfathering; securities that do not meet the revised definition must be reclassified. The Company completed a portfolio wide reassessment of all fixed income investments held at January 1, 2025 for compliance. Debt securities qualifying as bonds are classified as either issuer credit obligations ("ICO") or asset backed securities ("ABS") based on economic substance. Residual or first loss interests that do not have substantive credit enhancement are excluded from bond status and reported under SSAP No. 21R. As a result of adopting this guidance, certain investment classifications and related disclosures were updated, as further described in Note 5 – Investments. The adoption of this guidance did not have a material impact on the Company's financial position or results of operations.

On August 13, 2023, the NAIC adopted INT 23-01T — Net Negative (Disallowed) Interest Maintenance Reserve ("IMR") in response to market volatility and its impact on statutory surplus. INT 23-01T provides optional, limited-term guidance allowing insurers to admit up to 10% of adjusted general account capital and surplus as negative IMR, subject to RBC thresholds and other conditions. Adjusted capital excludes "soft assets" such as goodwill, electronic data processing equipment, net deferred tax assets, and admitted negative IMR. Negative IMR may be admitted first in the general account and then, if the percentage limit is not reached, to separate accounts proportionately between insulated and non-insulated accounts. If the insurer can demonstrate historical practice in which derivative gains were reversed to IMR and amortized, there is no exclusion for derivative losses. INT 23-01T was adopted by the Company in August 2023 and its effective period was extended on August 11, 2025, through December 31, 2026. The adoption of this guidance had no impact based on the position of the Company's investments as of December 31, 2025 and 2024.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Future Adoption of New Accounting Standards** 

In December 2025, the NAIC adopted revisions relating to private placement securities, debt security and residual interest disclosures. The revisions are effective December 31, 2026. The private placement securities revisions add investment schedule reporting and related aggregate disclosures by type of public and private security. The debt security and residual interest revisions clarify the location, frequency, and consistency of certain debt security disclosures and add disclosure requirements for residual interests, including the reporting entity's measurement method and transition information, if applicable. The Company is evaluating the effect of these adopted changes on its statutory financial statements. Based on the Company's current assessment, these revisions are expected to affect statutory reporting presentation and disclosures and are not currently expected to have a material effect on recognition or measurement.

The Company is also monitoring the broader NAIC project on interest maintenance reserve ("IMR"). In August 2025, SAPWG directed NAIC staff to proceed with the exposed IMR definition, subject to minor modifications, and to continue the longer-term SSAP No. 7 project on the basis that hypothetical IMR would be eliminated in the forthcoming issue paper and related revisions to SSAP No. 7. As a result, the key policy direction of the project including the proposed IMR definition and the removal of hypothetical IMR had been established at the SAPWG level, but those concepts had not yet been finalized in adopted SSAP No. 7 guidance as of December 31, 2025. The Company will continue to monitor future NAIC action and assess the effect of any final guidance on its statutory financial statements.

**Reconciliation Between Audited Financial Statements and NAIC Annual Statements** 

There were no differences in net income (loss) or capital and surplus between the audited financial statements and the NAIC statements as filed as of and for the years ended December 31, 2025, 2024 and 2023.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**5. Investments** 

**Bonds** 

Beginning in 2025, bond disclosures are presented consistent with the revised Annual Statement reporting framework that separates ICO from ABS. For ABS, we evaluate substantive credit enhancement and, where applicable, the criteria for non-financial ABS cash flows. Consistent with 2025 Annual Statement Instructions, related schedule attributes (e.g., payment due at maturity, current over collateralization percentage, investment characteristics such as IO/PO/PIK/deferred interest, and aggregate deferred interest) are captured in our investment records and Annual Statement schedules.

The carrying value and fair value of the Company's investments in bonds are summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Carrying<br>Value** | **Gross<br>Unrealized<br>Gains** | **Gross<br>Unrealized<br>Losses** | **Fair Value** |
| **(in millions)** | | | | |
|  **December 31, 2025:** |  |  |  |  |
|  **Issuer Credit Obligations** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government obligations | $**2852** | $**1** | $**(1026)** | $**1827** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other U.S. government obligations | **86** | **—** | **(5)** | **81** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Non-U.S. sovereign jurisdiction securities | **34** | **13** | **—** | **47** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Municipal bonds - general obligations | **28** | **—** | **(2)** | **26** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Municipal bonds - special revenue | **96** | **—** | **(18)** | **78** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Project finance bonds issued by operating entities | **75** | **1** | **(3)** | **73** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate bonds | **2937** | **29** | **(366)** | **2600** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Single entity backed obligations | **22** | **—** | **(2)** | **20** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bank loans | **11** | **—** | **(2)** | **9** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other issuer credit obligations | **12** | **—** | **—** | **12** |
|  Total issuer credit obligations | $**6153** | $**44** | $**(1424)** | $**4773** |
|  **Asset-Backed Securities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset-backed securities | **210** | **2** | **(17)** | **195** |
|  Total Bonds | $**6363** | $**46** | $**(1441)** | $**4968** |
|  **December 31, 2024:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government and agencies | $3022 | $1 | $(1046) | $1977 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; States and political subdivisions | 143 |  | (28) | 115 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign governments | 42 | 13 | (3) | 52 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate bonds | 2818 | 11 | (421) | 2408 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage-backed and asset-backed securities | 259 | 1 | (24) | 236 |
|  Total bonds | $6284 | $26 | $(1522) | $4788 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

A summary of the carrying value and fair value of the Company's investments in bonds at December 31, 2025, by contractual maturity, is as follows:

---

| | | |
|:---|:---|:---|
|  | **Carrying Value** | **Fair Value** |
| **(in millions)** | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Due in one year or less | $**88** | $**88** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Due after one year through five years | **715** | **707** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Due after five years through ten years | **672** | **672** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Due after ten years | **4656** | **3286** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Single entity backed and asset-backed securities | **232** | **215** |
|  Total | $**6363** | $**4968** |

---

The expected maturities in the foregoing table may differ from the contractual maturities because certain borrowers have the right to call or prepay obligations with or without call or prepayment penalties.

The Company maintains assets which are pledged as collateral in connection with various agreements and transactions. Additionally, the Company holds assets on deposit with government authorities as required by state law. The following table summarizes the carrying value or fair value, as applicable, of the pledged or deposited assets:

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions)** | | |
|  **At fair value:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds and cash pledged in support of over-the-counter derivative instruments | $**1** | $8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds and cash pledged in support of exchange-traded futures | **13** | 6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds and cash pledged in support of cleared interest rate swaps | **41** | 40 |
|  Total fair value | $**55** | $54 |
|  **At carrying value:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds on deposit with government authorities | $**—** | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds held in trust | **—** |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pledged collateral under reinsurance agreements | **—** |  |
|  Total carrying value | $**—** | $— |

---

At December 31, 2025 and 2024, the Company held below investment grade corporate bonds of $59 million and $81 million, with an aggregate fair value of $42 million and $62 million, respectively. The Company performs periodic evaluations of the relative credit standing of the issuers of these bonds.

The Company has a process in place to identify securities that could potentially have an impairment that is other-than-temporary. This process involves monitoring market events that could impact issuers' credit ratings, business climate, management changes, litigation and government actions, and other similar factors. This process also involves monitoring late payments, downgrades by rating agencies, key financial ratios, financial statements, revenue forecasts, and cash flow projections as indicators of credit issues.

At the end of each quarter, the MFC Loan Review Committee reviews all securities where there is evidence of impairment or a significant unrealized loss at the Balance Sheet date. Impairment is considered to have occurred, based on management's judgment, when it is deemed probable that the Company will not be able to collect all amounts due according to the debt security's contractual terms. The analysis focuses on each company's or project's ability to service its debts in a timely fashion and the length of time the security has been trading below amortized cost. The results of this analysis are reviewed by the Transaction and Portfolio Review Committee at MFC. This committee includes MFC's Chief Financial Officer, Chief Investment Officer, Chief Risk Officer, Chief Credit Officer, and other senior management. This quarterly process includes a fresh assessment of the credit quality of each investment in the entire fixed maturity security portfolio.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The Company considers relevant facts and circumstances in evaluating whether the impairment of a security is other-than-temporary. Relevant facts and circumstances considered include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer, including the current and future impact of any specific events; and (3) the Company's ability and intent to hold the security to maturity or until it recovers in value. To the extent the Company determines that a security is deemed to be other-than-temporarily impaired, the difference between book value and fair value would be charged to income. For asset-backed securities in an unrealized loss position, where the Company does not intend to sell or is not likely to be required to sell the security, the Company calculates an other-than-temporary impairment loss by subtracting the net present value of the projected future cash flows of the security from the amortized cost of the security. The net present value is calculated by discounting the Company's best estimate of projected future cash flows at the effective interest rate implicit in the debt security prior to impairment. The projection of future cash flows is subject to the same analysis the Company applies to its overall impairment evaluation process, as noted above, which incorporates security specific information such as late payments, downgrades by rating agencies, key financial ratios, financial statements, and fundamentals of the industry and geographic area in which the issuer operates, as well as overall macroeconomic conditions. The cash flow estimates, including prepayment assumptions, are based on data from third-party data sources or internal estimates, and are driven by assumptions regarding the underlying collateral, including default rates, recoveries, and changes in value.

There are a number of significant risks and uncertainties inherent in the process of monitoring impairments and determining if impairment is other-than-temporary. These risks and uncertainties include (1) the risk that the Company's assessment of an issuer's ability to meet all of its contractual obligations will change based on changes in the credit characteristics of that issuer; (2) the risk that the economic outlook will be worse than expected or have more of an impact on the issuer than anticipated; (3) the risk that fraudulent information could be provided to the Company's investment professionals who determine the fair value estimates and other-than-temporary impairments; and (4) the risk that new information obtained by the Company or changes in other facts and circumstances lead the Company to change its intent to hold the security to maturity or until it recovers in value. Any of these situations could result in a charge to income in a future period.

At December 31, 2025 and 2024, the Company had no Other-Than-Temporary Impairments (OTTI) for asset-backed securities.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The following table shows gross unrealized losses and fair values of bonds, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Less than 12 months** | **Less than 12 months** | **12 months or more** | **12 months or more** | **Total** | **Total** |
|  |<br>**Fair Value** | **Gross**<br>**Unrealized**<br>**Losses** |<br>**Fair Value** | **Gross**<br>**Unrealized**<br>**Losses** |<br>**Fair Value** | **Gross**<br>**Unrealized**<br>**Losses** |
| **(in millions)** | | | | | | |
|  **December 31, 2025:** |  |  |  |  |  |  |
|  U.S. government obligations | $**20** | $**(1)** | $**1753** | $**(1030)** | $**1773** | $**(1031)** |
|  Municipal bonds | **—** | **—** | **81** | **(20)** | **81** | **(20)** |
|  Non-U.S. sovereign jurisdictions | **—** | **—** | **—** | **—** | **—** | **—** |
|  Corporate bonds and other | **105** | **(1)** | **1600** | **(370)** | **1705** | **(371)** |
|  Single entity backed and asset-backed securities | **—** | **—** | **131** | **(19)** | **131** | **(19)** |
|  Total | $**125** | $**(2)** | $**3565** | $**(1439)** | $**3690** | $**(1441)** |
|  | **Less than 12 months** | **Less than 12 months** | **12 months or more** | **12 months or more** | **Total** | **Total** |
|  |  | **Gross** |  | **Gross** |  | **Gross** |
|  |  | **Unrealized** |  | **Unrealized** |  | **Unrealized** |
|  | **Fair Value** | **Losses** | **Fair Value** | **Losses** | **Fair Value** | **Losses** |
| **(in millions)** |  |  |  |  |  |  |
|  **December 31, 2024:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. government and agencies | $193 | $(7) | $1778 | $(1039) | $1971 | $(1046) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; States and political subdivisions | 17 | (1) | 96 | (27) | 113 | (28) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign governments | 1 |  | 6 | (3) | 7 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate bonds | 470 | (13) | 1574 | (408) | 2044 | (421) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage-backed and asset-backed securities | 29 | (1) | 148 | (23) | 177 | (24) |
|  Total | $710 | $(22) | $3602 | $(1500) | $4312 | $(1522) |

---

The sales of investments in bonds, including non-cash sales from reinsurance transactions, resulted in the following:

---

| | | | |
|:---|:---|:---|:---|
|  | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Proceeds | $**256** | $172 | $492 |
|  Realized gross gains | **2** | 2 | 1 |
|  Realized gross losses | **(5)** | (4) | (10) |

---

For the years ended December 31, 2025 and 2024, realized capital losses include $1 million and $0 million related to bonds that had experienced an other-than-temporary decline in value and were comprised of 1 and 0 securities, respectively.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The Company had no nonadmitted accrued investment income from bonds (unaffiliated) at December 31, 2025 and 2024.

**Affiliate Transactions** 

In 2025, the Company acquired at fair value, certain bonds from an affiliate, John Hancock Reassurance Company Ltd. ("JHRECO"), for $238 million.

In 2024, the Company acquired at fair value, certain bonds from an affiliate, Manulife Reinsurance Bermuda Limited ("MRBL"), for $30 million.

In 2024, the Company acquired at fair value, certain bonds from an affiliate, JHRECO, for $46 million.

**Preferred and Common Stocks** 

Cost and fair value of the Company's investments in preferred and common stocks are summarized as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |<br>**Cost** | **Gross**<br>**Unrealized**<br>**Gains** | **Gross**<br>**Unrealized**<br>**Losses** |<br>**Fair Value** |
| **(in millions)** | | | | |
|  **December 31, 2025:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stocks: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nonaffiliated | $**1** | $**—** | $**(1)** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stocks: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nonaffiliated | **25** | **—** | **(1)** | **24** |
|  Total stocks | $**26** | $**—** | $**(2)** | $**24** |
|  |  | **Gross** | **Gross** |  |
|  |  | **Unrealized** | **Unrealized** |  |
|  | **Cost** | **Gains** | **Losses** | **Fair Value** |
| **(in millions)** |  |  |  |  |
|  **December 31, 2024:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stocks: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nonaffiliated | $8 | $7 | $— | $15 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stocks: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nonaffiliated | 32 |  | (6) | 26 |
|  Total stocks | $40 | $7 | $(6) | $41 |

---

At December 31, 2025 and 2024, there were 5 and 4 nonaffiliated equity securities that had a gross unrealized loss excluding securities that have been written down to zero. The single largest unrealized loss was $1 million and $6 million at December 31, 2025 and 2024, respectively. The Company anticipates that these equity securities will recover in value in the near term.

The Company has a process in place to identify equity securities that could potentially have an impairment that is other-than-temporary. The Company considers relevant facts and circumstances in evaluating whether the impairment of a security is other-than-temporary. Relevant facts and circumstances include (1) the length of time the fair value has been below cost; (2) the financial position of the issuer; and (3) the Company's ability and intent to hold the security until it recovers. To the extent the Company determines that a security is deemed to be other-than-temporarily impaired, the difference between book value and fair value would be charged to income.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

For the years ended December 31, 2025, 2024 and 2023, realized capital losses include $14 million, $0 million, and $0 million related to preferred and common stocks that have experienced an other-than-temporary decline in value and were comprised of 1, 0, and 0 securities, respectively.

**Mortgage Loans on Real Estate** 

At December 31, 2025 and 2024, the mortgage loan portfolio was diversified by geographic region and specific collateral property type as displayed below. The Company controls credit risk through credit approvals, limits, and monitoring procedures.

---

| | |
|:---|:---|
| **December 31, 2025:** | |
| **Property Type** | <br>**Carrying Value** |
| **(in millions)** | |
|  Apartments | $**220** |
|  Industrial | **79** |
|  Office buildings | **91** |
|  Retail | **70** |
|  Agricultural | **—** |
|  Agribusiness | **—** |
|  Mixed use | **—** |
|  Other | **61** |
|  Allowance | **(4)** |
|  Total mortgage loans on real estate | $**517** |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Geographic Concentration** | **Carrying Value** |
| **(in millions)** | |
|  East North Central | $**21** |
|  East South Central | **7** |
|  Middle Atlantic | **125** |
|  Mountain | **9** |
|  New England | **18** |
|  Pacific | **230** |
|  South Atlantic | **51** |
|  West North Central | **19** |
|  West South Central | **41** |
|  Canada / Other | **—** |
|  Allowance | **(4)** |
|  Total mortgage loans on real estate | $**517** |

---

---

| | |
|:---|:---|
| **December 31, 2024:** | |
| **Property Type** | <br>**Carrying Value** |
| **(in millions)** | |
|  Apartments | $228 |
|  Industrial | 80 |
|  Office buildings | 92 |
|  Retail | 92 |
|  Agricultural |  |
|  Agribusiness |  |
|  Mixed use |  |
|  Other | 58 |
|  Allowance | (4) |
|  Total mortgage loans on real estate | $546 |

---

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<br> **Geographic Concentration** | **Carrying Value** |
| **(in millions)** | |
|  East North Central | $24 |
|  East South Central | 8 |
|  Middle Atlantic | 130 |
|  Mountain | 10 |
|  New England | 19 |
|  Pacific | 237 |
|  South Atlantic | 47 |
|  West North Central | 34 |
|  West South Central | 41 |
|  Canada / Other |  |
|  Allowance | (4) |
|  Total mortgage loans on real estate | $546 |

---

At December 31, 2025, the aggregate mortgages outstanding to any one borrower do not exceed $22 million.

During 2025, the respective maximum and minimum lending rates for mortgage loans issued were 6.51% and 5.50% for commercial loans. The Company issued no agricultural loans during 2025 or 2024. The Company issued no purchase money mortgages in 2025 or 2024. At the issuance of a loan, the percentage of any one loan to value of security, exclusive of insured, guaranteed, or purchase money mortgages does not exceed 75.00%. The average recorded investment in impaired loans was $10 million and $6 million at December 31, 2025 and 2024, respectively. The Company recognized $0 million, $0 million, and $0 million of interest income during the period the loans were impaired for the years ended December 31, 2025, 2024 and 2023, respectively.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The following table shows the age analysis of mortgage loans aggregated by type:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Farm** | **Residential** | **Commercial** | **Mezzanine** | **Total** |
| **(in millions)** | | | | | |
|  **December 31, 2025** |  |  |  |  |  |
|  **Recorded Investment** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Current | $**5** | $**—** | $**515** | $**—** | $**520** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30 - 59 Days Past Due | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60 - 89 Days Past Due | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 90 - 179 Days Past Due | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 180 + Days Past Due | **—** | **—** | **—** | **—** | **—** |
|  **Accruing Interest 90-179 Days Past Due** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Recorded Investment | **—** | **—** | **—** | **—** | **—** |
|  **Accruing Interest 180 + Days Past Due** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Recorded Investment | **—** | **—** | **—** | **1** | **1** |
|  **December 31, 2024** |  |  |  |  |  |
|  **Recorded Investment** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Current | $— | $— | $549 | $— | $549 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30 - 59 Days Past Due |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60 - 89 Days Past Due |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 90 - 179 Days Past Due |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 180 + Days Past Due |  |  |  |  |  |
|  **Accruing Interest 90-179 Days Past Due** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Recorded Investment |  |  |  | 1 | 1 |

---

The Company had no recorded investment of mortgage loans 90 to 179 days or 180 days or greater past due still accruing interest or where interest has been reduced in 2025 and 2024. The Company was not a participant or co-lender in a mortgage loan agreement in 2025 and 2024.

Generally, the terms of the restructured mortgage loans call for the Company to receive some form or combination of an equity participation in the underlying collateral, excess cash flows or an effective yield at the maturity of the loans sufficient to meet the original terms of the loans. There are no contractual commitments made to extend credit to debtors owning receivables whose terms have been modified in troubled debt restructurings. The Company accrues interest income on impaired loans to the extent deemed collectible and the loan continues to perform under its original or restructured contractual terms. Interest income on non-performing loans generally is recognized on a cash basis.

For mortgage loans, the Company evaluates credit quality through regular monitoring of credit related exposures, considering both qualitative and quantitative factors in assigning an internal risk rating ("IRR"). These ratings are updated at least annually.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The carrying value of mortgage loans by IRR was as follows:

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions)** | | |
|  AAA | $**—** | $— |
|  AA | **218** | 216 |
|  A | **167** | 198 |
|  BBB | **116** | 117 |
|  BB | **10** | 9 |
|  B and lower and unrated | **6** | 6 |
|  Total | **$517** | $546 |

---

**Real Estate** 

The composition of the Company's investment in real estate is summarized as follows:

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions)** | | |
|  Properties occupied by the company | $**—** | $— |
|  Properties held for the production of income | **137** | 135 |
|  Properties held for sale | **—** | 59 |
|  Less accumulated depreciation | **(34)** | (31) |
|  Total | $**103** | $163 |

---

At December 31, 2024, the Company had one commercial office real estate property held for sale. The Company owns 94% of the commercial real estate held for sale investment and JHLH owns the remaining 6%. Properties that the Company has the intent to sell are reported at the lower of depreciated cost or fair value, net of related obligations. The Company sold the real estate property in December 2025.

The Company recorded $0 million, $88 million, and $0 million of impairments on real estate investments during the years ended December 31, 2025, 2024 and 2023, respectively. The Company has a process in place to identify real estate properties that could potentially have an impairment. The process involves comparing market values to the book value on a quarterly basis, monitors for market value deficiency and applies an undiscounted cash flow test to those properties with market value deficiencies. Impairment losses are recognized in Net realized capital gains (losses) on the Summary of Operations.

**Other Invested Assets** 

The Company had no investments in partnerships or LLCs that exceed 10% of its admitted assets at December 31, 2025 and 2024.

Other invested assets primarily consist of investments in partnerships and LLCs. The Company recorded $0 million, $0 million, and $0 million of impairments on partnerships and LLCs in 2025, 2024, and 2023, respectively. Any impairment is based on significant judgement by the Company in determining whether the objective evidence of other-than-temporary impairment exists. The Company considers relevant facts and circumstances in evaluating whether the impairment of another invested asset is other-than-temporary. Relevant facts and circumstances include (1) the length of time the fair value has been below cost; (2) the financial position of the investee; (3) the Company's ability and intent to hold the other invested asset until it recovers. To the extent the Company determines that an other invested asset is deemed to be other-than-temporarily impaired, the difference between book and fair value would be charged to income.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Other** 

The Company had no exposure to the subprime mortgage related risk at December 31, 2025 and 2024.

At December 31, 2025 and 2024, the Company had an aggregate restricted assets admitted value of $105 million, representing 0.57% of total assets and 0.57% of admitted assets and $152 million, representing 0.84% of total assets and 0.84% of admitted assets, respectively. Refer to the Balance Sheet - Payables for collateral on derivatives and Investments Note – Pledged as Collateral and Repurchase Agreements for further details.

The Company enters into bilateral repurchase agreements for operational funding and to meet short-term liquidity funding requirements. The carrying value of the transferred assets and obligations related to their repurchase, which approximate fair value, are $0 million and $16 million as of December 31, 2025 and 2024, respectively. Securities transferred under the repurchase agreement are classified as NAIC 1 bonds and cash collateral was received. The Company has established a liability to return collateral received as part of the transaction

The Company enters into bilateral reverse repurchase agreements to meet short-term funding requirements and to generate interest income. As of December 31, 2025 and 2024, the Company had $0 million and $16 million of reverse repurchase agreements which are recorded as cash equivalents. The Company has a recognized receivable to return collateral as part of reverse repurchase agreement transaction.

**Net Investment Income and Net Realized and Other Gains (Losses)** 

Major categories of the Company's net investment income are summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Income: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds | $**204** | $191 | $191 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preferred stocks | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Common stocks | **1** | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans on real estate | **22** | 25 | 24 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate | **33** | 35 | 33 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy loans | **12** | 11 | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Cash, cash equivalents and short-term investments | **23** | 23 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other invested assets | **89** | 106 | 90 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives | **13** | 15 | 16 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other income | **(2)** | (2) | (4) |
|  Total investment income | **395** | 406 | 376 |
|  Expenses |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment expenses | **(36)** | (38) | (35) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment taxes, licenses and fees, excluding federal income taxes | **(4)** | (4) | (4) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Investment interest expense | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation on real estate and other invested assets | **(4)** | (6) | (5) |
|  Total investment expenses | **(44)** | (48) | (44) |
|  Net investment income | $**351** | $358 | $332 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

Other invested assets above represent income earned from the Company's investment in JHVTA.

Realized capital gains (losses) and amounts transferred to the IMR are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Years Ended** | **Years Ended** | **Years Ended** |
|  | **December 31,** | **December 31,** | **December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Realized capital gains (losses) | $**1** | $(72) | $9 |
|  Less amount transferred to the IMR (net of related tax benefit (expense) of $1 in 2025, $0 in 2024, and $2 in 2023 | **(4)** | (1) | (7) |
|  Realized capital gains (losses) before tax | **5** | (71) | 16 |
|  Less federal income taxes on realized capital gains (losses) before effect of transfer to the IMR | **7** | 23 | 38 |
|  Net realized capital gains (losses) | $**(2)** | $(94) | $(22) |

---

**Net Negative (Disallowed) IMR** 

At December 31, 2025 and 2024, the Company had no net negative (disallowed) IMR balance.

**6. Derivatives** 

Derivatives are financial contracts, the value of which is derived from underlying interest rates, foreign exchange rates, equity price movements, indices or other market risks arising from on-balance sheet financial instruments and selected anticipated transactions. The Company uses derivatives including swaps and futures agreements to manage current and anticipated exposures to changes in interest rates and equity market prices.

Over-the-counter ("OTC") bilateral swaps are contractual agreements between the Company and a counterparty to exchange a series of cash flows based upon rates applied to a notional amount. For interest rate swaps, counterparties generally exchange fixed or floating interest rate payments based on a notional value in a single currency.

Cleared OTC interest rate swaps are contractual agreements between the Company and a counterparty whereby the transaction must be cleared through a central clearing house, and subject to mandatory margin and reporting requirements.

Futures agreements are contractual obligations to buy or sell a financial instrument or foreign currency on a predetermined future date at a specified price. Futures agreements are contracts with standard amounts and settlement dates that are traded on regulated exchanges.

Options are contractual agreements whereby the holder has the right, but not the obligation, to buy (call option) or sell (put option) a security, exchange rate, interest rate, or other financial instrument at a predetermined price/rate within a specified time.

**Types of Derivatives and Derivative Strategies** 

**Interest Rate Contracts.** The Company uses interest rate futures contracts, OTC interest rate swap agreements and cleared interest rate swap agreements as part of its overall strategies of managing the duration of assets and liabilities or the average life of certain asset portfolios to specified targets. Interest rate swap agreements are contracts with counterparties to exchange interest rate payments of a differing character (i.e., fixed-rate payments exchanged for variable-rate payments) based on an underlying principal balance (notional principal). The net differential to be paid or received on interest rate swap agreements is accrued and recognized as a component of net investment income.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The Company uses interest rate swap agreements in effective fair value hedge accounting relationships. For its fair value hedging relationships, the Company uses interest rate swap agreements to hedge the risk of changes in fair value of existing fixed rate assets and liabilities arising from changes in benchmark interest rates.

The Company uses exchange-traded interest rate futures primarily to hedge mismatches between the duration of assets in a portfolio and the duration of liabilities supported by those assets, to hedge against changes in value of securities the Company owns or anticipates acquiring, and to hedge against changes in interest rates on anticipated liability issuances by replicating U.S. Treasury or swap curve performance. The Company utilizes exchange-traded interest rate futures in other hedging relationships.

**Equity Market Contracts.** Equity index futures contracts are contractual obligations to buy or sell a specified amount of an underlying equity index at an agreed contract price on a specified date. Equity index futures are contracts with standard amounts and settlement dates that are traded on regulated exchanges. The Company utilizes equity index futures in other hedging relationships.

Equity index options are contractual agreements whereby the holder has the right, but not the obligation, to buy (call option) or sell (put option) an underlying equity market index on or before a specified future date at a specified price. The Company utilizes equity index options in other hedging relationships.

The table below provides a summary of the gross notional amount and fair value of derivatives contracts for all derivatives in effective hedge accounting relationships and other hedging relationships:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| **(in millions)** |  |<br>**Notional**<br>**Amount** |<br>**Carrying**<br>**Value Assets** | **Carrying**<br>**Value**<br>**Liabilities** |<br>**Fair Value**<br>**Assets** |<br>**Fair Value**<br>**Liabilities** |
|  **Effective Hedge Accounting Relationships** | **Effective Hedge Accounting Relationships** |  |  |  |  |  |
|  Fair value hedges | Interest rate swaps | $**142** | $**1** | $**—** | $**29** | $**—** |
|  Cash flow hedges | Interest rate swaps | **—** | **—** | **—** | **—** | **—** |
|  **Total Derivatives in Effective Hedge Accounting Relationships** | **Total Derivatives in Effective Hedge Accounting Relationships** | $**142** | $**1** | $**—** | $**29** | $**—** |
|  **Other Hedging Relationships** | **Other Hedging Relationships** |  |  |  |  |  |
|  | Interest rate swaps | $**6482** | $**325** | $**235** | $**325** | $**235** |
|  | Interest rate futures | **24** | **—** | **—** | **—** | **—** |
|  | Equity index options | **138** | **3** | **—** | **3** | **—** |
|  | Equity index futures | **64** | **—** | **—** | **—** | **—** |
|  | Forwards | **—** | **—** | **—** | **—** | **—** |
|  **Total Derivatives in Other Hedging Relationships** | **Total Derivatives in Other Hedging Relationships** | $**6708** | $**328** | $**235** | $**328** | $**235** |
|  **Total Derivatives** |  | $**6850** | $**329** | $**235** | $**357** | $**235** |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
| **(in millions)** |  |<br>**Notional**<br>**Amount** |<br>**Carrying**<br>**Value Assets** | **Carrying**<br>**Value**<br>**Liabilities** |<br>**Fair Value**<br>**Assets** |<br>**Fair Value**<br>**Liabilities** |
|  **Effective Hedge Accounting Relationships** | **Effective Hedge Accounting Relationships** |  |  |  |  |  |
|  Fair value hedges | Interest rate swaps | $142 | $1 | $— | $30 | $— |
|  Cash flow hedges | Interest rate swaps |  |  |  |  |  |
|  **Total Derivatives in Effective Hedge Accounting Relationships** | **Total Derivatives in Effective Hedge Accounting Relationships** | $**142** | $**1** | $**—** | $**30** | $**—** |
|  **Other Hedging Relationships** | **Other Hedging Relationships** |  |  |  |  |  |
|  | Interest rate swaps | $6422 | $349 | $249 | $349 | $249 |
|  | Interest rate futures | 28 |  |  |  |  |
|  | Equity index options | 259 | 3 | 1 | 3 | 1 |
|  | Equity index futures | 47 |  |  |  |  |
|  | Forwards |  |  |  |  |  |
|  **Total Derivatives in Other Hedging Relationships** | **Total Derivatives in Other Hedging Relationships** | $6756 | $352 | $250 | $352 | $250 |
|  **Total Derivatives** |  | $6898 | $353 | $250 | $382 | $250 |

---

**Hedging Relationships** 

The Company does not enter into derivative contracts for speculative purposes. In certain circumstances, these hedges also meet the requirements for hedge accounting and are reported in a manner consistent with the hedged asset or liability. For the years ended December 31, 2025, 2024 and 2023, the Company recorded net unrealized gains/(losses) of $0 million, $0 million, and $0 million, respectively related to derivatives that no longer qualify for hedge accounting.

**Fair Value Hedges.** The Company uses interest rate swaps to manage its exposure to changes in fair value of fixed-rate financial instruments caused by changes in interest rates.

**Derivatives Not Designated as Hedging Instruments (Economic Hedges).** The Company enters into interest rate swap agreements and interest rate futures contracts to manage exposure to interest rates and equity index options to manage equity risk without designating the derivatives as hedging instruments.

The Company has certain variable annuity products with a guaranteed minimum withdrawal benefit ("GMWB"), guaranteed minimum death benefit ("GMDB"), guaranteed minimum income benefit ("GMIB") and retirement plan services ("RPS") –Guaranteed Income for Life ("GIFL") benefit. These guarantees are effectively an embedded option on the basket of mutual funds offered to contract holders. The Company manages a hedging program to reduce its exposure to certain contracts with the GMWB, GMDB, GMIB and RPS GIFL guarantees. This dynamic hedging program uses interest rate swap agreements, equity index futures (including but not limited to the Standard & Poor's 500 ("S&P"), Russell 2000, and MSCI EAFE indices), and U.S. Treasury futures to match the sensitivities of the GMWB, GMDB, GMIB and RPS GIFL liabilities to the market risk factors.

The Company deferred net realized gains (losses) of $0 million , $0 million, and $0 million (including $0 million, $0 million, and $0 million of gains (losses) for derivatives in other hedging relationships) related to interest rates for the years ended December 31, 2025, 2024 and 2023, respectively. Deferred net realized gains (losses) are reported in the IMR and amortized over the remaining period to expiration date.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

For the years ended December 31, 2025, 2024 and 2023 net gains and losses related to derivatives in other hedging relationships were recognized by the Company, and the components were recorded in net unrealized and net realized gains (losses) as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | <br> **Years ended December 31,** | <br> **Years ended December 31,** | <br> **Years ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  **Other Hedging Relationships** |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net unrealized capital gain (loss): |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate swaps | $**(10)** | $(30) | $(33) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate futures | **—** | 2 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options | **1** |  | 5 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index futures | **(2)** | 3 | (3) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Forwards | **—** | 1 | (2) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total net unrealized capital gain (loss) | $**(11)** | $(24) | $(34) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized capital gain (loss): |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate swaps | $**—** | $— | $21 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate futures | **—** |  | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options | **7** | 5 | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index futures | **(7)** | (10) | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Forwards | **—** | (1) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total net realized capital gain (loss) | $**—** | $(6) | $15 |
|  **Total gain (loss) from derivatives in other hedging relationships** | $**(11)** | $(30) | $(19) |

---

**Credit Risk** 

The Company's exposure to loss on derivatives is limited to the amount of any net gains that may have accrued with a particular counterparty. Gross derivative counterparty exposure is measured as the total fair value (including accrued interest) of all outstanding contracts in a gain position excluding any offsetting contracts in negative positions and the impact of collateral on hand. The Company may be exposed to credit-related losses in the event of nonperformance by counterparties to the derivative financial instruments. The current credit exposure of the Company's derivative contracts is limited to the fair value in excess of the collateral held at the reporting date.

The Company manages its credit risk by entering into transactions with creditworthy counterparties, obtaining collateral where appropriate, and entering into master netting agreements that provide for a netting of payments and receipts with a single counterparty. The Company enters into credit support annexes with its OTC derivative dealers in order to manage its credit exposure to those counterparties. As part of the terms and conditions of those agreements, the pledging and accepting of collateral in connection with the Company's derivative usage is required. As of December 31, 2025 and 2024, the Company had accepted collateral consisting of cash of $50 million and $66 million and various securities with a fair value of $109 million and $97 million , respectively, which are held in separate custodial accounts. In addition, the Company has pledged collateral to support both the OTC derivative instruments, exchange traded futures and cleared interest rate swap transactions. For further details regarding pledged collateral see the Investments Note.

Under U.S. regulations, certain interest rate swap agreements are required to be cleared through central clearing houses. These transactions are contractual agreements that require initial and variation margin collateral postings and are settled on a daily basis through a clearing house. As such, they reduce the credit risk exposure in the event of default by a counterparty.

**Financing Premiums** 

The following table presents the Company's aggregate, non-discounted total premium cost for derivative contracts with financing premiums and the premium cost due in each of the following years, and thereafter.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | |
|:---|:---|
| **Fiscal Year** | **Derivative Premium**<br>**Payments Due** |
| **(in millions)** | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2026 | $7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2027 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2028 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2029 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Thereafter |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total Future Settled Premiums | $7 |

---

---

| | | | |
|:---|:---|:---|:---|
|  |<br>**Undiscounted Future**<br>**Premium Commitments** | **Derivative Fair Value**<br>**With Premium**<br>**Commitments** | **Derivative Fair Value**<br>**Excluding Impact of**<br>**Future Settled Premiums** |
| **(in millions)** | | | |
|  Prior Year | $10 | $2 | $12 |
|  Current Year | $7 | $3 | $9 |

---

**7. Fair Value** 

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Financial Instruments Measured at Fair Value and Reported in the Balance Sheet after Initial Recognition –
This category includes assets and liabilities measured at fair value. Financial instruments in this category include common stocks, derivatives, and separate account assets and liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Other Financial Instruments Not Reported at Fair Value After Initial Recognition – This category includes
assets and liabilities as follows:

**Bonds –** For bonds, including corporate debt, U.S. Treasury, commercial and residential mortgage-backed securities, asset-backed securities, collateralized debt obligations, issuances by foreign governments, and obligations of state and political subdivisions, fair values are based on quoted market prices when available. When market prices are not available, fair value is generally estimated using discounted cash flow analyses, incorporating current market inputs for similar financial instruments with comparable terms and credit quality (matrix pricing). The significant inputs into these models include, but are not limited to, yield curves, credit risks and spreads, measures of volatility, and prepayment speeds.

**Mortgage Loans on Real Estate –** The fair value of unimpaired mortgage loans is estimated using discounted cash flows and takes into account the contractual maturities and discount rates, which were based on current market rates for similar maturity ranges and adjusted for risk due to the property type. The fair value of impaired mortgage loans is based on the net of the collateral less estimated cost to obtain and sell. Fair value of commercial mortgages is derived through an internal valuation methodology using both observable and unobservable inputs. Unobservable inputs include credit assumptions and liquidity spread adjustments. Fair value of fixed-rate residential mortgages is determined using the discounted cash flow method. Inputs used for valuation are primarily comprised of prevailing interest rates and prepayment rates, if applicable. Fair value of variable-rate residential mortgages is assumed to be their carrying value.

**Short-Term Investments** – Short-term investments are reported at amortized cost which approximates fair value.

**Policy Loans** – These loans are carried at unpaid principal balances, which approximate their fair values.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Policy Reserves** – Policy reserves consist of guaranteed investment contracts. The fair values associated with these financial instruments are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC's corporate spread. The fair value attributable to credit risk represents the present value of the spread.

**Policyholders' and Beneficiaries' Funds** – Includes term certain contracts and supplementary contracts without life contingencies. The fair values associated with the term certain contracts and supplementary contracts without life contingencies are determined by projecting cash flows and discounting the cash flows at current corporate rates, defined as U.S. Treasury rates plus MFC's corporate spread. The fair value attributable to credit risk represents the present value of the spread. Fair value disclosure is not required for those balances that can be withdrawn by the policyholder at any time without prior notice or penalty. The fair value is the amount estimated to be payable to the policyholder as of the reporting date which is generally the carrying value and provides no additional disclosure value.

**Financial Instruments Measured at Fair Value and Reported in the Balance Sheet after Initial Recognition** 

**Valuation Hierarchy** 

The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Fair value measurements that reflect unadjusted, quoted prices in active markets for
identical assets and liabilities that the Company has the ability to access at the measurement date reflecting market transactions. Level 1 assets primarily include exchange traded equity securities and certain separate account assets.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Fair value measurements using inputs other than quoted prices included within Level 1
that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in inactive markets,
inputs that are observable that are not prices (such as interest rates, credit risks, etc.), and inputs that are derived from or corroborated by observable market data. Also, included in the Level 2 category are certain separate account assets
and liabilities and derivative assets and liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Fair value measurements using significant nonmarket observable inputs. These include
valuations for assets and liabilities that are derived using data, some or all of which is not market observable data, including assumptions about risk. Level 3 securities include less liquid securities such as securities that have little or no
price transparency.

**Determination of Fair Value** 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction (not a forced liquidation or distress sale) between market participants at the measurement date, that is, an exit value.

When available, quoted market prices are used to determine fair value. If quoted market prices are not available, fair value is typically based upon alternative valuation techniques such as discounted cash flows, matrix pricing, consensus pricing services and other techniques. Broker quotes are generally used when external public vendor prices are not available.

The Company has a process in place that includes a review of price movements relative to the market, a comparison of prices between vendors, and a comparison to internal matrix pricing which uses predominately external observable data. Judgement is applied in adjusting external observable data for items including liquidity and credit factors.

The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy:

**Bonds** 

Refer to the previous page for the determination of fair value of bonds. Generally, impaired bonds with a NAIC designation rating of 6 whose cost is greater than its fair value are reported at fair value and are classified within Level 3.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Preferred Stocks** 

Preferred stocks with active markets are classified within Level 1, as fair values are based on quoted market prices. Preferred stocks not traded in active markets are classified within Level 3.

**Common Stocks** 

Common stocks with active markets are classified within Level 1, as fair values are based on quoted market prices. Common stocks not traded in active markets are classified within Level 3.

**Cash and Cash equivalents** 

The carrying values for cash and cash equivalents approximate their fair value due to the short-term maturities of these instruments.

**Derivatives** 

The fair value of derivatives is determined through the use of quoted market prices for exchange-traded derivatives or through the use of pricing models for OTC derivatives. The pricing models used are based on market standard valuation methodologies, and the inputs to these models are consistent with what a market participant would use when pricing the instruments. Derivative valuations can be affected by changes in interest rates, currency exchange rates, financial indices, credit spreads, default risk (including the counterparties to the contract), and volatility. The Company's derivatives are generally classified within Level 2 given the significant inputs to the pricing models for most OTC derivatives are observable or can be corroborated by observable market data. Inputs that are observable generally include interest rates, foreign currency exchange rates, and interest rate curves; however, certain OTC derivatives may rely on inputs that are significant to the fair value, but are unobservable in the market or cannot be derived principally from or corroborated by observable market data and would be classified within Level 3. Inputs that are unobservable generally include broker quotes, volatilities, and inputs that are outside of the observable portion of the interest rate curve or other relevant market measures. These unobservable inputs may involve significant management judgment or estimation.

Even though unobservable, these inputs are based on assumptions deemed appropriate given the circumstances and consistent with what market participants would use when pricing such instruments. The credit risk of both the counterparty and the Company are considered in determining the fair value for all OTC derivatives after taking into account the effects of netting agreements and collateral arrangements.

**Separate Account Assets and Liabilities** 

For separate accounts structured as a unitized fund, the fair value of the separate account assets is based on the fair value of the underlying funds owned by the separate account. Assets owned by the Company's separate accounts consist of investments in mutual funds with values that are based upon quoted market prices or reported net asset values ("NAV"). Open-ended mutual fund investments that are traded in an active market and have a publicly available price are included in Level 1. Investment performance related to separate account assets is fully offset by corresponding amounts credited to contract holders whose interest in the separate account assets is recorded by the Company as separate account liabilities. Separate account liabilities are set equal to the fair value of separate account assets.

The fair value of fund investments is based upon quoted market prices or reported net asset value ("NAV"). Fund investments that are traded in an active market and have a NAV that the Company can access at the measurement date are classified within Level 1. Level 2 assets consist primarily of bonds which are valued using matrix pricing with independent pricing data.

The following table presents the Company's assets and liabilities that are measured and reported at fair value in the Balance Sheets after initial recognition by fair value hierarchy level:

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Carrying**<br>**Value** | **Total Fair**<br>**Value** |<br>**Level 1** |<br>**Level 2** |<br>**Level 3** | **Net Asset**<br>**Value (NAV)** |
| **(in millions)** | | | | | | |
|  **Assets:** |  |  |  |  |  |  |
|  Bond with NAIC 6 rating: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuer credit obligations | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset-backed securities |  |  |  |  |  |  |
|  Total bonds with NAIC 6 rating | **—** | **—** | **—** | **—** | **—** | **—** |
|  Perpetual preferred stocks: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc |  |  |  |  |  |  |
|  Total perpetual preferred stocks | **—** | **—** | **—** | **—** | **—** | **—** |
|  Common stocks: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc | 24 | 24 | 21 |  | 3 |  |
|  Total common stocks | **24** | **24** | **21** | **—** | **3** | **—** |
|  Cash and cash equivalents | **789** | **789** | **130** | **659** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate swaps | **325** | **325** | **—** | **325** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate treasury locks | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate options | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate futures | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency swaps | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency forwards | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency futures | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity total return swaps | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options | **3** | **3** | **—** | **3** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index futures | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Credit default swaps | **—** | **—** | **—** | **—** | **—** | **—** |
|  Total derivatives | **328** | **328** | **—** | **328** | **—** | **—** |
|  Assets held in separate accounts | **8677** | **8677** | **8677** | **—** | **—** | **—** |
|  **Total assets** | $**9818** | $**9818** | $**8828** | $**987** | $**3** | $**—** |
|  **Liabilities:** |  |  |  |  |  |  |
|  Derivatives: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate swaps | $**235** | $**235** | $**—** | $**235** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate treasury locks | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate options | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate futures | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency swaps | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency forwards | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency futures | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity total return swaps | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index futures | **—** | **—** | **—** | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Forward contracts | **—** | **—** | **—** | **—** | **—** | **—** |
|  Total derivatives | **235** | **235** | **—** | **235** | **—** | **—** |
|  Liabilities held in separate accounts | **8677** | **8677** | **8677** | **—** | **—** | **—** |
|  **Total liabilities** | $**8912** | $**8912** | $**8677** | $**235** | $**—** | $**—** |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Carrying**<br>**Value** | **Total Fair**<br>**Value** |<br>**Level 1** |<br>**Level 2** |<br>**Level 3** | **Net Asset**<br>**Value (NAV)** |
| **(in millions)** | | | | | | |
|  Assets: |  |  |  |  |  |  |
|  Bond with NAIC 6 rating: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuer credit obligations | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset-backed securities |  |  |  |  |  |  |
|  Total bonds with NAIC 6 rating |  |  |  |  |  |  |
|  Perpetual preferred stocks: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc | 15 | 15 |  |  | 15 |  |
|  Total perpetual preferred stocks | 15 | 15 |  |  | 15 |  |
|  Common stocks: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc | 26 | 26 | 21 |  | 5 |  |
|  Total common stocks | 26 | 26 | 21 |  | 5 |  |
|  Cash and cash equivalents | 23 | 23 | 23 |  |  |  |
|  Derivatives: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate swaps | 349 | 349 |  | 349 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate treasury locks |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate options |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate futures |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency swaps |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency forwards |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency futures |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity total return swaps |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options | 3 | 3 |  | 3 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index futures |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Credit default swaps |  |  |  |  |  |  |
|  Total derivatives | 352 | 352 |  | 352 |  |  |
|  Assets held in separate accounts | 8460 | 8460 | 8460 |  |  |  |
|  **Total assets** | $8876 | $8876 | $8504 | $352 | $20 | $— |
|  **Liabilities:** |  |  |  |  |  |  |
|  Derivatives: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate swaps | $249 | $249 | $— | $249 | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate treasury locks |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate options |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Interest rate futures |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency swaps |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency forwards |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Foreign currency futures |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity total return swaps |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index options | 1 | 1 |  | 1 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Equity index futures |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Forward contracts |  |  |  |  |  |  |
|  Total derivatives | 250 | 250 |  | 250 |  |  |
|  Liabilities held in separate accounts | 8460 | 8460 | 8460 |  |  |  |
|  **Total liabilities** | $8710 | $8710 | $8460 | $250 | $— | $— |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Fair Value of Financial Instruments Not Reported at Fair Value in the Balance Sheet** 

The table below presents the carrying amounts and fair value by fair value hierarchy level for certain assets and liabilities that are not reported at fair value in the Balance Sheets:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Carrying**<br>**Value** | **Fair**<br>**Value** |<br>**Level 1** |<br>**Level 2** |<br>**Level 3** |
| **(in millions)** | | | | | |
|  **Assets:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds (1) | $6363 | $4968 | $— | $4949 | $19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Redeemable preferred stocks |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans on real estate | 517 | 488 |  |  | 488 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate | 103 | 227 |  |  | 227 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Short-term investments | 14 | 14 |  | 14 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy loans | 234 | 234 |  | 234 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives in effective hedge accounting and RSAT relationships | 1 | 29 |  | 29 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | 7232 | 5960 |  | 5226 | 734 |
|  **Liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consumer notes | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Borrowed money |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy reserves | 63 | 63 |  |  | 63 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholders' and beneficiaries' funds | 117 | 123 |  | 123 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives in effective hedge accounting and RSAT relationships |  |  |  |  |  |
|  **Total liabilities** | $180 | $186 | $— | $123 | $63 |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Carrying** | **Fair** |  |  |  |
|  | **Value** | **Value** | **Level 1** | **Level 2** | **Level 3** |
| **(in millions)** |  |  |  |  |  |
|  **Assets:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bonds (1) | $6284 | $4788 | $— | $4758 | $30 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Redeemable preferred stocks |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortgage loans on real estate | 546 | 493 |  |  | 493 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Real estate | 163 | 290 |  |  | 290 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Short-term investments | 5 | 5 |  | 5 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy loans | 217 | 217 |  | 217 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives in effective hedge accounting and RSAT relationships | 1 | 30 |  | 30 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | 7216 | 5823 |  | 5010 | 813 |
|  **Liabilities:** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consumer notes | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Borrowed money |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policy reserves | 63 | 62 |  |  | 62 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Policyholders' and beneficiaries' funds | 118 | 125 |  | 125 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Derivatives in effective hedge accounting and RSAT relationships |  |  |  |  |  |
|  **Total liabilities** | $181 | $187 | $— | $125 | $62 |

---

(1) Bonds are carried at amortized cost unless they have NAIC designation rating of 6.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Level 3 Financial Instruments** 

The changes in Level 3 financial instruments measured and reported at fair value for the years ended December 31, 2025, 2024 and 2023, are summarized as follows:

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Net realized/unrealized** | **Net realized/unrealized** | | | | | | | | |
|  | | **gains (losses) included** | **gains (losses) included** | | | | | | | | |
|  | | **in:** | **in:** | | | | | | **Transfers** | **Transfers** | |
|  |<br><br>**Balance at**<br>**January**<br>**1, 2025** | **Net**<br>**income**<br>**(1)** |<br>**Surplus** | **Amounts**<br>**credited to**<br>**separate**<br>**account**<br>**liabilities**<br>**(2)** |<br><br><br>**Purchases** |<br><br><br>**Issuances** |<br><br><br>**Sales** |<br><br><br>**Settlements** | **Into**<br>**Level 3**<br>**(3)** |<br>**Out of**<br>**Level 3 (3)** |<br><br>**Balance at**<br>**December 31,**<br>**2025** |
| **(in millions)** | | | | | | | | | | | |
|  Bonds with NAIC 6 rating: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Issuer credit obligations | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp; Asset-backed securities | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** |
|  Total bonds with NAIC 6 rating | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** |
|  Perpetual preferred stocks: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** |
|  Total perpetual preferred stocks | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** |
|  Common stocks: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc | **5** | **(7)** | **5** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **3** |
|  Total common stocks | **5** | **(7)** | **5** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **3** |
|  Net derivatives | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** |
|  Separate account assets/liabilities | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** | **—** |
|  Total | $**5** | $**(7)** | $**5** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**3** |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Net realized/unrealized** | **Net realized/unrealized** | | | | | | | | |
|  | | **gains (losses) included** | **gains (losses) included** | | | | | | | | |
|  | | **in:** | **in:** | | | | | | **Transfers** | **Transfers** | |
|  |<br>**Balance at**<br>**January 1,**<br>**2024** | **Net income**<br>**(1)** |<br>**Surplus** | **Amounts**<br>**credited to**<br>**separate**<br>**account**<br>**liabilities (2)** |<br><br>**Purchases** |<br><br>**Issuances** |<br><br>**Sales** |<br><br>**Settlements** | **Into Level 3**<br>**(3)** | **Out of**<br>**Level 3 (3)** |<br>**Balance at**<br>**December 31,**<br>**2024** |
| **(in millions)** | | | | | | | | | | | |
|  Bonds with NAIC 6 rating: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Issuer credit obligations | $— | $— | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp; Asset-backed securities |  |  |  |  |  |  |  |  |  |  |  |
|  Total bonds with NAIC 6 rating |  |  |  |  |  |  |  |  |  |  |  |
|  Perpetual preferred stocks: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc |  |  |  |  |  |  |  |  |  |  |  |
|  Total perpetual preferred stocks |  |  |  |  |  |  |  |  |  |  |  |
|  Common stocks: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc | 14 |  | (9) |  |  |  |  |  |  |  | 5 |
|  Total common stocks | 14 |  | (9) |  |  |  |  |  |  |  | 5 |
|  Net derivatives | (1) |  | 1 |  |  |  |  |  |  |  |  |
|  Separate account assets/liabilities |  |  |  |  |  |  |  |  |  |  |  |
|  Total | $13 | $— | $(8) | $— | $— | $— | $— | $— | $— | $— | $5 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | | **Net realized/unrealized** | **Net realized/unrealized** | | | | | | | | |
|  | | **gains (losses) included** | **gains (losses) included** | | | | | | | | |
|  | | **in:** | **in:** | | | | | | **Transfers** | **Transfers** | |
|  |<br><br>**Balance at**<br>**January 1,**<br>**2023** |<br>**Net income**<br>**(1)** |<br>**Surplus** | **Amounts**<br>**credited to**<br>**separate**<br>**account**<br>**liabilities**<br>**(2)** |<br><br><br>**Purchases** |<br><br><br>**Issuances** |<br><br><br>**Sales** |<br><br><br>**Settlements** | **Into**<br>**Level 3**<br>**(3)** |<br>**Out of**<br>**Level 3 (3)** |<br><br>**Balance at**<br>**December**<br>**31, 2023** |
| **(in millions)** | | | | | | | | | | | |
|  Bonds with NAIC 6 rating: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Issuer credit obligations | $— | $— | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Asset-backed securities |  |  |  |  |  |  |  |  |  |  |  |
|  Total bonds with NAIC 6 rating |  |  |  |  |  |  |  |  |  |  |  |
|  Perpetual preferred stocks: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc |  |  |  |  |  |  |  |  |  |  |  |
|  Total perpetual preferred stocks |  |  |  |  |  |  |  |  |  |  |  |
|  Common stocks: |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Industrial and misc | 19 |  | (5) |  |  |  |  |  |  |  | 14 |
|  Total common stocks | 19 |  | (5) |  |  |  |  |  |  |  | 14 |
|  Net derivatives |  |  | (1) |  |  |  |  |  |  |  | (1) |
|  Separate account assets/liabilities |  |  |  |  |  |  |  |  |  |  |  |
|  Total | $19 | $— | $(6) | $— | $— | $— | $— | $— | $— | $— | $13 |

---

(1) This amount is included in net realized capital gains (losses) on the Statements of Operations.

(2) Changes in the fair value of separate account assets are credited directly to separate account liabilities in
accordance with NAIC SAP and are not reflected in income.

(3) For financial instruments that are transferred into and/or out of Level 3, the Company uses the fair value
of the instruments at the beginning of the reporting period.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The transfers into Level 3 primarily result from securities that were impaired during the year or securities where a lack of observable market data (versus the previous year) resulted in reclassifying instruments into Level 3. The transfers out of Level 3 primarily result from observable market data becoming available for that instrument, thus eliminating the need to extrapolate market data beyond observable points. Additionally, securities carried at fair value at the beginning of the period but carried at amortized cost at the end of the period due to rating change or change in fair value relative to amortized cost, are included in transfers out of Level 3. Conversely, any securities carried at amortized cost at the beginning of the period and carried at fair value at the end of the year due to Securities Valuation Office ("SVO") rating change or change in fair value relative to amortized cost, are included into transfers into Level 3.

**8. Reinsurance** 

Certain premiums and benefits are assumed from or ceded to affiliate and other insurance companies under various reinsurance agreements. The Company entered into these reinsurance agreements to shift underlying risk on certain of its products, and to improve cash flow and statutory capital. The ceded reinsurance agreements provide the Company with increased capacity to write larger risks and maintain its exposure to loss within its capital resources.

Total reinsurance amounts included in the Company's accompanying statutory-basis financial statements were as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Years ended December 31,** | **Years ended December 31,** | **Years ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums earned |  |  |  |
|  Direct | $**1001** | $1021 | $1007 |
|  Assumed | **102** | 101 | 109 |
|  Ceded | **(226)** | (215) | (197) |
|  Net | $**877** | $907 | $919 |
|  Benefits to policyholders ceded | $**(556)** | $(606) | $(659) |

---

Reserve amounts ceded to reinsurers not authorized in the State of New York are mostly covered by funds withheld assets, letters of credit or trust agreements. Amounts payable or recoverable for reinsurance on policy and contract liabilities are not subject to periodic or maximum limits. At December 31, 2025, any material recoveries were collateralized or settled by the assuming company.

Neither the Company nor any of its related parties control, directly or indirectly, any external reinsurers with whom the Company conducts business. No policies issued by the Company have been reinsured with a foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. The Company does not have any reinsurance agreements in effect under which the reinsurer may unilaterally cancel the agreement. At December 31, 2025, there were no reinsurance agreements in effect such that the amount of losses paid or accrued through the statement date may result in a payment to the reinsurer of amounts which, in aggregate and allowing for offset of mutual credits from other reinsurance agreements with the same reinsurer, exceed the total direct premium collected under the reinsured policies.

As of December 31, 2025, if all reinsurance agreements were cancelled the estimated aggregate reduction in unassigned surplus is $526 million.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The following tables and commentary disclose the reinsurance treaty transactions considered material to the Company.

**Non-Affiliated Reinsurance** 

The table and commentary below consist of the impact of the New York Life ("NYL") Agreements:

---

| | | | |
|:---|:---|:---|:---|
|  | **Years ended December 31,** | **Years ended December 31,** | **Years ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums ceded | $**(43)** | $(42) | $(33) |
|  Premiums assumed | **17** | 17 | 17 |
|  Benefits ceded | **(142)** | (126) | (127) |
|  Benefits assumed | **57** | 50 | 51 |
|  Other reinsurance receivable (payable) | **(5)** | 4 |  |
|  Funds held by or deposited with reinsured companies | **649** | 678 | 703 |

---

Effective July 1, 2015, the Company entered into coinsurance reinsurance agreements with NYL to cede 100% quota share ("QS") of the Company's John Hancock Life Insurance ("JHLICO") Closed Block policies ("NYL 100% Coinsurance"). In addition, NYL agreed to retrocede 40% QS of the same policy risks back to the Company under a coinsurance funds withheld ("FWH") agreement ("NYL 40% FWH Retrocession"). Collectively, these agreements are known as the NYL Agreements. The NYL 100% Coinsurance keeps the assets supporting the JHLICO Closed Block together in NYL, and the NYL 40% FWH Retrocession adjusts the net reinsurance to NYL to 60% of the JHLICO Closed Block policies at risk.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

*The table and commentary below consist of the impact of the Jackson National Life Insurance Company ("Jackson") Agreement:* 

---

| | | | |
|:---|:---|:---|:---|
|  | **Year ended December 31,** | **Year ended December 31,** | **Year ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums ceded, net | $**—** | $— | $— |
|  Benefits ceded, net | **(28)** | (30) | (30) |
|  Funds held by or deposited with reinsured companies | **—** |  |  |
|  Other reinsurance receivable | **3** | 3 | 3 |
|  Other amounts payable on reinsurance | **—** |  |  |

---

Effective January 1, 2019, the Company entered into a coinsurance agreement with Jackson, a wholly-owned subsidiary of Prudential plc, to cede 90% QS of a block of legacy group pay-out annuities. The transaction was structured such that the Company transferred the policy liabilities and related invested assets. Under the terms of the agreement, the Company will maintain responsibility for servicing the policies.

*The table and commentary below consist of the impact of the Global Atlantic Financial Group ("GAFG") Agreement:* 

---

| | | | |
|:---|:---|:---|:---|
|  | **Years ended December 31,** | **Years ended December 31,** | **Years ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums ceded, net | $**—** | $— | $— |
|  Benefits ceded, net | **(72)** | (112) | (126) |
|  Other reinsurance receivable | **6** | 13 | 21 |
|  Other amounts payable on reinsurance | **—** |  |  |

---

Effective July 1, 2012, the Company entered into a coinsurance agreement with GAFG, formerly named Commonwealth Annuity ("CWA"), to cede its fixed deferred annuities at 90% quota share ("QS"). The transaction was structured such that the Company transferred the actuarial liabilities and related invested assets. Under the terms of the agreement, the Company will maintain responsibility for servicing the policies.

*The table and commentary below consist of the impact of the Venerable Holdings, Inc ("Venerable") Agreements:* 

---

| | | | |
|:---|:---|:---|:---|
|  | **Years ended December 31,** | **Years ended December 31,** | **Years ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums ceded, net | $**—** | $— | $(1) |
|  Benefits ceded, net | **(144)** | (147) | (119) |
|  Other reinsurance receivable | **—** |  |  |
|  Other amounts payable on reinsurance | **—** |  | 1 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

On September 30, 2022, the Company entered into a Principal Transaction Agreement with Venerable Holdings, Inc. ("Venerable") to cede 80% QS of a block of the Company's legacy U.S. variable annuity ("VA") policies effective on October 1, 2022. Under the terms of the agreement the Company will retain responsibility for the maintenance of the policies with no intended impact to VA policyholders. The transaction was structured as coinsurance for the general fund liabilities and modified coinsurance for the separate account liabilities. The Company transferred policy liabilities of $98 million and cash paid of $54 million. The Company recorded a pre-tax gain of $44 million and an increase of $35 million to statutory surplus which was deferred and will be amortized over a period of approximately twenty years. The transaction closed on October 3, 2022.

**Affiliated Reinsurance** 

*The table and commentary below consist of the impact of the reinsurance agreements with its parent, JHUSA:* 

---

| | | | |
|:---|:---|:---|:---|
|  | **Years ended December 31,** | **Years ended December 31,** | **Years ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums assumed, net | $**84** | $84 | $92 |
|  Benefits assumed, net | **322** | 307 | 371 |
|  Other reinsurance receivable | **8** | 2 | 6 |
|  Other amounts payable on reinsurance | **27** | 36 | 31 |
|  Funds withheld from unauthorized reinsurers | **—** |  |  |
|  Treaty settlement received (paid) | **(128)** | (130) | (110) |

---

On January 1, 2010, the assets supporting the policyholders who reside in the state of New York ("NY business") were transferred from JHUSA to the Company. The transfer included participating traditional life insurance, universal life insurance, fixed deferred and immediate annuities, participating pension contracts where assets were held in separate accounts, and variable annuities. The NY business was transferred using assumption reinsurance, modified coinsurance and coinsurance with cut-through provisions.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

*The table and commentary below consist of the impact of the reinsurance agreements with an affiliate, Manulife Reinsurance Limited ("MRL"):* 

---

| | | | |
|:---|:---|:---|:---|
|  | **Years ended December 31,** | **Years ended December 31,** | **Years ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Premiums ceded | $**10** | $9 | $9 |
|  Benefits ceded | **(19)** | (16) | (21) |
|  Other reinsurance receivable | **—** |  |  |
|  Other amounts payable on reinsurance | **1** | 1 | 1 |
|  Funds withheld from unauthorized reinsurers | **261** | 284 | 314 |
|  Treaty Settlement received (paid) | **(3)** | (3) | (3) |

---

Effective July 1, 2005, the Company entered into a reinsurance agreement with MRL to reinsure 90% of all risks not already reinsured to third parties on selected single and joint survivorship guaranteed universal life contracts. The agreement is written on a coinsurance FWH basis.

In 2025 and 2024, the Company did not commute any material ceded reinsurance.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**9. Federal Income Taxes** 

The components of the net deferred tax asset/(liability) ("DTA"/"DTL") are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  |<br>**(1)**<br>**Ordinary** |<br>**(2)**<br>**Capital** | **(3)**<br>**(Col 1 + 2)**<br>**Total** |
| **(in millions)** | | | |
| (a) Gross deferred tax assets | $**285** | $**6** | $**291** |
| (b) Statutory valuation allowance adjustments | **—** | **—** | **—** |
| (c) Adjusted gross deferred tax assets (a - b) | **285** | **6** | **291** |
| (d) Deferred tax assets nonadmitted | **105** | **—** | **105** |
| (e) Subtotal net admitted deferred tax asset (c - d) | **180** | **6** | **186** |
| (f) Deferred tax liabilities | **68** | **28** | **96** |
| (g) Net admitted deferred tax asset / (net deferred tax liability) (e - f) | $**112** | $**(22)** | $**90** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  |<br>**(4)**<br>**Ordinary** |<br>**(5)**<br>**Capital** | **(6)**<br>**(Col 4 + 5)**<br>**Total** |
| **(in millions)** | | | |
| (a) Gross deferred tax assets | $282 | $19 | $301 |
| (b) Statutory valuation allowance adjustments |  |  |  |
| (c) Adjusted gross deferred tax assets (a - b) | 282 | 19 | 301 |
| (d) Deferred tax assets nonadmitted | 103 |  | 103 |
| (e) Subtotal net admitted deferred tax asset (c - d) | 179 | 19 | 198 |
| (f) Deferred tax liabilities | 65 | 39 | 104 |
| (g) Net admitted deferred tax asset / (net deferred tax liability) (e - f) | $114 | $(20) | $94 |
|  | **Change** | **Change** | **Change** |
|  | **(7)**<br> **(Col 1 - 4)** | **(8)<br>(Col 2 - 5)** | **(9)**<br> **(Col 7 + 8)** |
|  | **Ordinary** | **Capital** | **Total** |
| **(in millions)** |  |  |  |
| (a) Gross deferred tax assets | $3 | $(13) | $(10) |
| (b) Statutory valuation allowance adjustments |  |  |  |
| (c) Adjusted gross deferred tax assets (a - b) | 3 | (13) | (10) |
| (d) Deferred tax assets nonadmitted | 2 |  | 2 |
| (e) Subtotal net admitted deferred tax asset (c - d) | 1 | (13) | (12) |
| (f) Deferred tax liabilities | 3 | (11) | (8) |
| (g) Net admitted deferred tax asset / (net deferred tax liability) (e - f) | $(2) | $(2) | $(4) |

---

The Company has not recorded a valuation allowance with respect to the realizability of its deferred tax assets. In assessing the need for a valuation allowance, management considered the future reversal of taxable temporary differences, future taxable income exclusive of reversing temporary differences, taxable income in the carry back period, as well as tax planning strategies. Tax planning strategies were considered to the extent they were both prudent and feasible and if implemented, would result in the realization of deferred tax assets. Based on management's assessment of all available information, management believes that it is more likely than not the Company will realize the full benefit of its deferred tax assets.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The amount of adjusted gross deferred tax assets admitted under each component and the resulting increase in deferred tax assets by character are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **(1)<br>Ordinary** | **(2)<br>Capital** | **(3)**<br>**(Col 1 + 2)**<br>**Total** |
| **(in millions)** | | | |
| 2. Admission calculation components SSAP No. 101 |  |  |  |
| (a) Federal income taxes paid in prior years recoverable through loss carrybacks | $**—** | $**5** | $**5** |
| (b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation |  |  |  |
|  (The lesser of 2(b)1 and 2(b)2 below) | **85** | **—** | **85** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date | **85** | **—** | **85** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Adjusted gross deferred tax assets allowed per limitation threshold | **218** | **—** | **218** |
| (c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities | **95** | **1** | **96** |
| (d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c)) | $**180** | $**6** | $**186** |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **(4)<br>Ordinary** | **(5)<br>Capital** | **(6)**<br>**(Col 4 + 5)**<br>**Total** |
| **(in millions)** |  |  |  |
| 2. Admission calculation components SSAP No. 101 |  |  |  |
| (a) Federal income taxes paid in prior years recoverable through loss carrybacks | $— | $18 | $18 |
| (b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation |  |  |  |
|  (The lesser of 2(b)1 and 2(b)2 below) | 75 |  | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date | 75 |  | 75 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Adjusted gross deferred tax assets allowed per limitation threshold | 220 |  | 220 |
| (c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities | 104 | 1 | 105 |
| (d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c)) | $179 | $19 | $198 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | | |
|:---|:---|:---|:---|
|  | **Change** | **Change** | **Change** |
|  | **(7)**<br>**(Col 1 - 4)<br>Ordinary** | **(8)<br>(Col 2 - 5)<br>Capital** | **(9)**<br>**(Col 7 + 8)**<br>**Total** |
| **(in millions)** | | | |
| 2. Admission calculation components SSAP No. 101 |  |  |  |
| (a) Federal income taxes paid in prior years recoverable through loss carrybacks | $— | $(13) | $(13) |
| (b) Adjusted gross deferred tax assets expected to be realized (excluding the amount of deferred tax assets from 2(a) above) after application of the threshold limitation |  |  |  |
|  (The lesser of 2(b)1 and 2(b)2 below) | 10 |  | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted gross deferred tax assets expected to be realized following the Balance Sheet date | 10 |  | 10 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Adjusted gross deferred tax assets allowed per limitation threshold | (2) |  | (2) |
| (c) Adjusted gross deferred tax assets (excluding the amount of deferred tax assets from 2(a) and 2(b) above) offset by gross deferred tax liabilities | (9) |  | (9) |
| (d) Deferred tax assets admitted as the result of application of SSAP No. 101. Total (2(a) + 2(b) + 2(c)) | $1 | $(13) | $(12) |

---

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| **(in millions)** |  |  |
| (a) Ratio percentage used to determine recovery period and threshold limitation amount | **1563%** | 1244% |
| (b) Amount of adjusted capital and surplus used to determine recovery period and threshold limitation in 2(b)2 above | **$1456** | $1464 |

---

Impact of tax planning strategies is as follows:

---

| | | |
|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** |
|  | **(1)<br>Ordinary** | **(2)<br>Capital** |
| **(in millions)** | | |
| (a) Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted Gross DTAs Amount From Note 9A1(c) | $285 | $6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies | 0% | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e) | $180 | $6 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies | 0% | 0% |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | |
|:---|:---|:---|
|  | **December 31, 2024** | **December 31, 2024** |
|  | **(3)<br>Ordinary** | **(4)<br>Capital** |
| **(in millions)** | | |
| (a) Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted Gross DTAs Amount From Note 9A1(c) | $282 | $19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies | 0% | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e) | $179 | $19 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies | 0% | 0% |
|  | **Change** | **Change** |
|  | **(5)**<br>**(Col 1 - 3)<br>Ordinary** | **(6)<br>(Col 2 - 4)<br>Capital** |
| **(in millions)** |  |  |
| (a) Determination of Adjusted Gross Deferred Tax Assets and Net Admitted Deferred Tax Assets by tax character as a percentage |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Adjusted Gross DTAs Amount From Note 9A1(c) | $3 | $(13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Percentage of Adjusted Gross DTAs By Tax Character Attributable To The Impact of Tax Planning Strategies | 0% | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Net Admitted Adjusted Gross DTAs Amount from Note 9A1(e) | $1 | $(13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4. Percentage of Net Admitted Adjusted Gross DTAs by Tax Character Attributable To The Impact of Tax Planning Strategies | 0% | 0% |

---

The Company's tax planning strategies do not include the use of reinsurance.

There are no unrecognized deferred tax liabilities for amounts described in ASC 740-10-25-3.

Current income taxes incurred consist of the following major components:

---

| | | | |
|:---|:---|:---|:---|
|  | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **(1)<br>2025** | **(2)<br>2024** | **(3)**<br>**(Col 1 - 2)<br>Change** |
| **(in millions)** | | | |
| 1. Current income tax |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Federal | $2 | $11 | $(9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Foreign |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Subtotal | 2 | 11 | (9) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Federal income tax expense (benefit) on net capital gains | 7 | 23 | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Utilization of capital loss carryforwards |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Other |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Federal and foreign income taxes incurred | $9 | $34 | $(25) |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31,** | **December 31,** | **December 31,** |
|  | **(1)<br>2025** | **(2)<br>2024** | **(3)**<br>**(Col 1 - 2)<br>Change** |
| **(in millions)** | | | |
| 2. Deferred Tax Assets: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Ordinary: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Discounting of unpaid losses | $**—** | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Unearned premium reserve | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Policyholder reserves | **224** | 211 | 13 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Investments | **1** | 2 | (1) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Deferred acquisition costs | **36** | 36 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) Policyholder dividends accrual | **3** | 3 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(7) Fixed assets | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(8) Compensation and benefits accrual | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(9) Pension accrual | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(10) Receivables - nonadmitted | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(11) Net operating loss carryforward | **4** |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(12) Tax credit carry-forward | **8** | 5 | 3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(13) Other (including items <5% of total ordinary tax assets) | **9** | 25 | (16) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(99) Subtotal | $**285** | $282 | $3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Statutory valuation allowance adjustment | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Nonadmitted | **105** | 103 | 2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) Admitted ordinary deferred tax assets (2a99 - 2b - 2c) | $**180** | $179 | $1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) Capital: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Investments | $**6** | $19 | $(13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Net capital loss carryforward | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Real estate | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Other (including items <5% of total capital tax assets) | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(99) Subtotal | $**6** | $19 | $(13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) Statutory valuation allowance adjustment | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) Nonadmitted | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) Admitted capital deferred tax assets (2e99 - 2f - 2g) | $**6** | $19 | $(13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Admitted deferred tax assets (2d +2h) | $**186** | $198 | $(12) |
| 3. Deferred tax liabilities: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Ordinary: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Investments | $**65** | $62 | $3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Fixed assets | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Deferred and uncollected premium | **1** | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Policyholder reserves | **2** | 2 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Other (including items <5% of total ordinary tax liabilities) | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(99) Subtotal | $**68** | $65 | $3 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Capital: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Investments | $**28** | $39 | $(11) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Real estate | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Other (including items <5% of total capital tax liabilities) | **—** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(99) Subtotal | $**28** | $39 | $(11) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Deferred tax liabilities (3a99 + 3b99) | $**96** | $104 | $(8) |
| 4. Net deferred tax assets/liabilities (2i - 3c) | $**90** | $94 | $(4) |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

The change in net deferred income taxes is comprised of the following:

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31,** | **December 31,** | **December 31,** |
|  | **2025** | **2024** | **Change** |
| **(in millions)** | | | |
|  Total deferred tax assets | $**291** | $301 | $(10) |
|  Total deferred tax liabilities | **96** | 104 | (8) |
|  Net deferred tax assets (liabilities) | $**195** | $197 | $(2) |
|  Tax effect of unrealized gains and losses |  |  | 10 |
|  Tax effect of unrealized foreign exchange gains (losses) |  |  | (1) |
|  Other |  |  | $— |
|  Change in net deferred income taxes |  |  | $(11) |

---

The provision for federal and foreign income taxes incurred is different from that which would be obtained by applying the statutory federal income tax rate of 21% to income before income tax (including realized capital gains). The significant items causing this difference are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **Years Ended December 31,** | **Years Ended December 31,** | **Years Ended December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Ordinary provisions computed at statutory rate | $**7** | $74 | $64 |
|  Net realized capital gains (losses) before IMR at statutory rate | **8** | (4) | (1) |
|  Change in nonadmitted assets | **—** |  |  |
|  Reinsurance | **14** | (12) | (7) |
|  Valuation allowance | **—** |  |  |
|  Tax-exempt income | **—** |  |  |
|  Nondeductible expenses | **—** |  |  |
|  Foreign tax expense gross up | **—** |  |  |
|  Amortization of IMR | **(5)** | (5) | (4) |
|  Tax recorded in surplus | **—** |  |  |
|  Dividend received deduction | **(3)** | (3) | (4) |
|  Investment in subsidiaries | **(1)** | (1) | (1) |
|  Prior year adjustment | **—** |  | (2) |
|  Tax credits | **(2)** | (2) | (1) |
|  Change in tax reserve | **—** |  |  |
|  Pension | **—** |  |  |
|  Tax rate change | **—** |  |  |
|  Other | **2** | 1 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total | $**20** | $48 | $44 |
|  Federal and foreign income taxes incurred | $**2** | $11 | $(32) |
|  Capital gains tax | **7** | 23 | 38 |
|  Change in net deferred income taxes | **11** | 14 | 38 |
|  Total statutory income tax expense (benefit) | $**20** | $48 | $44 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

As of December 31, 2025, the Company had the following carry forwards:

---

| | | | |
|:---|:---|:---|:---|
|  | **Origination Year** | **Expiration Year** | **Amount** |
|  **Net Operating Losses** |  |  |  |
|  | 2025 | N/A | 4 |
|  |  |  | $4 |
|  **General Business Credits** | 2022 | 2042 | 1 |
|  |  |  | $1 |
|  **Foreign Tax Credits** | 2022 | 2032 | 2 |
|  | 2023 | 2033 |  |
|  | 2024 | 2034 | 3 |
|  | 2025 | 2035 | 2 |
|  |  |  | $7 |

---

Federal income taxes incurred on capital gains available for recoupment in the event of future net capital losses were $1 million, $14 million and $6 million for 2025, 2024 and 2023, respectively.

The Company has no deposits under Section 6603 of the Internal Revenue Code.

The Company is included in the consolidated federal income tax return of JHFC with the following entities:

Essex Corporation

Manulife Investment Management Farmland Services Inc.

Guide Financial, Inc.

Manulife Investment Management Agriculture Services Inc.

Manulife Investment Management Forest Management Inc.

Manulife Investment Management Timberland and Agriculture Inc.

JH 575 Rengstorff LLC

JH Hostetler LLC

JH Kearny Mesa 5 LLC

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

JH Kearny Mesa 7 LLC

JH Kearny Mesa 9 LLC

JH Networking Insurance Agency Inc.

JH Ott LLC

JH Tulare 8 LLC

John Hancock Assignment Company

John Hancock Financial Corporation

John Hancock Financial Network Inc.

John Hancock Funding Company LLC

John Hancock Insurance Agency Inc.

Resource Life Insurance Company

John Hancock Life & Health Insurance Company

John Hancock Life Insurance Company (USA)

John Hancock Realty Advisors Inc.

John Hancock Realty Mgt. Inc.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

John Hancock Reassurance Company Ltd.

John Hancock Signature Services Inc.

Manulife Investment Management Timberland and Agriculture GP Inc.

Manulife (Michigan) Reassurance Company

Manulife Reinsurance (Bermuda) Limited

Manulife Reinsurance Limited

Manulife Service Corporation

MCC Asset Management Inc.

PT Timber Inc.

JH Signature Insurance Agency, Inc.

The Manufacturers Investment Corporation

In accordance with the income tax sharing agreements in effect for the applicable tax years, the Company's income tax expense (benefit) is computed as if the Company filed separate federal income tax returns with tax benefits provided for operating losses and tax credits when utilized by the consolidated group. Intercompany settlements of income taxes are made through an increase or reduction to amounts due to or from affiliates. Such settlements occur on a periodic basis in accordance with the tax sharing agreements.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

Taxes receivable from (payable to) JHUSA, are ($8) million and ($34) million at December 31, 2025 and 2024, respectively, and are included in other assets or current federal income taxes payable on the Balance Sheets.

The Company joins in the filing of a consolidated US federal income tax return with its affiliates and also files income tax returns in various state and local jurisdictions. The Company is under continuous examination by the Internal Revenue Service ("IRS"). The IRS completed the audit of tax years 2014-2015 and 2016-2018 with one issue remaining in appeals. The Company accrued a $49 million interest benefit associated with these tax years. The audit of tax years 2019-2021 commenced in September of 2022 and is still open.

A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

---

| | | |
|:---|:---|:---|
|  | **2025** | **2024** |
| **(in millions)** | | |
|  Balance at beginning of year | $**2** | $2 |
|  Additions based on tax positions related to the current year |  |  |
|  Payments |  |  |
|  Additions for tax positions of prior years |  |  |
|  Reductions for tax positions of prior years |  |  |
|  Balance at end of year | $**2** | $2 |

---

Included in the balances as of December 31, 2025 and 2024, are $2 million and $2 million, respectively, of unrecognized benefits that, if recognized, would affect the Company's effective tax rate. Included in the balances as of December 31, 2025 and 2024 are $0 million and $0 million, respectively, of tax positions for which the ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.

The Company has no unrecognized tax benefits that will significantly increase or decrease in the next twelve months.

The Company recognizes interest accrued related to unrecognized tax benefits and penalties in income tax expense in the Statements of Operations. The Company recognized approximately $0 million, $0 million and $0 million of interest expense / (benefit) in each of the years ended December 31, 2025, 2024, and 2023, respectively. The Company had approximately $0 million and $0 million accrued for interest as of December 31, 2025 and 2024, respectively. The Company did not recognize any material penalties for the years ended December 31, 2025, 2024 and 2023.

The Inflation Reduction Act ("Act") was enacted on August 16, 2022, and included a new corporate alternative minimum tax ("CAMT") that goes into effect for tax years beginning after 2022. The Company is a member of a controlled group of corporations whose adjusted financial statement income qualifies it as an "applicable corporation" and therefore subject to CAMT. For the year-ended December 31, 2025, the Company's best estimate of its CAMT liability is zero which is calculated based on all relevant guidance to date. In addition, the company has made an accounting policy election to disregard CAMT when evaluating the need for a valuation allowance on its regular non-CAMT DTA's.

In 2018, the Company updated policy level tax reserves in accordance with the Tax Cuts and Jobs Act and reflected impacts of $24 million in its temporary differences for Actuarial Liabilities in both deferred tax assets and deferred tax liabilities. The transitional deferred tax asset is being amortized into taxable income over 8 years, in the amount of $3 million per year.

On June 20, 2024, Canada enacted the Global Minimum Tax Act, retrospective to fiscal periods commencing on or after December 31, 2023. The Company's ultimate parent, Manulife Financial Corporation ("MFC"), is in scope of this legislation because it is located in Canada and will be required to pay additional Global Minimum Taxes ("GMT") in Canada in respect of its global entities whose effective tax rate is below 15%. MFC's entities will also be subject to GMT in those jurisdictions where a Qualifying Domestic Minimum Top-up Tax ("QDMTT") is in effect. The Company did not incur any expense associated with the GMT in 2025.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**10. Capital and Surplus** 

There are no restrictions placed on the Company's unassigned surplus other than restrictions on dividend payments described below.

Under New York State insurance laws ("NYSIL"), no insurer without the prior approval of the Superintendent, may pay any shareholder dividend in the calendar year immediately following a calendar year for which the insurer's net gain from operations, after tax, not including realized capital gains, was negative. NYSIL also limits the aggregate amount of dividends a life insurer may pay in any calendar year out of positive earned surplus, to the greater of (i) 10% of its statutory policyholders' surplus as of the immediately preceding calendar year or (ii) the Company's statutory net gain from operations, after tax, not including realized capital gains and (losses) for the immediately preceding calendar year, not to exceed 30% of its statutory policyholders' surplus as of the immediately preceding calendar year.

In addition, NYSIL allows for a shareholder dividend even if the company does not have sufficient positive earned surplus, limited to the lesser of (i) 10% of its statutory policyholders' surplus as of the immediately preceding calendar year or (ii) the Company's statutory net gain from operations, after tax, not including realized capital gains and (losses) for the immediately preceding calendar year. The Company paid shareholder dividends of $100 million, $100 million, and $100 million to its parent, JHUSA, in 2025, 2024 and 2023, respectively.

Life/health insurance companies are subject to certain Risk-Based Capital ("RBC") requirements as specified by the NAIC. Under those requirements, the amount of capital and surplus maintained by a life/health insurance company is to be determined based on the various risk factors related to it. As of December 31, 2025 and 2024, based on calculations pursuant to those requirements, the Company's total adjusted capital exceeds the company action level RBC.

**11. Related Party Transactions** 

**Service Agreements** 

The Company has formal service agreements with JHUSA whereby the Company will pay a fee for services received under the agreements which include legal, personnel, marketing, investment accounting, and certain other administrative services and are billed based on intercompany cost allocations or total average daily net assets. Costs incurred under the agreements were $52 million, $49 million, and $49 million at December 31, 2025, 2024 and 2023, respectively. As of December 31, 2025 and 2024, the Company had amounts payable of $10 million and $11 million, respectively.

The Company has an Administrative Service Agreement with JHVTA and John Hancock Investment Management LLC ("JHIM") (formerly John Hancock Advisers, LLC) pursuant to which the Company will provide certain administrative and related functional support services as required by JHVTA and JHIM in connection with variable contracts issued by the Company which provide for investment in selected portfolios of JHVTA and JHIM. For such services, JHVTA and JHIM will pay the Company a quarterly fee equal to a percentage of the average daily net assets of the funds attributable to the contracts issued by the Company. The amount earned under the agreement was $12 million, $12 million and $12 million for the years ended December 31, 2025, 2024 and 2023 respectively.

The Company has an Underwriting and Distribution Agreement with JHD pursuant to which JHD is appointed as the principal underwriter and exclusive distributor of the variable life and other products issued by the Company. For the years ended December 31, 2025, 2024 and 2023, the Company was billed by JHD for underwriting commissions of $29 million, $30 million, and $30 million, respectively. The Company had amounts payable for services provided of $2 million and $2 million at December 31, 2025 and 2024, respectively.

Management believes the allocation methods used are reasonable and appropriate in the circumstances; however, the Company's Balance Sheets and Statements of Operations may not necessarily be indicative of the financial condition that would have existed if the Company operated as an unaffiliated entity.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Other** 

During 2025, 2024 and 2023, respectively, the Company received dividends of $13 million, $15 million, and $16 million from JHVTA. These dividends are included in the Company's net investment income.

The Company did not own any shares of the stock of its parent, JHUSA, or its ultimate parent, MFC, at December 31, 2025 and 2024.

The Company is party to the Third Restated and Amended Liquidity Pool and Loan Facility Agreement effective July 1, 2023, with JHUSA. Pursuant to the agreement, participating affiliates are permitted to invest their excess cash in the liquidity pool and earn interest calculated at a rate that is reset daily to the one-month U.S. Dollar Secured Overnight Financing Rate ("SOFR") less 0.05%, subject to an aggregate limit of $5 billion and an amount not to exceed 10% of the Company's admitted assets as shown in the last financial statement filed with the Insurance Division. As of December 31, 2025, the Company's share of the liquidity pool was $658 million which is included in Cash, Cash equivalents and Short-term investments in the Balance Sheets. As of December 31 2024, the Company had a receivable from JHUSA in the amount of $472 million, which was included in amounts due from affiliates in the Balance Sheets.

The Company did not recognize any impairment write-down for its investment in subsidiaries, controlled or affiliated companies for the years ended December 31, 2025, 2024 and 2023, respectively.

The Company also enters into reinsurance transactions with its affiliates. Refer to the Reinsurance Note for further details.

**12. Commitments, Contingencies and Legal Proceedings** 

*Commitments:* The Company has extended commitments to purchase long-term bonds of $7 million, to purchase other invested assets of $73 million, and issue agricultural and commercial mortgages of $4 million at December 31, 2025. Approximately 35% of these commitments expire in 2025.

Contingencies: As of December 31, 2025, the Company does not have any material contingencies.

*Legal Proceedings:* The Company is regularly involved in litigation, both as a defendant and as a plaintiff. The litigation naming the Company as a defendant ordinarily involves its activities as a provider of insurance protection and wealth management products, and a taxpayer. In addition, the Insurance Department, the New York Attorney General, the Securities and Exchange Commission ("SEC"), the Financial Regulatory Authority, and other government and regulatory bodies regularly make inquiries and, from time to time, require the production of information or conduct examinations concerning the Company's compliance with, among other things, insurance laws, securities laws, and laws governing the activities of broker-dealers. An estimation of the range of potential outcomes in any given matter is often unavailable until such matters have developed and sufficient information emerges to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts, and the progress of settlement negotiations. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation contingencies and updates its accruals and estimates of reasonably possible losses or ranges of loss based on such reviews.

In September 2023, a lawsuit was initiated against the Company in the U.S. District Court of the Southern District of New York as a putative class action on behalf of all current and former owners of universal life insurance policies issued by the Company that state that "cost of insurance ("COI") rates will be based on future expectations that include taxes." The Plaintiff's theory is that the Company impermissibly failed to decrease the COI rates charged to these policy owners after the implementation of the Tax Cuts and Jobs Act of 2018. It is too early in the litigation to offer any reliable opinion about the scope of the class policies that may be at issue or the likely outcome.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**13. Annuity Actuarial Reserves** 

The Company's annuity actuarial reserves and deposit fund liabilities and related separate account liabilities that are subject to discretionary withdrawal (with adjustment), subject to discretionary withdrawal (without adjustment), and not subject to discretionary withdrawal provisions are summarized as follows:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **General<br>Account** | **Separate<br>Account with<br>Guarantees** | **Separate<br>Account<br>Nonguaranteed** | **Total** | **Percent of<br>Total** |
| **(in millions)** | | | | | |
|  Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With fair value adjustment | $**42** | $**—** | $**—** | $**42** | **0%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At book value less current surrender charge of 5% or more | **—** | **—** | **—** | **—** | **0%** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At fair value | **—** | **—** | **8186** | **8186** | **81%** |
|  Total with adjustment or at fair value | **42** | **—** | **8186** | **8228** | **81%** |
|  At book value without adjustment (minimal or no charge or adjustment) | **700** | **—** | **—** | **700** | **7%** |
|  Not subject to discretionary withdrawal | **1204** | **—** | **3** | **1207** | **12%** |
|  Total (gross) | **1946** | **—** | **8189** | **10135** | **100%** |
|  Reinsurance ceded | **827** | **—** | **—** | **827** |  |
|  Total (net) | $1119 | $— | $8189 | $9308 |  |
|  Amount included in book value less current surrender charge above that will move to book value without adjustment in the year after the statement date | $**—** | $**—** | $**—** | $**—** |  |
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **General<br>Account** | **Separate<br>Account with<br>Guarantees** | **Separate<br>Account<br>Nonguaranteed** | **Total** | **Percent of<br>Total** |
| **(in millions)** |  |  |  |  |  |
|  Subject to discretionary withdrawal: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; With fair value adjustment | $39 | $— | $— | $39 | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At book value less current surrender charge of 5% or more | 2 |  |  | 2 | 0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; At fair value |  |  | 8014 | 8014 | 80% |
|  Total with adjustment or at fair value | 41 |  | 8014 | 8055 | 80% |
|  At book value without adjustment (minimal or no charge or adjustment) | 773 |  |  | 773 | 8% |
|  Not subject to discretionary withdrawal | 1239 |  | 4 | 1243 | 12% |
|  Total (gross) | 2053 |  | 8018 | 10071 | 100% |
|  Reinsurance ceded | 900 |  |  | 900 |  |
|  Total (net) | $1153 | $— | $8018 | $9171 |  |
|  Amount included in book value less current surrender charge above that will move to book value without adjustment in the year after the statement date | $1 | $— | $— | $1 |  |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**14. Life Actuarial Reserves** 

The Company's life actuarial reserves and related separate account liabilities that are subject to discretionary withdrawal and not subject to discretionary withdrawal provisions are summarized as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
|  | **Account Value** | **Cash Value** | **Reserve** |
| A. General Account |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies with Cash Value | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Universal Life | **276** | **276** | **284** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Universal Life with Secondary Guarantees | **1369** | **1302** | **3414** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Indexed Universal Life | **—** | **—** | **1** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Indexed Universal Life with Secondary Guarantees | **198** | **185** | **204** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. Indexed Life | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. Other Permanent Cash Value Life Insurance | **2294** | **2294** | **2300** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable Life | **35** | **35** | **12** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable Universal Life | **149** | **148** | **164** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. Miscellaneous Reserves | **—** | **—** | **1155** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies without Cash Value | **—** | **—** | **386** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental Death Benefits | **—** | **—** | **1** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability - Active Lives | **—** | **—** | **4** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability - Disabled Lives | **—** | **—** | **23** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous Reserves | **—** | **—** | **19** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | $**4321** | $**4240** | $**7967** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance Ceded | **1514** | **1509** | **2394** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) - (4) | $**2807** | $**2731** | $**5573** |
| B. Separate Account with Guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable Life | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable Universal Life | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies without Cash Value | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental Death Benefits | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability - Active Lives | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability - Disabled Lives | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous Reserves | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | $**—** | $**—** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance Ceded | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) - (4) | $**—** | $**—** | $**—** |
| C. Separate Account Nonguaranteed |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable Life | $**12** | $**12** | $**—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable Universal Life | **502** | **495** | **479** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies without Cash Value | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental Death Benefits | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability - Active Lives | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability - Disabled Lives | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous Reserves | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | $**514** | $**507** | $**479** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance Ceded | **—** | **—** | **—** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) - (4) | $**514** | $**507** | $**479** |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31, 2024** | **December 31, 2024** | **December 31, 2024** |
|  | **Account Value** | **Cash Value** | **Reserve** |
| A. General Account |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies with Cash Value | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Universal Life | 274 | 274 | 280 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Universal Life with Secondary Guarantees | 1373 | 1284 | 3310 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Indexed Universal Life |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Indexed Universal Life with Secondary Guarantees | 180 | 166 | 181 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. Indexed Life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. Other Permanent Cash Value Life Insurance | 2385 | 2385 | 2387 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable Life | 36 | 36 | 12 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable Universal Life | 146 | 146 | 158 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. Miscellaneous Reserves |  |  | 1106 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies without Cash Value |  |  | 401 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental Death Benefits |  |  | 1 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability - Active Lives |  |  | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability - Disabled Lives |  |  | 26 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous Reserves |  |  | 18 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | $4394 | $4291 | $7885 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance Ceded | 1589 | 1582 | 2483 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) - (4) | $2805 | $2709 | $5402 |
| B. Separate Account with Guarantees |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable Life | $— | $— | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable Universal Life |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies without Cash Value |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental Death Benefits |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability - Active Lives |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability - Disabled Lives |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous Reserves |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance Ceded |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) - (4) |  |  |  |
| C. Separate Account Nonguaranteed |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) Subject to discretionary withdrawal, surrender values, or policy loans: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Variable Life | $12 | $12 | $— |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Variable Universal Life | 456 | 446 | 431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) Not subject to discretionary withdrawal or no cash values |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. Term Policies without Cash Value |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. Accidental Death Benefits |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. Disability - Active Lives |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. Disability - Disabled Lives |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. Miscellaneous Reserves |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) Total (gross: direct + assumed) | $468 | $458 | $431 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4) Reinsurance Ceded |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(5) Total (net) (3) - (4) | $468 | $458 | $431 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**Death-related premium provisions** 

Certain life insurance contracts issued by the Company provide that deferred fractional premiums are not deducted from the amount otherwise payable and that premium paid beyond the date of death is returned, as applicable under the contract terms.

At December 31, 2025 and 2024, reserves for deferred fractional premiums and return of premium were $24 million and $26 million, respectively.

**Contract for which gross premiums are less than net premiums** 

The Company has certain life insurance contracts in force for which gross premiums are less than net premiums under the applicable statutory valuation basis.

At December 31, 2025 and 2024, the amount of insurance in force subject to this condition was $6,435 million and $6,434 million, respectively, and the related reserves were $342 million and $353 million, respectively.

**Deferred and uncollected premiums** 

At December 31, 2025 and 2024, deferred and uncollected life insurance premiums and annuity considerations were $4 million and $5 million, respectively, with no gross amount reported.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**15. Separate Accounts** 

Separate accounts held by the Company include individual and group variable annuity and variable life products that offer guaranteed and non-guaranteed returns. The net investment experience of the separate account is credited directly to the policyholder and can be positive or negative.

For guarantees of amounts in the event of death, the net amount at risk is defined as the excess of the initial sum insured over the current sum insured for fixed premium variable life insurance contracts, and, for other variable life insurance contracts, is equal to the sum insured when the account value is zero and the policy is still in force.

The deposits related to variable annuities generally provide a GMDB. For annuity products, this can take the form of either (a) return of no less than total deposits made to the contract less any partial withdrawals; (b) total deposits made to the contract less any partial withdrawals plus a minimum return; (c) the highest contract value on a specified anniversary date minus any withdrawals following the contract anniversary; or (d) a combination benefit of (b) and (c) above. The assets and liabilities of these accounts are carried at fair value. The GMDB reserve is held in the Company's general account policy reserves.

Contracts with GMIB provides a guaranteed lifetime annuity which may be elected by the contract holder after a stipulated waiting period (ten years), and which may be larger than what the contract account balance could purchase at then-current annuity purchase rates.

Multiple variations of an optional GMWB rider have also been offered by the Company. The GMWB rider provides contract holders a guaranteed annual withdrawal amount over a specified time period or in some cases for as long as they live. In general, guaranteed annual withdrawal amounts are based on deposits and may be reduced if withdrawals exceed allowed amounts. Guaranteed amounts may also be increased as a result of "step-up" provisions which increase the benefit base to higher account values at specified intervals. Guaranteed amounts may also be increased if withdrawals are deferred over a specified period. In addition, certain versions of the GMWB rider extend lifetime guarantees to spouses.

Unaffiliated reinsurance has been utilized to mitigate risk related to some of the guarantee benefit riders. Hedging has also been utilized to mitigate risk related to some of the GMWB riders.

For GMDB, the net amount at risk is defined as the current guaranteed minimum death benefit in excess of the current account balance. For GMIB, the net amount at risk is defined as the excess of the current annuitization income base over the current account value. For GMWB, the net amount at risk is defined as the excess of the current guaranteed withdrawal amount over the current account value. For all the guarantees, the net amount at risk is floored at zero at the single contract level.

The deposits related to the variable life insurance contracts are invested in separate accounts and the Company guarantees a specified death benefit if certain specified premiums are paid by the policyholder, regardless of separate account performance.

All of the Company's separate account assets were legally insulated at December 31, 2025 and 2024. The assets legally insulated from the general account are attributed to the following products/transactions:

---

| | | |
|:---|:---|:---|
| **Product/Transaction** | | |
|  | **December 31,** | **December 31,** |
| **(in millions)** | **2025** | **2024** |
|  Group Annuity Contracts (401K) | $**6293** | $6102 |
|  Variable and Fixed Annuities | **1899** | 1919 |
|  Life Insurance | **485** | 439 |
|  Total | $**8677** | $8460 |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

To compensate the general account for the risk taken, the separate account paid risk charges and amounts toward separate account guarantees as follows:

---

| | | |
|:---|:---|:---|
|  | **Risk Charges Paid to<br>General Account** | **Amounts toward<br>Separate Account<br>Guarantees** |
| **(in millions)** | | |
| 2025 | $10 | $9 |
| 2024 | $11 | $6 |
| 2023 | $11 | $6 |
| 2022 | $12 | $6 |
| 2021 | $12 | $3 |

---

The Company had the following variable annuities with guaranteed benefits:

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions, except for ages)** | | |
|  Account value | $**1896** | $1717 |
|  Amount of reserve held | **41** | 62 |
|  Net amount at risk - gross | **197** | 342 |
|  Weighted average attained age | **75** | 74 |

---

The following assumptions and methodology were used to determine the amounts above at December 31, 2025 and 2024:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reg 213 is used in both years to determine the aggregate reserve for the variable annuity products.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Reg 213 prescribes an Economic Scenario Generator ("ESG") for stochastic fund returns and stochastic
interest rate scenarios to be used for valuation but allows for proprietary generators to be used. Starting with year 2026 the company will no longer use a proprietary scenario generator. The company will comply with the requirements of Reg 213 by
using the prescribed economic scenarios and following prescribed procedures for deriving corporate yields.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In 2025 and 2024, annuity mortality is based on the Ruark Variable Annuity Table, which is based on an industry
study of variable annuity deaths. The table is further adjusted by factors varied by rider types (living benefit/GMDB only) and qualified and non-qualified business.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• In 2025 and 2024, annuity base lapse rates vary by product, policy year, and rider type, where the lapse rates
are prescribed under the New York Special Considerations Letter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• For variable annuities, the applicable swap curve at December 31 is used for discounting in both years.

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

Account balances of variable contracts with guarantees were invested in separate accounts with the following characteristics:

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| (in millions) |  |  |
|  Type of Fund |  |  |
|  Equity | $**1465** | $1253 |
|  Balanced | **570** | 560 |
|  Bonds | **214** | 216 |
|  Money Market | **9** | 10 |
|  Total | $**2258** | $2039 |

---

Information regarding the nonguaranteed separate accounts of the Company is as follows:

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions)** | | |
|  Premiums, deposits and other considerations | $**794** | $794 |
|  Reserves for accounts with assets at: |  |  |
|  Fair value | **8668** | 8448 |
|  Amortized cost | **—** |  |
|  Total | $**8668** | $8448 |

---

---

| | | |
|:---|:---|:---|
|  | **December 31,** | **December 31,** |
|  | **2025** | **2024** |
| **(in millions)** | | |
|  Reserves for separate accounts by withdrawal characteristics: |  |  |
|  Subject to discretionary withdrawal: |  |  |
|  With fair value adjustment | $**—** | $— |
|  At book value without fair value adjustments and with current surrender charge of 5% or more | **39** | 44 |
|  At fair value | **8582** | 8344 |
|  At book value without fair value adjustments and with current surrender charge of less than 5% | **44** | 56 |
|  Subtotal | **8665** | 8444 |
|  Not subject to discretionary withdrawal | **3** | 4 |
|  Total | $**8668** | $8448 |

---

Amounts transferred to and from separate accounts are as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | **December 31,** | **December 31,** | **December 31,** |
|  | **2025** | **2024** | **2023** |
| **(in millions)** | | | |
|  Transfers to separate accounts | $**853** | $859 | $801 |
|  Transfers from separate accounts | **1775** | 1396 | 1227 |
|  Net transfers to (from) separate accounts | $**(922)** | $(537) | $(426) |

---

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE COMPANY OF NEW YORK** 

**NOTES TO STATUTORY-BASIS FINANCIAL STATEMENTS** 

**16. Subsequent Events** 

The Company evaluated the recognition and disclosure of subsequent events for its December 31, 2025 financial statements through April 8, 2026, the date the financial statements were issued. The Company did not have any subsequent events requiring disclosure.

------

##### [**Table of Contents**](#toc)
A U D I T E D F I N A N C I A L S T A T E M E N T S

JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK

SEPARATE ACCOUNT A

December 31, 2025

1 of 71

------

##### [**Table of Contents**](#toc)
JOHN HANCOCK LIFE INSURANCE CO OF

NEW YORK SEPARATE ACCOUNT A

Audited Financial Statements

December 31, 2025

**Contents** 

---

| | |
|:---|:---|
|  [Report of Independent Registered Public Accounting Firm](#afins51109_1) | 3 |
|  [Statements of Assets and Liabilities](#afins51109_2) | 6 |
|  [Statements of Operations and Changes in Contract Owners' Equity](#afins51109_3) | 23 |
|  [Notes to Financial Statements](#afins51109_4) | 56 |

---

2 of 71

------

##### [**Table of Contents**](#toc)
Report of Independent Registered Public Accounting Firm

To the Board of Directors of John Hancock Life Insurance Company of New York and Contract Owners of JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A.

**Opinion on the Financial Statements** 

We have audited the accompanying statements of assets and liabilities of each of the subaccounts listed in the Appendix that comprise JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A (the Separate Account) as of December 31, 2025, and the related statements of operations and changes in contract owners' equity for the two years in the period then ended, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of each subaccount as of December 31, 2025, and the results of its operations and changes in contract owners' equity for each of the two years then ended, in conformity with U.S. generally accepted accounting principles.

**Basis for Opinion** 

These financial statements are the responsibility of the Separate Account's management. Our responsibility is to express an opinion on each of the subaccounts' financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with respect to the Separate Account in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our procedures included confirmation of securities owned as of December 31, 2025, by correspondence with the fund companies or their transfer agents, as applicable. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

![LOGO](g51109dsp001.jpg)

We have served as the auditor of the Separate Account since 1996.

Boston, Massachusetts

April 15, 2026

3 of 71

------

##### [**Table of Contents**](#toc)
Appendix

Subaccounts comprising

JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; 500 Index Fund Series I | International Small Company Trust Series I |
| &nbsp;&nbsp;&nbsp; 500 Index Fund Series II | International Small Company Trust Series II |
| &nbsp;&nbsp;&nbsp; 500 Index Fund Series NAV | Investment Quality Bond Trust Series I |
| &nbsp;&nbsp;&nbsp; Active Bond Trust Series I | Investment Quality Bond Trust Series II |
| &nbsp;&nbsp;&nbsp; Active Bond Trust Series II | Lifestyle Balanced Portfolio Series I |
| &nbsp;&nbsp;&nbsp; American Asset Allocation Trust Series I | Lifestyle Balanced Portfolio Series II |
| &nbsp;&nbsp;&nbsp; American Asset Allocation Trust Series II | Lifestyle Conservative Portfolio Series I |
| &nbsp;&nbsp;&nbsp; American Global Growth Trust Series II | Lifestyle Conservative Portfolio Series II |
| &nbsp;&nbsp;&nbsp; American Global Growth Trust Series III | Lifestyle Growth Portfolio Series I |
| &nbsp;&nbsp;&nbsp; American Growth Trust Series II | Lifestyle Growth Portfolio Series II |
| &nbsp;&nbsp;&nbsp; American Growth Trust Series III | Lifestyle Growth Portfolio Series NAV |
| &nbsp;&nbsp;&nbsp; American Growth-Income Trust Series I | Lifestyle Moderate Portfolio Series I |
| &nbsp;&nbsp;&nbsp; American Growth-Income Trust Series II | Lifestyle Moderate Portfolio Series II |
| &nbsp;&nbsp;&nbsp; American Growth-Income Trust Series III | Managed Volatility Balanced Portfolio Series I |
| &nbsp;&nbsp;&nbsp; American International Trust Series II | Managed Volatility Balanced Portfolio Series II |
| &nbsp;&nbsp;&nbsp; American International Trust Series III | Managed Volatility Conservative Portfolio Series I |
| &nbsp;&nbsp;&nbsp; Blue Chip Growth Trust Series I | Managed Volatility Conservative Portfolio Series II |
| &nbsp;&nbsp;&nbsp; Blue Chip Growth Trust Series II | Managed Volatility Growth Portfolio Series I |
| &nbsp;&nbsp;&nbsp; Capital Appreciation Value Trust Series II | Managed Volatility Growth Portfolio Series II |
| &nbsp;&nbsp;&nbsp; Core Bond Trust Series I | Managed Volatility Moderate Portfolio Series I |
| &nbsp;&nbsp;&nbsp; Core Bond Trust Series II | Managed Volatility Moderate Portfolio Series II |
| &nbsp;&nbsp;&nbsp; Disciplined Value Emerging Markets Value Trust Series II | Mid Cap Growth Trust Series I |
| &nbsp;&nbsp;&nbsp; Disciplined Value International Trust Series I | Mid Cap Growth Trust Series II |
| &nbsp;&nbsp;&nbsp; Disciplined Value International Trust Series II | Mid Cap Index Trust Series I |
| &nbsp;&nbsp;&nbsp; Equity Income Trust Series I | Mid Cap Index Trust Series II |
| &nbsp;&nbsp;&nbsp; Equity Income Trust Series II | Mid Value Trust Series I |
| &nbsp;&nbsp;&nbsp; Financial Industries Trust Series I | Mid Value Trust Series II |
| &nbsp;&nbsp;&nbsp; Financial Industries Trust Series II | Money Market Trust Series I |
| &nbsp;&nbsp;&nbsp; Fundamental All Cap Core Trust Series II | Money Market Trust Series II |
| &nbsp;&nbsp;&nbsp; Fundamental Large Cap Value Trust Series I | Money Market Trust Series NAV |
| &nbsp;&nbsp;&nbsp; Fundamental Large Cap Value Trust Series II | Opportunistic Fixed Income Trust Series I |
| &nbsp;&nbsp;&nbsp; Global Equity Trust Series I | Opportunistic Fixed Income Trust Series II |
| &nbsp;&nbsp;&nbsp; Global Equity Trust Series II | Real Estate Securities Trust Series I |
| &nbsp;&nbsp;&nbsp; Health Sciences Trust Series I | Real Estate Securities Trust Series II |
| &nbsp;&nbsp;&nbsp; Health Sciences Trust Series II | Science & Technology Trust Series I |
| &nbsp;&nbsp;&nbsp; High Yield Trust Series I | Science & Technology Trust Series II |
| &nbsp;&nbsp;&nbsp; High Yield Trust Series II | Select Bond Trust Series I |
| &nbsp;&nbsp;&nbsp; International Equity Index Series I | Select Bond Trust Series II |
| &nbsp;&nbsp;&nbsp; International Equity Index Series II | Short Term Government Income Trust Series I |
| &nbsp;&nbsp;&nbsp; International Equity Index Series NAV | Short Term Government Income Trust Series II |

---

4 of 71

------

##### [**Table of Contents**](#toc)
Appendix

Subaccounts comprising

JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp; Small Cap Core Trust Series II | Strategic Income Opportunities Trust Series II |
| &nbsp;&nbsp;&nbsp; Small Cap Index Trust Series I | Total Bond Market Series Trust NAV |
| &nbsp;&nbsp;&nbsp; Small Cap Index Trust Series II | Total Bond Market Trust Series II |
| &nbsp;&nbsp;&nbsp; Small Cap Opportunities Trust Series I | Total Stock Market Index Trust Series I |
| &nbsp;&nbsp;&nbsp; Small Cap Opportunities Trust Series II | Total Stock Market Index Trust Series II |
| &nbsp;&nbsp;&nbsp; Small Cap Stock Trust Series II | U.S. Growth Trust - Series I |
| &nbsp;&nbsp;&nbsp; Small Company Value Trust Series I | U.S. Growth Trust - Series II |
| &nbsp;&nbsp;&nbsp; Small Company Value Trust Series II | Ultra Short Term Bond Trust Series II |
| &nbsp;&nbsp;&nbsp; Strategic Income Opportunities Trust Series I |  |

---

5 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>500 Index Fund<br>Series I | $nan<br>500 Index Fund <br>Series II | $nan<br>500 Index Fund <br>Series NAV | $nan<br>Active Bond Trust <br>Series I | $nan<br>Active Bond Trust <br>Series II | $nan<br>American Asset<br> Allocation Trust <br>Series I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $18143230 | $22608486 | $7211046 | $537776 | $15699371 | $5241147 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $18051578 | $22568925 | $7211046 | $528431 | $15681346 | $5221445 |
|  Contracts in payout (annuitization) | 91652 | 39561 |  | 9345 | 18025 | 19702 |
|  Total net assets | $18143230 | $22608486 | $7211046 | $537776 | $15699371 | $5241147 |
|  Units outstanding | 296138 | 384219 | 121580 | 26056 | 806630 | 149535 |
|  Unit value | $61.27 | $58.84 | $59.31 | $20.64 | $19.46 | $35.05 |
|  Shares | 260566 | 324928 | 103547 | 64404 | 1875672 | 506391 |
|  Cost | $9581595 | $13995316 | $4381206 | $598296 | $17102622 | $5441463 |

---

*See accompanying notes.* 

6 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>American Asset<br> Allocation Trust <br>Series II | $nan<br>American Global<br>Growth Trust Series<br>II | $nan<br>American Global<br>Growth Trust Series<br>III | $nan<br>American Growth <br>Trust Series II | $nan<br>American Growth <br>Trust Series III | $nan<br>American Growth-<br>Income Trust Series<br>I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $52648179 | $7462221 | $5540 | $78108752 | $385141 | $6859246 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $52619299 | $7385675 | $5540 | $77978949 | $385141 | $6795365 |
|  Contracts in payout (annuitization) | 28880 | 76546 |  | 129803 |  | 63881 |
|  Total net assets | $52648179 | $7462221 | $5540 | $78108752 | $385141 | $6859246 |
|  Units outstanding | 1566714 | 166743 | 96 | 658757 | 4173 | 82061 |
|  Unit value | $33.60 | $44.75 | $57.71 | $118.57 | $92.29 | $83.59 |
|  Shares | 5081871 | 472592 | 346 | 3913264 | 18898 | 361965 |
|  Cost | $54565848 | $7022225 | $5325 | $61843774 | $311592 | $5850813 |

---

*See accompanying notes.* 

7 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>American Growth-<br>Income Trust Series<br>II | $nan<br>American Growth-<br>Income Trust Series<br>III | $nan<br>American<br> International Trust <br>Series II | $nan<br>American<br> International Trust <br>Series III | $nan<br>Blue Chip Growth <br>Trust Series I | $nan<br>Blue Chip Growth <br>Trust Series II |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $67458392 | $470723 | $29615914 | $196345 | $27747239 | $15677463 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $67328223 | $470723 | $29560836 | $196345 | $27578389 | $15673780 |
|  Contracts in payout (annuitization) | 130169 |  | 55078 |  | 168850 | 3683 |
|  Total net assets | $67458392 | $470723 | $29615914 | $196345 | $27747239 | $15677463 |
|  Units outstanding | 900165 | 7163 | 801804 | 8320 | 186649 | 152808 |
|  Unit value | $74.94 | $65.72 | $36.94 | $23.60 | $148.66 | $102.60 |
|  Shares | 3590122 | 24919 | 1602593 | 10688 | 806137 | 506869 |
|  Cost | $55621596 | $386732 | $25690931 | $170865 | $24242478 | $13270757 |

---

*See accompanying notes.* 

8 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Capital<br>Appreciation Value<br>Trust Series II | $nan<br>Core Bond Trust <br>Series I | $nan<br>Core Bond Trust <br>Series II | $nan<br>Disciplined Value<br>Emerging Markets<br>Value Trust Series<br>II | $nan<br>Disciplined Value<br> International Trust <br>Series I | $nan<br>Disciplined Value<br> International Trust <br>Series II |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $16033537 | $4637058 | $4713471 | $2806265 | $3340085 | $5287060 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $16033537 | $4632538 | $4710319 | $2801182 | $3319195 | $5285042 |
|  Contracts in payout (annuitization) |  | 4520 | 3152 | 5083 | 20890 | 2018 |
|  Total net assets | $16033537 | $4637058 | $4713471 | $2806265 | $3340085 | $5287060 |
|  Units outstanding | 355236 | 262134 | 288459 | 170941 | 95143 | 141154 |
|  Unit value | $45.13 | $17.69 | $16.34 | $16.42 | $35.11 | $37.46 |
|  Shares | 1349624 | 408912 | 416384 | 228709 | 185767 | 294708 |
|  Cost | $15654531 | $5132586 | $5185823 | $2143015 | $2498206 | $4033046 |

---

*See accompanying notes.* 

9 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Equity Income <br>Trust Series I | $nan<br>Equity Income <br>Trust Series II | $nan<br>Financial Industries<br>Trust Series I | $nan<br>Financial Industries<br>Trust Series II | $nan<br>Fundamental All <br>Cap Core Trust<br>Series II | $nan<br>Fundamental Large <br>Cap Value Trust<br>Series I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $18734182 | $12293816 | $766166 | $1865151 | $4468503 | $22831969 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $18511035 | $12289657 | $766144 | $1865151 | $4468503 | $22518343 |
|  Contracts in payout (annuitization) | 223147 | 4159 | 22 |  |  | 313626 |
|  Total net assets | $18734182 | $12293816 | $766166 | $1865151 | $4468503 | $22831969 |
|  Units outstanding | 189809 | 258673 | 18065 | 42827 | 48491 | 347889 |
|  Unit value | $98.70 | $47.53 | $42.41 | $43.55 | $92.15 | $65.63 |
|  Shares | 1422489 | 944951 | 51283 | 126709 | 147768 | 847827 |
|  Cost | $19461426 | $12888570 | $647601 | $1519521 | $4076265 | $19463169 |

---

*See accompanying notes.* 

10 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Fundamental Large<br>Cap Value Trust<br>Series II | $nan<br>Global Equity Trust<br>Series I | $nan<br>Global Equity Trust<br>Series II | $nan<br>Health Sciences <br>Trust Series I | $nan<br>Health Sciences <br>Trust Series II | $nan<br>High Yield Trust <br>Series I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $20064925 | $5947401 | $3358587 | $3128959 | $5356232 | $1065868 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $20040668 | $5911978 | $3350294 | $3121097 | $5335751 | $1056409 |
|  Contracts in payout (annuitization) | 24257 | 35423 | 8293 | 7862 | 20481 | 9459 |
|  Total net assets | $20064925 | $5947401 | $3358587 | $3128959 | $5356232 | $1065868 |
|  Units outstanding | 342079 | 99633 | 97921 | 25552 | 46445 | 37082 |
|  Unit value | $58.66 | $59.69 | $34.30 | $122.45 | $115.32 | $28.74 |
|  Shares | 735788 | 246269 | 140468 | 135277 | 281315 | 222985 |
|  Cost | $17543675 | $4787071 | $2918503 | $3493957 | $6115463 | $1110226 |

---

*See accompanying notes.* 

11 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>High Yield Trust <br>Series II | $nan<br>International Equity<br>Index Series I | $nan<br>International Equity<br>Index Series II | $nan<br>International Equity<br>Index Series NAV | $nan<br>International Small <br>Company Trust<br>Series I | $nan<br>International Small <br>Company Trust<br>Series II |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $2477480 | $835346 | $3099362 | $848320 | $1287522 | $1588083 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $2466088 | $835346 | $3090559 | $848320 | $1278193 | $1588011 |
|  Contracts in payout (annuitization) | 11392 |  | 8803 |  | 9329 | 72 |
|  Total net assets | $2477480 | $835346 | $3099362 | $848320 | $1287522 | $1588083 |
|  Units outstanding | 85989 | 33486 | 129414 | 43139 | 40613 | 52643 |
|  Unit value | $28.81 | $24.95 | $23.95 | $19.66 | $31.70 | $30.17 |
|  Shares | 501514 | 34012 | 126093 | 34555 | 80370 | 99379 |
|  Cost | $2500560 | $625847 | $2255656 | $598514 | $1030164 | $1278796 |

---

*See accompanying notes.* 

12 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Investment Quality<br> Bond Trust Series I | $nan<br>Investment Quality<br> Bond Trust Series II | $nan<br>Lifestyle Balanced <br>Portfolio Series I | $nan<br>Lifestyle Balanced <br>Portfolio Series II | $nan<br>Lifestyle<br>Conservative<br> Portfolio Series I | $nan<br>Lifestyle<br>Conservative<br> Portfolio Series II |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $1451315 | $10284410 | $6087779 | $230099154 | $1781653 | $33081486 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $1439613 | $10283832 | $6079358 | $229839153 | $1772289 | $32912323 |
|  Contracts in payout (annuitization) | 11702 | 578 | 8421 | 260001 | 9364 | 169163 |
|  Total net assets | $1451315 | $10284410 | $6087779 | $230099154 | $1781653 | $33081486 |
|  Units outstanding | 45837 | 543377 | 271455 | 10200431 | 107483 | 1986619 |
|  Unit value | $31.66 | $18.93 | $22.43 | $22.56 | $16.58 | $16.65 |
|  Shares | 148853 | 1054811 | 443392 | 16685943 | 149342 | 2763700 |
|  Cost | $1592921 | $11190708 | $6214469 | $234366799 | $1922017 | $35249455 |

---

*See accompanying notes.* 

13 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Lifestyle Growth <br>Portfolio Series I | $nan<br>Lifestyle Growth<br> Portfolio Series II | $nan<br>Lifestyle Growth <br>Portfolio Series<br>NAV | $nan<br>Lifestyle Moderate <br>Portfolio Series I | $nan<br>Lifestyle Moderate <br>Portfolio Series II | $nan<br>Managed Volatility <br>Balanced Portfolio<br>Series I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $10210625 | $537739175 | $134192 | $1647439 | $64029632 | $3595031 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $10210617 | $537497477 | $134192 | $1647439 | $63822912 | $3595031 |
|  Contracts in payout (annuitization) | 8 | 241698 |  |  | 206720 |  |
|  Total net assets | $10210625 | $537739175 | $134192 | $1647439 | $64029632 | $3595031 |
|  Units outstanding | 380110 | 19643780 | 6101 | 81975 | 3145826 | 112142 |
|  Unit value | $26.86 | $27.37 | $22.00 | $20.10 | $20.35 | $32.06 |
|  Shares | 703696 | 36932636 | 9255 | 126144 | 4880307 | 329517 |
|  Cost | $10668241 | $552310396 | $139901 | $1701987 | $66499850 | $3732125 |

---

*See accompanying notes.* 

14 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Managed Volatility <br>Balanced Portfolio<br>Series II | $nan<br>Managed Volatility <br>Conservative<br>Portfolio Series I | $nan<br>Managed Volatility <br>Conservative<br>Portfolio Series II | $nan<br>Managed Volatility <br>Growth Portfolio<br>Series I | $nan<br>Managed Volatility <br>Growth Portfolio<br>Series II | $nan<br>Managed Volatility <br>Moderate Portfolio<br>Series I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $104513796 | $520557 | $19037794 | $3838460 | $131518647 | $1256939 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $104280381 | $520557 | $19033503 | $3838460 | $131477160 | $1256939 |
|  Contracts in payout (annuitization) | 233415 |  | 4291 |  | 41487 |  |
|  Total net assets | $104513796 | $520557 | $19037794 | $3838460 | $131518647 | $1256939 |
|  Units outstanding | 3953086 | 18734 | 981877 | 112022 | 4604840 | 33655 |
|  Unit value | $26.44 | $27.79 | $19.39 | $34.27 | $28.56 | $37.35 |
|  Shares | 9659316 | 51337 | 1892425 | 327234 | 11260158 | 119595 |
|  Cost | $109444854 | $552222 | $20757391 | $3972989 | $135038620 | $1328681 |

---

*See accompanying notes.* 

15 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Managed Volatility <br>Moderate Portfolio<br>Series II | $nan<br>Mid Cap Growth <br>Trust Series I | $nan<br>Mid Cap Growth <br>Trust Series II | $nan<br>Mid Cap Index <br>Trust Series I | $nan<br>Mid Cap Index <br>Trust Series II | $nan<br>Mid Value Trust <br>Series I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $36832017 | $6579128 | $7246173 | $3861894 | $7497656 | $1417359 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $36832017 | $6485236 | $7237226 | $3861689 | $7497656 | $1395262 |
|  Contracts in payout (annuitization) |  | 93892 | 8947 | 205 |  | 22097 |
|  Total net assets | $36832017 | $6579128 | $7246173 | $3861894 | $7497656 | $1417359 |
|  Units outstanding | 1519449 | 93092 | 88564 | 51809 | 119525 | 23143 |
|  Unit value | $24.24 | $70.67 | $81.82 | $74.54 | $62.73 | $61.24 |
|  Shares | 3538138 | 574095 | 812351 | 185045 | 362731 | 151589 |
|  Cost | $38807601 | $7019221 | $5643497 | $3705032 | $7221692 | $1470424 |

---

*See accompanying notes.* 

16 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Mid Value Trust <br>Series II | $nan<br>Money Market <br>Trust Series I | $nan<br>Money Market <br>Trust Series II | $nan<br>Money Market<br> Trust Series NAV | $nan<br>Opportunistic Fixed<br> Income Trust Series <br>I | $nan<br>Opportunistic Fixed<br> Income Trust Series <br>II |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $6901820 | $1037790 | $3873921 | $287222 | $1212317 | $4157213 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $6901820 | $1023847 | $3864874 | $287222 | $1199328 | $4151153 |
|  Contracts in payout (annuitization) |  | 13943 | 9047 |  | 12989 | 6060 |
|  Total net assets | $6901820 | $1037790 | $3873921 | $287222 | $1212317 | $4157213 |
|  Units outstanding | 116685 | 65731 | 320420 | 22121 | 29698 | 199092 |
|  Unit value | $59.15 | $15.79 | $12.09 | $12.98 | $40.82 | $20.88 |
|  Shares | 736587 | 1037790 | 3873921 | 287222 | 110613 | 387078 |
|  Cost | $7161223 | $1037790 | $3873921 | $287222 | $1289405 | $4571392 |

---

*See accompanying notes.* 

17 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Real Estate<br> Securities Trust <br>Series I | $nan<br>Real Estate<br> Securities Trust <br>Series II | $nan<br>Science &<br> Technology Trust <br>Series I | $nan<br>Science &<br> Technology Trust <br>Series II | $nan<br>Select Bond Trust <br>Series I | $nan<br>Select Bond Trust <br>Series II |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $934034 | $2637851 | $11770713 | $11447130 | $404331 | $43512005 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $933763 | $2636223 | $11733985 | $11444203 | $404331 | $43406703 |
|  Contracts in payout (annuitization) | 271 | 1628 | 36728 | 2927 |  | 105302 |
|  Total net assets | $934034 | $2637851 | $11770713 | $11447130 | $404331 | $43512005 |
|  Units outstanding | 12301 | 48852 | 105956 | 80772 | 26668 | 3236699 |
|  Unit value | $75.93 | $54.00 | $111.09 | $141.72 | $15.16 | $13.44 |
|  Shares | 46216 | 130716 | 467277 | 581959 | 33977 | 3650336 |
|  Cost | $877195 | $2548957 | $8227159 | $7984513 | $443671 | $47160185 |

---

*See accompanying notes.* 

18 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Short Term<br>Government Income<br>Trust Series I | $nan<br>Short Term<br>Government Income<br>Trust Series II | $nan<br>Small Cap Core<br> Trust Series II (a) | $nan<br>Small Cap Index <br>Trust Series I | $nan<br>Small Cap Index <br>Trust Series II | $nan<br>Small Cap<br> Opportunities Trust <br>Series I |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $1464848 | $1797726 | $1832940 | $230003 | $4320755 | $2740641 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $1436211 | $1797726 | $1832940 | $230003 | $4320755 | $2740641 |
|  Contracts in payout (annuitization) | 28637 |  |  |  |  |  |
|  Total net assets | $1464848 | $1797726 | $1832940 | $230003 | $4320755 | $2740641 |
|  Units outstanding | 122745 | 158831 | 46654 | 4506 | 84751 | 39204 |
|  Unit value | $11.93 | $11.32 | $39.29 | $51.04 | $50.98 | $69.91 |
|  Shares | 124668 | 152998 | 150984 | 15562 | 295335 | 99012 |
|  Cost | $1469046 | $1780748 | $2157892 | $223321 | $4004561 | $2603324 |
|  | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. |

---

*See accompanying notes.* 

19 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Small Cap<br>Opportunities Trust<br>Series II | $nan<br>Small Cap Stock<br>Trust Series II | $nan<br>Small Company<br>Value Trust Series I | $nan<br>Small Company<br>Value Trust Series<br>II | $nan<br>Strategic Income<br>Opportunities Trust<br>Series I | $nan<br>Strategic Income<br>Opportunities Trust<br>Series II |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $4013568 | $1770662 | $1795377 | $4105757 | $1521215 | $3046696 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $4013568 | $1770662 | $1777976 | $4101627 | $1494149 | $3040591 |
|  Contracts in payout (annuitization) |  |  | 17401 | 4130 | 27066 | 6105 |
|  Total net assets | $4013568 | $1770662 | $1795377 | $4105757 | $1521215 | $3046696 |
|  Units outstanding | 61366 | 32420 | 26486 | 76074 | 58547 | 125340 |
|  Unit value | $65.40 | $54.62 | $67.79 | $53.97 | $25.98 | $24.31 |
|  Shares | 150716 | 285131 | 191814 | 473559 | 121309 | 242378 |
|  Cost | $3686698 | $1716939 | $1810011 | $4187620 | $1597922 | $3213388 |

---

*See accompanying notes.* 

20 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $nan<br>Total Bond Market <br>Series Trust NAV | $nan<br>Total Bond Market <br>Trust Series II | $nan<br>Total Stock Market<br> Index Trust Series I | $nan<br>Total Stock Market<br> Index Trust Series II | $nan<br>U.S. Growth Trust - <br>Series I (b) | $nan<br>U.S. Growth Trust - <br>Series II (c) |
|  **Total Assets** |  |  |  |  |  |  |
|  Investments at fair value | $514713 | $4007499 | $4319464 | $6932708 | $14940142 | $10452450 |
|  **Net Assets** |  |  |  |  |  |  |
|  Contracts in accumulation | $514713 | $4007499 | $4290549 | $6932708 | $14850855 | $10452450 |
|  Contracts in payout (annuitization) |  |  | 28915 |  | 89287 |  |
|  Total net assets | $514713 | $4007499 | $4319464 | $6932708 | $14940142 | $10452450 |
|  Units outstanding | 37951 | 328526 | 73044 | 94338 | 200219 | 96846 |
|  Unit value | $13.56 | $12.20 | $59.14 | $73.49 | $74.62 | $107.93 |
|  Shares | 56686 | 440869 | 132540 | 214369 | 2243265 | 2177594 |
|  Cost | $562215 | $4088784 | $3084296 | $4852973 | $11594698 | $8758636 |
|  | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. |
|  | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. |

---

*See accompanying notes.* 

21 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF ASSETS AND LIABILITIES** 

**December 31, 2025** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | |
|:---|:---|
|  | $nan<br>Ultra Short Term<br> Bond Trust Series II |
|  **Total Assets** |  |
|  Investments at fair value | $11427485 |
|  **Net Assets** |  |
|  Contracts in accumulation | $11427475 |
|  Contracts in payout (annuitization) | 10 |
|  Total net assets | $11427485 |
|  Units outstanding | 974849 |
|  Unit value | $11.72 |
|  Shares | 1003291 |
|  Cost | $11483044 |

---

*See accompanying notes.* 

22 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>500 Index Fund Series I | <br>500 Index Fund Series I | <br>500 Index Fund Series II | <br>500 Index Fund Series II | 500 Index Fund Series NAV | 500 Index Fund Series NAV |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $176142 | $160358 | $179015 | $170347 | $75324 | $77407 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (236597) | (222041) | (314534) | (303158) | (103973) | (109039) |
|  Net investment income (loss) | (60455) | (61683) | (135519) | (132811) | (28649) | (31632) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 271030 | 186198 | 327562 | 233935 | 111470 | 86538 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 886149 | 877226 | 1196285 | 1108977 | 701816 | 693264 |
|  Realized gains (losses) | 1157179 | 1063424 | 1523847 | 1342912 | 813286 | 779802 |
|  Unrealized appreciation (depreciation) during the period | 1371447 | 2111222 | 1587393 | 2749500 | 228396 | 735064 |
|  Net increase (decrease) in net assets from operations | 2468171 | 3112963 | 2975721 | 3959601 | 1013033 | 1483234 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 1735 | 3722 | 5204 | 5184 |  | 200 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 727164 | (79985) | (100347) | (227797) | (70606) | (214399) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (1010523) | (1146027) | (1083744) | (919322) | (1011937) | (885198) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (3614) | (3936) | (67975) | (64867) | (32194) | (34441) |
|  Net increase (decrease) in net assets from principal transactions | (285238) | (1226226) | (1246862) | (1206802) | (1114737) | (1133838) |
|  Total increase (decrease) in net assets | 2182933 | 1886737 | 1728859 | 2752799 | (101704) | 349396 |
|  Net assets at beginning of period | 15960297 | 14073560 | 20879627 | 18126828 | 7312750 | 6963354 |
|  Net assets at end of period | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;18143230 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15960297 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;22608486 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;20879627 | $7211046 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7312750 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 301861 | 327060 | 409708 | 436069 | 143204 | 167466 |
|  Units issued | 17808 | 4354 | 50432 | 45165 | 627 | 828 |
|  Units redeemed | (23531) | (29553) | (75921) | (71526) | (22251) | (25090) |
|  Units, end of period | 296138 | 301861 | 384219 | 409708 | 121580 | 143204 |

---

*See accompanying notes.* 

23 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Active Bond Trust Series I | <br>Active Bond Trust Series I | Active Bond Trust Series II | Active Bond Trust Series II | American Asset Allocation Trust Series I | American Asset Allocation Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $25978 | $22756 | $663750 | $552897 | $110548 | $88606 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (8920) | (9575) | (243672) | (248832) | (75415) | (74471) |
|  Net investment income (loss) | 17058 | 13181 | 420078 | 304065 | 35133 | 14135 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |  | 376006 | 292856 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (14957) | (21559) | (372836) | (334199) | (234251) | (244342) |
|  Realized gains (losses) | (14957) | (21559) | (372836) | (334199) | 141755 | 48514 |
|  Unrealized appreciation (depreciation) during the period | 31488 | 11517 | 766905 | 99434 | 471371 | 600708 |
|  Net increase (decrease) in net assets from operations | 33589 | 3139 | 814147 | 69300 | 648259 | 663357 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 1800 | 1000 | 2640 | 5565 | 9015 | 1725 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (4105) | 7860 | 1032398 | 1258636 | 19701 | 163686 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (92225) | (105509) | (1462405) | (1563525) | (631778) | (457677) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (222) | (323) | (42719) | (47635) | (1369) | (1871) |
|  Net increase (decrease) in net assets from principal transactions | (94752) | (96972) | (470086) | (346959) | (604431) | (294137) |
|  Total increase (decrease) in net assets | (61163) | (93833) | 344061 | (277659) | 43828 | 369220 |
|  Net assets at beginning of period | 598939 | 692772 | 15355310 | 15632969 | 5197319 | 4828099 |
|  Net assets at end of period | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;537776 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;598939 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15699371 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;15355310 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5241147 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5197319 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 30658 | 35644 | 831033 | 850823 | 169261 | 180000 |
|  Units issued | 358 | 478 | 92033 | 76808 | 3724 | 8996 |
|  Units redeemed | (4960) | (5464) | (116436) | (96598) | (23450) | (19735) |
|  Units, end of period | 26056 | 30658 | 806630 | 831033 | 149535 | 169261 |

---

*See accompanying notes.* 

24 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>American Asset Allocation Trust Series II | <br>American Asset Allocation Trust Series II | American Global Growth Trust Series II | American Global Growth Trust Series II | American Global Growth Trust Series III | American Global Growth Trust Series III |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $1024340 | $859767 | $67988 | $83028 | $86 | $77 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (753183) | (783283) | (108978) | (122059) | (44) | (42) |
|  Net investment income (loss) | 271157 | 76484 | (40990) | (39031) | 42 | 35 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 3750713 | 3117787 | 582939 | 838480 | 427 | 523 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (2637660) | (2625130) | 104430 | (15696) | 35 | 51 |
|  Realized gains (losses) | 1113053 | 492657 | 687369 | 822784 | 462 | 574 |
|  Unrealized appreciation (depreciation) during the period | 5273244 | 6579174 | 716652 | 156930 | 526 | 10 |
|  Net increase (decrease) in net assets from operations | 6657454 | 7148315 | 1363031 | 940683 | 1030 | 619 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 872 | 30 | 9100 | 9620 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (244284) | (1034757) | (552964) | (560988) | (391) | (36) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (6514181) | (5300586) | (1085342) | (911347) | (299) | (296) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (313725) | (342715) | (36989) | (42234) | (54) | (52) |
|  Net increase (decrease) in net assets from principal transactions | (7071318) | (6678028) | (1666195) | (1504949) | (744) | (384) |
|  Total increase (decrease) in net assets | (413864) | 470287 | (303164) | (564266) | 286 | 235 |
|  Net assets at beginning of period | 53062043 | 52591756 | 7765385 | 8329651 | 5254 | 5019 |
|  Net assets at end of period | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;52648179 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;53062043 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7462221 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7765385 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5540 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5254 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 1792247 | 2029442 | 206185 | 246672 | 110 | 119 |
|  Units issued | 23938 | 5792 | 3298 | 2349 | 2 | 5 |
|  Units redeemed | (249471) | (242987) | (42740) | (42836) | (16) | (14) |
|  Units, end of period | 1566714 | 1792247 | 166743 | 206185 | 96 | 110 |

---

*See accompanying notes.* 

25 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>American Growth Trust Series II | <br>American Growth Trust Series II | American Growth Trust Series III | American Growth Trust Series III | American Growth-Income Trust Series I | American Growth-Income Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $420884 | $- | $3517 | $237 | $90905 | $53702 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (1183792) | (1205689) | (3697) | (3405) | (95966) | (101390) |
|  Net investment income (loss) | (762908) | (1205689) | (180) | (3168) | (5061) | (47688) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 6153516 | 6622967 | 29401 | 29074 | 654793 | 452685 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 464540 | 1159659 | 9811 | 2649 | 147507 | 55693 |
|  Realized gains (losses) | 6618056 | 7782626 | 39212 | 31723 | 802300 | 508378 |
|  Unrealized appreciation (depreciation) during the period | 7342356 | 13474194 | 27073 | 61387 | 173684 | 886406 |
|  Net increase (decrease) in net assets from operations | 13197504 | 20051131 | 66105 | 89942 | 970923 | 1347096 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 10973 | 13808 |  |  | 1296 | 1140 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (2902024) | (7337611) | (9195) | (21245) | 22268 | 29945 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (9953971) | (10279897) | (26398) | (22193) | (1052074) | (1027086) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (236144) | (262490) | (3462) | (3408) | (1698) | (1741) |
|  Net increase (decrease) in net assets from principal transactions | (13081166) | (17866190) | (39055) | (46846) | (1030208) | (997742) |
|  Total increase (decrease) in net assets | 116338 | 2184941 | 27050 | 43096 | (59285) | 349354 |
|  Net assets at beginning of period | 77992414 | 75807473 | 358091 | 314995 | 6918531 | 6569177 |
|  Net assets at end of period | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;78108752 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;77992414 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;385141 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;358091 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6859246 | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6918531 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 773676 | 967779 | 4614 | 5282 | 95990 | 111498 |
|  Units issued | 25372 | 8050 | 124 |  | 1488 | 5753 |
|  Units redeemed | (140291) | (202153) | (565) | (668) | (15417) | (21261) |
|  Units, end of period | 658757 | 773676 | 4173 | 4614 | 82061 | 95990 |

---

*See accompanying notes.* 

26 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>American Growth-Income Trust Series II | <br>American Growth-Income Trust Series II | American Growth-Income Trust Series III | American Growth-Income Trust Series III | American International Trust Series II | American International Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $850655 | $478002 | $8454 | $5123 | $211473 | $192603 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (1029152) | (1055979) | (4438) | (4319) | (452289) | (470695) |
|  Net investment income (loss) | (178497) | (577977) | 4016 | 804 | (240816) | (278092) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 6624540 | 4481111 | 45326 | 29716 |  | 29207 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 2091897 | 644829 | 11976 | 4696 | (906038) | (1342824) |
|  Realized gains (losses) | 8716437 | 5125940 | 57302 | 34412 | (906038) | (1313617) |
|  Unrealized appreciation (depreciation) during the period | 1289207 | 8796005 | 11997 | 56588 | 7544682 | 2064986 |
|  Net increase (decrease) in net assets from operations | 9827147 | 13343968 | 73315 | 91804 | 6397828 | 473277 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 9804 | 13093 |  |  | 6150 | 10155 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (1013413) | (3952981) | (9435) | (22007) | (2140024) | 1594387 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (8106406) | (8190694) | (42530) | (35621) | (3475668) | (3630727) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (223817) | (248810) | (4556) | (4473) | (108731) | (121283) |
|  Net increase (decrease) in net assets from principal transactions | (9333832) | (12379392) | (56521) | (62101) | (5718273) | (2147468) |
|  Total increase (decrease) in net assets | 493315 | 964576 | 16794 | 29703 | 679555 | (1674191) |
|  Net assets at beginning of period | 66965077 | 66000501 | 453929 | 424226 | 28936359 | 30610550 |
|  Net assets at end of period | $67458392 | $66965077 | $470723 | $453929 | $29615914 | $28936359 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 1033327 | 1236642 | 8080 | 9276 | 973289 | 1036162 |
|  Units issued | 12140 | 12553 | 90 |  | 5069 | 80042 |
|  Units redeemed | (145302) | (215868) | (1007) | (1196) | (176554) | (142915) |
|  Units, end of period | 900165 | 1033327 | 7163 | 8080 | 801804 | 973289 |

---

*See accompanying notes.* 

27 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>American International Trust Series III | <br>American International Trust Series III | Blue Chip Growth Trust Series I | Blue Chip Growth Trust Series I | Blue Chip Growth Trust Series II | Blue Chip Growth Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $2495 | $2041 | $- | $- | $- | $- |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (1889) | (1846) | (392931) | (380113) | (225513) | (223710) |
|  Net investment income (loss) | 606 | 195 | (392931) | (380113) | (225513) | (223710) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  | 182 | 3912686 | 2193921 | 2375115 | 1329409 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (4135) | (3870) | 317046 | 373697 | (359808) | (432926) |
|  Realized gains (losses) | (4135) | (3688) | 4229732 | 2567618 | 2015307 | 896483 |
|  Unrealized appreciation (depreciation) during the period | 47273 | 8258 | 357892 | 5159566 | 530417 | 3516145 |
|  Net increase (decrease) in net assets from operations | 43744 | 4765 | 4194693 | 7347071 | 2320211 | 4188918 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  | 9578 | 2494 | 11802 | 13852 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (15154) | 11639 | (704441) | (239511) | (83913) | (661743) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (15034) | (19083) | (3321432) | (2285569) | (1882618) | (1614042) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (1920) | (1867) | (5126) | (5840) | (37440) | (39691) |
|  Net increase (decrease) in net assets from principal transactions | (32108) | (9311) | (4021421) | (2528426) | (1992169) | (2301624) |
|  Total increase (decrease) in net assets | 11636 | (4546) | 173272 | 4818645 | 328042 | 1887294 |
|  Net assets at beginning of period | 184709 | 189255 | 27573967 | 22755322 | 15349421 | 13462127 |
|  Net assets at end of period | $196345 | $184709 | $27747239 | $27573967 | $15677463 | $15349421 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 9810 | 10243 | 218966 | 243124 | 173960 | 203557 |
|  Units issued |  | 644 | 1644 | 1605 | 7389 | 5844 |
|  Units redeemed | (1490) | (1077) | (33961) | (25763) | (28541) | (35441) |
|  Units, end of period | 8320 | 9810 | 186649 | 218966 | 152808 | 173960 |

---

*See accompanying notes.* 

28 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Capital Appreciation Value Trust Series II | Capital Appreciation Value Trust Series II | Core Bond Trust Series I | Core Bond Trust Series I | Core Bond Trust Series II | Core Bond Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $294526 | $108281 | $193763 | $153903 | $189081 | $164867 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (242189) | (258695) | (66148) | (62766) | (72324) | (78163) |
|  Net investment income (loss) | 52337 | (150414) | 127615 | 91137 | 116757 | 86704 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 1621124 | 152453 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 202577 | 24363 | (53935) | (80348) | (166569) | (247014) |
|  Realized gains (losses) | 1823701 | 176816 | (53935) | (80348) | (166569) | (247014) |
|  Unrealized appreciation (depreciation) during the period | (384561) | 1644392 | 156230 | (7136) | 280045 | 136476 |
|  Net increase (decrease) in net assets from operations | 1491477 | 1670794 | 229910 | 3653 | 230233 | (23834) |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 59085 | 11701 | 120 | 120 |  | 12191 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 77856 | (198068) | 426866 | 295336 | 387759 | (115276) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (2217556) | (1661779) | (190805) | (304781) | (465917) | (892545) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (111778) | (113777) | (1008) | (1231) | (10469) | (11680) |
|  Net increase (decrease) in net assets from principal transactions | (2192393) | (1961923) | 235173 | (10556) | (88627) | (1007310) |
|  Total increase (decrease) in net assets | (700916) | (291129) | 465083 | (6903) | 141606 | (1031144) |
|  Net assets at beginning of period | 16734453 | 17025582 | 4171975 | 4178878 | 4571865 | 5603009 |
|  Net assets at end of period | $16033537 | $16734453 | $4637058 | $4171975 | $4713471 | $4571865 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 405975 | 455404 | 249077 | 250041 | 294033 | 359402 |
|  Units issued | 9003 | 5052 | 26571 | 21074 | 41777 | 11410 |
|  Units redeemed | (59742) | (54481) | (13514) | (22038) | (47351) | (76779) |
|  Units, end of period | 355236 | 405975 | 262134 | 249077 | 288459 | 294033 |

---

*See accompanying notes.* 

29 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Disciplined Value Emerging Markets Value<br>Trust Series II | Disciplined Value Emerging Markets Value<br>Trust Series II | Disciplined Value International Trust Series I | Disciplined Value International Trust Series I | Disciplined Value International Trust Series<br>II | Disciplined Value International Trust Series<br>II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $27122 | $113884 | $54024 | $8774 | $80295 | $6104 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (40595) | (43802) | (45199) | (44185) | (77504) | (73852) |
|  Net investment income (loss) | (13473) | 70082 | 8825 | (35411) | 2791 | (67748) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  | 236157 | 258665 | 387105 | 410364 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 61060 | (3708) | 103235 | 104212 | 263932 | 210895 |
|  Realized gains (losses) | 61060 | (3708) | 339392 | 362877 | 651037 | 621259 |
|  Unrealized appreciation (depreciation) during the period | 694674 | (174232) | 646235 | (360435) | 953134 | (612555) |
|  Net increase (decrease) in net assets from operations | 742261 | (107858) | 994452 | (32969) | 1606962 | (59044) |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 3661 | 740 | 200 | 480 | 12562 | 8387 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (269681) | (179066) | (34861) | 12716 | (196255) | (83640) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (408477) | (255603) | (274331) | (409196) | (527557) | (381558) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (12189) | (12770) | (954) | (994) | (11687) | (12933) |
|  Net increase (decrease) in net assets from principal transactions | (686686) | (446699) | (309946) | (396994) | (722937) | (469744) |
|  Total increase (decrease) in net assets | 55575 | (554557) | 684506 | (429963) | 884025 | (528788) |
|  Net assets at beginning of period | 2750690 | 3305247 | 2655579 | 3085542 | 4403035 | 4931823 |
|  Net assets at end of period | $2806265 | $2750690 | $3340085 | $2655579 | $5287060 | $4403035 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 217219 | 250479 | 105066 | 119735 | 162841 | 178889 |
|  Units issued | 10007 | 11885 | 975 | 3622 | 7624 | 10647 |
|  Units redeemed | (56285) | (45145) | (10898) | (18291) | (29311) | (26695) |
|  Units, end of period | 170941 | 217219 | 95143 | 105066 | 141154 | 162841 |

---

*See accompanying notes.* 

30 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Equity Income Trust Series I | <br>Equity Income Trust Series I | Equity Income Trust Series II | Equity Income Trust Series II | Financial Industries Trust Series I | Financial Industries Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $444984 | $308912 | $275194 | $189676 | $8720 | $7114 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (263244) | (280571) | (184518) | (205424) | (11580) | (10646) |
|  Net investment income (loss) | 181740 | 28341 | 90676 | (15748) | (2860) | (3532) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 2943889 | 838290 | 1959083 | 573094 | 34983 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (166005) | (209705) | 107347 | (20496) | 1004 | (2633) |
|  Realized gains (losses) | 2777884 | 628585 | 2066430 | 552598 | 35987 | (2633) |
|  Unrealized appreciation (depreciation) during the period | (774198) | 1215685 | (730423) | 725376 | 38722 | 174499 |
|  Net increase (decrease) in net assets from operations | 2185426 | 1872611 | 1426683 | 1262226 | 71849 | 168334 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 21712 | 3682 | 8592 | 20726 | 275 | 480 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (68604) | (121556) | (143580) | (273660) | (12456) | 808 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (1672956) | (2285145) | (1410703) | (2462195) | (12959) | (75957) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (4227) | (4993) | (29787) | (36384) | (163) | (243) |
|  Net increase (decrease) in net assets from principal transactions | (1724075) | (2408012) | (1575478) | (2751513) | (25303) | (74912) |
|  Total increase (decrease) in net assets | 461351 | (535401) | (148795) | (1489287) | 46546 | 93422 |
|  Net assets at beginning of period | 18272831 | 18808232 | 12442611 | 13931898 | 719620 | 626198 |
|  Net assets at end of period | $18734182 | $18272831 | $12293816 | $12442611 | $766166 | $719620 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 209807 | 239671 | 293639 | 357837 | 18683 | 20801 |
|  Units issued | 1264 | 494 | 6391 | 9402 | 20 | 386 |
|  Units redeemed | (21262) | (30358) | (41357) | (73600) | (638) | (2504) |
|  Units, end of period | 189809 | 209807 | 258673 | 293639 | 18065 | 18683 |

---

*See accompanying notes.* 

31 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Financial Industries Trust Series II | Financial Industries Trust Series II | <br>Fundamental All Cap Core Trust Series II | <br>Fundamental All Cap Core Trust Series II | Fundamental Large Cap Value Trust Series I | Fundamental Large Cap Value Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $18232 | $17100 | $9387 | $- | $234057 | $70236 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (29361) | (33597) | (74581) | (88903) | (323372) | (334385) |
|  Net investment income (loss) | (11129) | (16497) | (65194) | (88903) | (89315) | (264149) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 85784 |  | 500203 | 481187 | 2837497 | 2225899 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (33291) | (70158) | 319132 | 586384 | 1041666 | 1176159 |
|  Realized gains (losses) | 52493 | (70158) | 819335 | 1067571 | 3879163 | 3402058 |
|  Unrealized appreciation (depreciation) during the period | 137002 | 621334 | (664559) | 171867 | (841526) | 64398 |
|  Net increase (decrease) in net assets from operations | 178366 | 534679 | 89582 | 1150535 | 2948322 | 3202307 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 400 | 375 |  | 4017 | 29690 | 7486 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (21844) | (415590) | 19006 | (73860) | (253498) | (40170) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (351849) | (247033) | (1056211) | (1320956) | (2207711) | (2667383) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (4038) | (6345) | (15589) | (18376) | (5802) | (6449) |
|  Net increase (decrease) in net assets from principal transactions | (377331) | (668593) | (1052794) | (1409175) | (2437321) | (2706516) |
|  Total increase (decrease) in net assets | (198965) | (133914) | (963212) | (258640) | 511001 | 495791 |
|  Net assets at beginning of period | 2064116 | 2198030 | 5431715 | 5690355 | 22320968 | 21825177 |
|  Net assets at end of period | $1865151 | $2064116 | $4468503 | $5431715 | $22831969 | $22320968 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 51776 | 70463 | 60804 | 77402 | 388563 | 438571 |
|  Units issued | 346 | 961 | 2163 | 1621 | 3766 | 5775 |
|  Units redeemed | (9295) | (19648) | (14476) | (18218) | (44440) | (55783) |
|  Units, end of period | 42827 | 51776 | 48491 | 60805 | 347889 | 388563 |

---

*See accompanying notes.* 

32 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Fundamental Large Cap Value Trust Series<br>II | Fundamental Large Cap Value Trust Series<br>II | Global Equity Trust Series I | Global Equity Trust Series I | Global Equity Trust Series II | Global Equity Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $168139 | $31434 | $70418 | $66203 | $34456 | $36685 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (316550) | (345783) | (79360) | (80682) | (51721) | (56750) |
|  Net investment income (loss) | (148411) | (314349) | (8942) | (14479) | (17265) | (20065) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 2441104 | 2090732 | 630513 | 282870 | 358663 | 183369 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 1504064 | 1602296 | 281329 | 301082 | 181309 | 97345 |
|  Realized gains (losses) | 3945168 | 3693028 | 911842 | 583952 | 539972 | 280714 |
|  Unrealized appreciation (depreciation) during the period | (1137363) | (292469) | (22950) | (72939) | (11440) | 56262 |
|  Net increase (decrease) in net assets from operations | 2659394 | 3086210 | 879950 | 496534 | 511267 | 316911 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 5994 | 7786 | 1530 | 2014 | 360 | 360 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (158765) | (788146) | (21582) | (7332) | (218680) | (221168) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (3305716) | (3044951) | (512890) | (601384) | (484522) | (267575) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (61469) | (68025) | (5776) | (5870) | (10223) | (11879) |
|  Net increase (decrease) in net assets from principal transactions | (3519956) | (3893336) | (538718) | (612572) | (713065) | (500262) |
|  Total increase (decrease) in net assets | (860562) | (807126) | 341232 | (116038) | (201798) | (183351) |
|  Net assets at beginning of period | 20925487 | 21732613 | 5606169 | 5722207 | 3560385 | 3743736 |
|  Net assets at end of period | $20064925 | $20925487 | $5947401 | $5606169 | $3358587 | $3560385 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 403652 | 482682 | 109625 | 121543 | 120228 | 137013 |
|  Units issued | 3317 | 3812 | 1158 | 991 | 1169 | 1625 |
|  Units redeemed | (64890) | (82842) | (11150) | (12909) | (23476) | (18410) |
|  Units, end of period | 342079 | 403652 | 99633 | 109625 | 97921 | 120228 |

---

*See accompanying notes.* 

33 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Health Sciences Trust Series I | <br>Health Sciences Trust Series I | Health Sciences Trust Series II | Health Sciences Trust Series II | High Yield Trust Series I | High Yield Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $- | $- | $1 | $- | $78846 | $77831 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (42783) | (49035) | (74553) | (93831) | (14599) | (15027) |
|  Net investment income (loss) | (42783) | (49035) | (74552) | (93831) | 64247 | 62804 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 383535 | 205072 | 795322 | 449634 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (17027) | 20288 | (339276) | (105425) | (12380) | (15710) |
|  Realized gains (losses) | 366508 | 225360 | 456046 | 344209 | (12380) | (15710) |
|  Unrealized appreciation (depreciation) during the period | 147838 | (148565) | 431216 | (149733) | 10192 | 31981 |
|  Net increase (decrease) in net assets from operations | 471563 | 27760 | 812710 | 100645 | 62059 | 79075 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 240 | 240 | 400 | 375 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (35563) | (21775) | (227712) | 43161 | 4570 | 36728 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (107300) | (384459) | (530727) | (1243589) | (94508) | (84495) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (1056) | (1741) | (13705) | (19129) | (2636) | (2572) |
|  Net increase (decrease) in net assets from principal transactions | (143679) | (407735) | (771744) | (1219182) | (92574) | (50339) |
|  Total increase (decrease) in net assets | 327884 | (379975) | 40966 | (1118537) | (30515) | 28736 |
|  Net assets at beginning of period | 2801075 | 3181050 | 5315266 | 6433803 | 1096383 | 1067647 |
|  Net assets at end of period | $3128959 | $2801075 | $5356232 | $5315266 | $1065868 | $1096383 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 26905 | 30640 | 53596 | 64170 | 39913 | 41667 |
|  Units issued | 157 | 250 | 590 | 2193 | 1318 | 2171 |
|  Units redeemed | (1510) | (3985) | (7741) | (12767) | (4149) | (3925) |
|  Units, end of period | 25552 | 26905 | 46445 | 53596 | 37082 | 39913 |

---

*See accompanying notes.* 

34 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>High Yield Trust Series II | <br>High Yield Trust Series II | International Equity Index Series I | International Equity Index Series I | International Equity Index Series II | International Equity Index Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $170281 | $185382 | $17134 | $10930 | $60134 | $44171 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (38559) | (43836) | (11154) | (10073) | (48268) | (52281) |
|  Net investment income (loss) | 131722 | 141546 | 5980 | 857 | 11866 | (8110) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (29881) | (32990) | 32038 | 11356 | 184967 | 73409 |
|  Realized gains (losses) | (29881) | (32990) | 32038 | 11356 | 184967 | 73409 |
|  Unrealized appreciation (depreciation) during the period | 36053 | 86257 | 165939 | 11771 | 636375 | 45436 |
|  Net increase (decrease) in net assets from operations | 137894 | 194813 | 203957 | 23984 | 833208 | 110735 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 1400 | 1480 |  |  | 520 | 495 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (46723) | (70188) | 8093 | 64000 | (554601) | (346280) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (363474) | (276440) | (56283) | (42880) | (217401) | (156427) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (9505) | (11217) | (256) | (267) | (9249) | (10843) |
|  Net increase (decrease) in net assets from principal transactions | (418302) | (356365) | (48446) | 20853 | (780731) | (513055) |
|  Total increase (decrease) in net assets | (280408) | (161552) | 155511 | 44837 | 52477 | (402320) |
|  Net assets at beginning of period | 2757888 | 2919440 | 679835 | 634998 | 3046885 | 3449205 |
|  Net assets at end of period | $2477480 | $2757888 | $835346 | $679835 | $3099362 | $3046885 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 100113 | 112589 | 35607 | 34458 | 165294 | 192692 |
|  Units issued | 4598 | 3400 | 2328 | 3392 | 1662 | 70420 |
|  Units redeemed | (18722) | (15876) | (4449) | (2243) | (37542) | (97818) |
|  Units, end of period | 85989 | 100113 | 33486 | 35607 | 129414 | 165294 |

---

*See accompanying notes.* 

35 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | International Equity Index Series NAV | International Equity Index Series NAV | <br>International Small Company Trust Series I | <br>International Small Company Trust Series I | International Small Company Trust Series II | International Small Company Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $18114 | $14134 | $26282 | $29113 | $30244 | $43943 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (13221) | (13959) | (17158) | (15419) | (24663) | (27524) |
|  Net investment income (loss) | 4893 | 175 | 9124 | 13694 | 5581 | 16419 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  | 51765 | 7971 | 64390 | 12840 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 33407 | 18479 | 18401 | 2663 | 58308 | 23789 |
|  Realized gains (losses) | 33407 | 18479 | 70166 | 10634 | 122698 | 36629 |
|  Unrealized appreciation (depreciation) during the period | 178185 | 8317 | 258443 | (7134) | 340210 | (23046) |
|  Net increase (decrease) in net assets from operations | 216485 | 26971 | 337733 | 17194 | 468489 | 30002 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  | 381 | 397 |  | 1035 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (54930) | 23376 | (22242) | 13055 | (290916) | (140868) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (61780) | (122960) | (73114) | (41300) | (184547) | (279503) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (3560) | (3932) | (324) | (344) | (5460) | (7048) |
|  Net increase (decrease) in net assets from principal transactions | (120270) | (103516) | (95299) | (28192) | (480923) | (426384) |
|  Total increase (decrease) in net assets | 96215 | (76545) | 242434 | (10998) | (12434) | (396382) |
|  Net assets at beginning of period | 752105 | 828650 | 1045088 | 1056086 | 1600517 | 1996899 |
|  Net assets at end of period | $848320 | $752105 | $1287522 | $1045088 | $1588083 | $1600517 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 49886 | 56790 | 43861 | 45024 | 70185 | 88598 |
|  Units issued | 25 | 1760 | 26 | 760 | 502 | 2287 |
|  Units redeemed | (6772) | (8664) | (3274) | (1923) | (18044) | (20700) |
|  Units, end of period | 43139 | 49886 | 40613 | 43861 | 52643 | 70185 |

---

*See accompanying notes.* 

36 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Investment Quality Bond Trust Series I | Investment Quality Bond Trust Series I | <br>Investment Quality Bond Trust Series II | <br>Investment Quality Bond Trust Series II | Lifestyle Balanced Portfolio Series I | Lifestyle Balanced Portfolio Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $64752 | $45906 | $451321 | $327874 | $178774 | $143108 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (20583) | (20985) | (156025) | (155818) | (78449) | (81606) |
|  Net investment income (loss) | 44169 | 24921 | 295296 | 172056 | 100325 | 61502 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |  | 310069 | 152657 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (21824) | (60521) | (312971) | (211080) | (35024) | (35246) |
|  Realized gains (losses) | (21824) | (60521) | (312971) | (211080) | 275045 | 117411 |
|  Unrealized appreciation (depreciation) during the period | 52943 | 41225 | 526981 | 66633 | 316243 | 234802 |
|  Net increase (decrease) in net assets from operations | 75288 | 5625 | 509306 | 27609 | 691613 | 413715 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 505 | 505 |  | 600 | 2400 | 2400 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 147893 | (44508) | 336184 | 1044043 | 11238 | 24204 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (102995) | (230161) | (941052) | (902168) | (480448) | (503500) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (1607) | (1760) | (37185) | (42598) | (19188) | (19486) |
|  Net increase (decrease) in net assets from principal transactions | 43796 | (275924) | (642053) | 99877 | (485998) | (496382) |
|  Total increase (decrease) in net assets | 119084 | (270299) | (132747) | 127486 | 205615 | (82667) |
|  Net assets at beginning of period | 1332231 | 1602530 | 10417157 | 10289671 | 5882164 | 5964831 |
|  Net assets at end of period | $1451315 | $1332231 | $10284410 | $10417157 | $6087779 | $5882164 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 45409 | 55161 | 583835 | 579425 | 294707 | 319986 |
|  Units issued | 5134 | 1190 | 52651 | 68498 | 11878 | 1887 |
|  Units redeemed | (4706) | (10942) | (93109) | (64088) | (35130) | (27166) |
|  Units, end of period | 45837 | 45409 | 543377 | 583835 | 271455 | 294707 |

---

*See accompanying notes.* 

37 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Lifestyle Balanced Portfolio Series II | Lifestyle Balanced Portfolio Series II | <br>Lifestyle Conservative Portfolio Series I | <br>Lifestyle Conservative Portfolio Series I | Lifestyle Conservative Portfolio Series II | Lifestyle Conservative Portfolio Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $5926101 | $5276469 | $65529 | $57837 | $1099323 | $1075970 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (3310803) | (3506469) | (26961) | (29741) | (508418) | (565013) |
|  Net investment income (loss) | 2615298 | 1770000 | 38568 | 28096 | 590905 | 510957 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 11931241 | 6095626 | 1157 | 3294 | 22910 | 65884 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (1483162) | (2116949) | (53901) | (42357) | (1041728) | (1052160) |
|  Realized gains (losses) | 10448079 | 3978677 | (52744) | (39063) | (1018818) | (986276) |
|  Unrealized appreciation (depreciation) during the period | 13558086 | 10589700 | 156998 | 69570 | 3189442 | 1506490 |
|  Net increase (decrease) in net assets from operations | 26621463 | 16338377 | 142822 | 58603 | 2761529 | 1031171 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 285756 | 573297 | 301 | 2163 | 34326 | 40570 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (321985) | 1103235 | 65594 |  | 154219 | (778346) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (30873413) | (28447787) | (265288) | (212069) | (6221917) | (4001450) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (1331492) | (1486934) | (1672) | (1911) | (283876) | (313970) |
|  Net increase (decrease) in net assets from principal transactions | (32241134) | (28258189) | (201065) | (211817) | (6317248) | (5053196) |
|  Total increase (decrease) in net assets | (5619671) | (11919812) | (58243) | (153214) | (3555719) | (4022025) |
|  Net assets at beginning of period | 235718825 | 247638637 | 1839896 | 1993110 | 36637205 | 40659230 |
|  Net assets at end of period | $230099154 | $235718825 | $1781653 | $1839896 | $33081486 | $36637205 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 11709110 | 13148069 | 120109 | 133782 | 2377773 | 2710082 |
|  Units issued | 133311 | 213934 | 3922 | 3945 | 88554 | 54646 |
|  Units redeemed | (1641990) | (1652893) | (16548) | (17618) | (479708) | (386955) |
|  Units, end of period | 10200431 | 11709110 | 107483 | 120109 | 1986619 | 2377773 |

---

*See accompanying notes.* 

38 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Lifestyle Growth Portfolio Series I | <br>Lifestyle Growth Portfolio Series I | Lifestyle Growth Portfolio Series II | Lifestyle Growth Portfolio Series II | Lifestyle Growth Portfolio Series NAV | Lifestyle Growth Portfolio Series NAV |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $254461 | $205326 | $11415795 | $10135002 | $3463 | $2638 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (134697) | (137768) | (7390776) | (7694259) | (1533) | (1466) |
|  Net investment income (loss) | 119764 | 67558 | 4025019 | 2440743 | 1930 | 1172 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 753234 | 369658 | 39831964 | 19953245 | 9818 | 4545 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (41937) | (81818) | (7342193) | (9252987) | (889) | (1184) |
|  Realized gains (losses) | 711297 | 287840 | 32489771 | 10700258 | 8929 | 3361 |
|  Unrealized appreciation (depreciation) during the period | 561309 | 580155 | 36793304 | 36930217 | 7394 | 6886 |
|  Net increase (decrease) in net assets from operations | 1392370 | 935553 | 73308094 | 50071218 | 18253 | 11419 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 17280 | 14980 | 2039754 | 3110061 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (77491) | 31697 | (2760320) | (562245) |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (768908) | (1172083) | (57284441) | (64939549) | (5578) | (5578) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (27612) | (28021) | (3194895) | (3401605) |  |  |
|  Net increase (decrease) in net assets from principal transactions | (856731) | (1153427) | (61199902) | (65793338) | (5578) | (5578) |
|  Total increase (decrease) in net assets | 535639 | (217874) | 12108192 | (15722120) | 12675 | 5841 |
|  Net assets at beginning of period | 9674986 | 9892860 | 525630983 | 541353103 | 121517 | 115676 |
|  Net assets at end of period | $10210625 | $9674986 | $537739175 | $525630983 | $134192 | $121517 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 414851 | 466338 | 22084168 | 24961145 | 6378 | 6681 |
|  Units issued | 1124 | 6524 | 304722 | 391913 |  |  |
|  Units redeemed | (35865) | (58011) | (2745110) | (3268890) | (277) | (303) |
|  Units, end of period | 380110 | 414851 | 19643780 | 22084168 | 6101 | 6378 |

---

*See accompanying notes.* 

39 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Lifestyle Moderate Portfolio Series I | Lifestyle Moderate Portfolio Series I | Lifestyle Moderate Portfolio Series II | Lifestyle Moderate Portfolio Series II | Managed Volatility Balanced Portfolio<br>Series I | Managed Volatility Balanced Portfolio<br>Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $52389 | $46361 | $1800263 | $1674040 | $101990 | $99004 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (23646) | (26844) | (936305) | (1006566) | (54759) | (61639) |
|  Net investment income (loss) | 28743 | 19517 | 863958 | 667474 | 47231 | 37365 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 44042 | 35415 | 1738827 | 1294143 | 143465 | 15897 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (38463) | (53355) | (783146) | (1434898) | (103345) | (302099) |
|  Realized gains (losses) | 5579 | (17940) | 955681 | (140755) | 40120 | (286202) |
|  Unrealized appreciation (depreciation) during the period | 132703 | 96823 | 4847128 | 3120430 | 208034 | 569155 |
|  Net increase (decrease) in net assets from operations | 167025 | 98400 | 6666767 | 3647149 | 295385 | 320318 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  | 9746 | 12156 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 595 | 1068 | (254495) | (554489) | 1262 | 31511 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (208743) | (390384) | (7982290) | (7926511) | (625660) | (1103244) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (1735) | (2449) | (424965) | (458726) | (11048) | (11058) |
|  Net increase (decrease) in net assets from principal transactions | (209883) | (391765) | (8652004) | (8927570) | (635446) | (1082791) |
|  Total increase (decrease) in net assets | (42858) | (293365) | (1985237) | (5280421) | (340061) | (762473) |
|  Net assets at beginning of period | 1690297 | 1983662 | 66014869 | 71295290 | 3935092 | 4697565 |
|  Net assets at end of period | $1647439 | $1690297 | $64029632 | $66014869 | $3595031 | $3935092 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 93285 | 114725 | 3594191 | 4093727 | 129740 | 169415 |
|  Units issued | 3489 | 44 | 26022 | 62351 | 59 | 2236 |
|  Units redeemed | (14799) | (21484) | (474387) | (561887) | (17657) | (41911) |
|  Units, end of period | 81975 | 93285 | 3145826 | 3594191 | 112142 | 129740 |

---

*See accompanying notes.* 

40 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Managed Volatility Balanced Portfolio<br>Series II | Managed Volatility Balanced Portfolio<br>Series II | Managed Volatility Conservative Portfolio<br>Series I | Managed Volatility Conservative Portfolio<br>Series I | Managed Volatility Conservative Portfolio<br>Series II | Managed Volatility Conservative Portfolio<br>Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $2587064 | $2681623 | $19171 | $17533 | $638335 | $627504 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (1561901) | (1720052) | (8043) | (8709) | (284088) | (322254) |
|  Net investment income (loss) | 1025163 | 961571 | 11128 | 8824 | 354247 | 305250 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 4004240 | 470850 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (2721967) | (4096258) | (7690) | (48899) | (362443) | (716944) |
|  Realized gains (losses) | 1282273 | (3625408) | (7690) | (48899) | (362443) | (716944) |
|  Unrealized appreciation (depreciation) during the period | 5933766 | 11416316 | 31564 | 49375 | 1337851 | 844381 |
|  Net increase (decrease) in net assets from operations | 8241202 | 8752479 | 35002 | 9300 | 1329655 | 432687 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 10601 | 14698 |  |  | 125 | 300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (493329) | (147316) |  | (73579) | 55778 | (742843) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (16515888) | (14043657) | (46620) | (157261) | (2194819) | (2963392) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (721798) | (800168) | (71) | (113) | (169998) | (193744) |
|  Net increase (decrease) in net assets from principal transactions | (17720414) | (14976443) | (46691) | (230953) | (2308914) | (3899679) |
|  Total increase (decrease) in net assets | (9479212) | (6223964) | (11689) | (221653) | (979259) | (3466992) |
|  Net assets at beginning of period | 113993008 | 120216972 | 532246 | 753899 | 20017053 | 23484045 |
|  Net assets at end of period | $104513796 | $113993008 | $520557 | $532246 | $19037794 | $20017053 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 4656952 | 5305911 | 20273 | 28137 | 1101803 | 1322820 |
|  Units issued | 41784 | 35192 |  | 1840 | 16466 | 10211 |
|  Units redeemed | (745650) | (684151) | (1539) | (9704) | (136392) | (231228) |
|  Units, end of period | 3953086 | 4656952 | 18734 | 20273 | 981877 | 1101803 |

---

*See accompanying notes.* 

41 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Managed Volatility Growth Portfolio Series<br>I | Managed Volatility Growth Portfolio Series<br>I | Managed Volatility Growth Portfolio Series<br>II | Managed Volatility Growth Portfolio Series<br>II | Managed Volatility Moderate Portfolio<br>Series I | Managed Volatility Moderate Portfolio<br>Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $87663 | $68409 | $2548784 | $2578795 | $39052 | $35832 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (49043) | (44884) | (1921803) | (2133715) | (17700) | (23710) |
|  Net investment income (loss) | 38620 | 23525 | 626981 | 445080 | 21352 | 12122 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 208095 | 19646 | 7312427 | 860009 | 25153 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (43880) | (71680) | (3287357) | (5695057) | (29155) | (106200) |
|  Realized gains (losses) | 164215 | (52034) | 4025070 | (4835048) | (4002) | (106200) |
|  Unrealized appreciation (depreciation) during the period | 126636 | 350323 | 6488375 | 18342214 | 72404 | 209153 |
|  Net increase (decrease) in net assets from operations | 329471 | 321814 | 11140426 | 13952246 | 89754 | 115075 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  | 692305 | 108396 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 279839 | 143534 | (552104) | (1087492) | 116 | 415 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (140743) | (258110) | (17850290) | (17862142) | (120797) | (595808) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (10004) | (10015) | (910647) | (1007967) | (1258) | (1339) |
|  Net increase (decrease) in net assets from principal transactions | 129092 | (124591) | (18620736) | (19849205) | (121939) | (596732) |
|  Total increase (decrease) in net assets | 458563 | 197223 | (7480310) | (5896959) | (32185) | (481657) |
|  Net assets at beginning of period | 3379897 | 3182674 | 138998957 | 144895916 | 1289124 | 1770781 |
|  Net assets at end of period | $3838460 | $3379897 | $131518647 | $138998957 | $1256939 | $1289124 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 109067 | 113423 | 5292321 | 6078333 | 37101 | 55771 |
|  Units issued | 10918 | 4681 | 60758 | 48927 | 9 | 16 |
|  Units redeemed | (7963) | (9037) | (748239) | (834939) | (3455) | (18686) |
|  Units, end of period | 112022 | 109067 | 4604840 | 5292321 | 33655 | 37101 |

---

*See accompanying notes.* 

42 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Managed Volatility Moderate Portfolio<br>Series II | Managed Volatility Moderate Portfolio<br>Series II | Mid Cap Growth Trust Series I | Mid Cap Growth Trust Series I | Mid Cap Growth Trust Series II | Mid Cap Growth Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $1022511 | $1040247 | $- | $- | $- | $- |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (519050) | (586535) | (99071) | (94724) | (112008) | (130135) |
|  Net investment income (loss) | 503461 | 453712 | (99071) | (94724) | (112008) | (130135) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 757369 |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (1024642) | (1257135) | (383681) | (501385) | (304954) | (3656909) |
|  Realized gains (losses) | (267273) | (1257135) | (383681) | (501385) | (304954) | (3656909) |
|  Unrealized appreciation (depreciation) during the period | 2450698 | 3435193 | 780577 | 1918270 | 718590 | 5476435 |
|  Net increase (decrease) in net assets from operations | 2686886 | 2631770 | 297825 | 1322161 | 301628 | 1689391 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 102360 | 450 | 1239 | 1045 | 13242 | 9740 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (438099) | (616486) | 4516 | (67838) | 77329 | (1546188) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (5247158) | (5321702) | (414498) | (560873) | (471536) | (1536586) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (281063) | (313955) | (2572) | (2697) | (13643) | (21130) |
|  Net increase (decrease) in net assets from principal transactions | (5863960) | (6251693) | (411315) | (630363) | (394608) | (3094164) |
|  Total increase (decrease) in net assets | (3177074) | (3619923) | (113490) | 691798 | (92980) | (1404773) |
|  Net assets at beginning of period | 40009091 | 43629014 | 6692618 | 6000820 | 7339153 | 8743926 |
|  Net assets at end of period | $36832017 | $40009091 | $6579128 | $6692618 | $7246173 | $7339153 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 1766405 | 2051289 | 98998 | 109486 | 93719 | 134994 |
|  Units issued | 12554 | 7046 | 683 | 214 | 2255 | 482 |
|  Units redeemed | (259510) | (291930) | (6589) | (10702) | (7410) | (41757) |
|  Units, end of period | 1519449 | 1766405 | 93092 | 98998 | 88564 | 93719 |

---

*See accompanying notes.* 

43 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Mid Cap Index Trust Series I | Mid Cap Index Trust Series I | Mid Cap Index Trust Series II | Mid Cap Index Trust Series II | Mid Value Trust Series I | Mid Value Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $45610 | $42031 | $76285 | $71082 | $16126 | $5412 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (55529) | (61549) | (114416) | (126396) | (21360) | (24360) |
|  Net investment income (loss) | (9919) | (19518) | (38131) | (55314) | (5234) | (18948) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 276711 | 137246 | 543731 | 276131 | 248942 | 79963 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (29253) | (39663) | 5420 | (16482) | 11509 | 8713 |
|  Realized gains (losses) | 247458 | 97583 | 549151 | 259649 | 260451 | 88676 |
|  Unrealized appreciation (depreciation) during the period | (43293) | 386135 | (151177) | 681971 | (196910) | 150811 |
|  Net increase (decrease) in net assets from operations | 194246 | 464200 | 359843 | 886306 | 58307 | 220539 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 283 | 433 | 3672 | 11217 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 73791 | (301079) | 59492 | (117744) | (15287) | 25464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (339011) | (388823) | (875597) | (932908) | (114113) | (289721) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (669) | (851) | (22642) | (25377) | (507) | (860) |
|  Net increase (decrease) in net assets from principal transactions | (265606) | (690320) | (835075) | (1064812) | (129907) | (265117) |
|  Total increase (decrease) in net assets | (71360) | (226120) | (475232) | (178506) | (71600) | (44578) |
|  Net assets at beginning of period | 3933254 | 4159374 | 7972888 | 8151394 | 1488959 | 1533537 |
|  Net assets at end of period | $3861894 | $3933254 | $7497656 | $7972888 | $1417359 | $1488959 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 55769 | 65799 | 133371 | 151528 | 25321 | 29874 |
|  Units issued | 1543 | 360 | 3323 | 2787 | 309 | 528 |
|  Units redeemed | (5503) | (10390) | (17169) | (20944) | (2487) | (5081) |
|  Units, end of period | 51809 | 55769 | 119525 | 133371 | 23143 | 25321 |

---

*See accompanying notes.* 

44 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Mid Value Trust Series II | <br>Mid Value Trust Series II | Money Market Trust Series I | Money Market Trust Series I | Money Market Trust Series II | Money Market Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $66203 | $13090 | $44708 | $65894 | $150472 | $220665 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (104912) | (111547) | (16725) | (20231) | (58633) | (70585) |
|  Net investment income (loss) | (38709) | (98457) | 27983 | 45663 | 91839 | 150080 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 1206878 | 368697 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (17203) | (20236) |  |  |  |  |
|  Realized gains (losses) | 1189675 | 348461 |  |  |  |  |
|  Unrealized appreciation (depreciation) during the period | (894714) | 709893 |  |  |  |  |
|  Net increase (decrease) in net assets from operations | 256252 | 959897 | 27983 | 45663 | 91839 | 150080 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 2961 | 45 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 39764 | 36540 | 69785 | (292742) | 8473 | (45926) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (577860) | (806620) | (323208) | 125937 | (524213) | (687383) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (18530) | (21321) | (2011) | (2058) | (42077) | (51911) |
|  Net increase (decrease) in net assets from principal transactions | (553665) | (791356) | (255434) | (168863) | (557817) | (785220) |
|  Total increase (decrease) in net assets | (297413) | 168541 | (227451) | (123200) | (465978) | (635140) |
|  Net assets at beginning of period | 7199233 | 7030692 | 1265241 | 1388441 | 4339899 | 4975039 |
|  Net assets at end of period | $6901820 | $7199233 | $1037790 | $1265241 | $3873921 | $4339899 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 126647 | 141578 | 80778 | 93704 | 368458 | 437445 |
|  Units issued | 1604 | 8063 | 4031 | 975 | 10782 | 8945 |
|  Units redeemed | (11566) | (22994) | (19078) | (13901) | (58820) | (77932) |
|  Units, end of period | 116685 | 126647 | 65731 | 80778 | 320420 | 368458 |

---

*See accompanying notes.* 

45 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Money Market Trust Series NAV | Money Market Trust Series NAV | Opportunistic Fixed Income Trust Series I | Opportunistic Fixed Income Trust Series I | Opportunistic Fixed Income Trust Series II | Opportunistic Fixed Income Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $11750 | $15109 | $73427 | $33451 | $248795 | $133740 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (4772) | (5011) | (16496) | (15127) | (63507) | (67362) |
|  Net investment income (loss) | 6978 | 10098 | 56931 | 18324 | 185288 | 66378 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) |  |  | (17251) | (21869) | (94937) | (125190) |
|  Realized gains (losses) |  |  | (17251) | (21869) | (94937) | (125190) |
|  Unrealized appreciation (depreciation) during the period |  |  | 47526 | (15713) | 211833 | (30905) |
|  Net increase (decrease) in net assets from operations | 6978 | 10098 | 87206 | (19258) | 302184 | (89717) |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  | 165 | 180 | 3513 | 14343 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 6415 | (7912) | 196104 | 2608 | 171670 | 152390 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (27408) | (21500) | (80056) | (108583) | (471627) | (575430) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (1102) | (1483) | (293) | (397) | (13665) | (15563) |
|  Net increase (decrease) in net assets from principal transactions | (22095) | (30895) | 115920 | (106192) | (310109) | (424260) |
|  Total increase (decrease) in net assets | (15117) | (20797) | 203126 | (125450) | (7925) | (513977) |
|  Net assets at beginning of period | 302339 | 323136 | 1009191 | 1134641 | 4165138 | 4679115 |
|  Net assets at end of period | $287222 | $302339 | $1212317 | $1009191 | $4157213 | $4165138 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 23822 | 26294 | 26797 | 29906 | 214465 | 235879 |
|  Units issued | 787 | 685 | 5101 | 205 | 15323 | 13512 |
|  Units redeemed | (2488) | (3157) | (2200) | (3314) | (30696) | (34926) |
|  Units, end of period | 22121 | 23822 | 29698 | 26797 | 199092 | 214465 |

---

*See accompanying notes.* 

46 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Real Estate Securities Trust Series I | <br>Real Estate Securities Trust Series I | Real Estate Securities Trust Series II | Real Estate Securities Trust Series II | Science & Technology Trust Series I | Science & Technology Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $17484 | $21866 | $45447 | $60667 | $- | $- |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (13799) | (16901) | (42588) | (49008) | (156146) | (143623) |
|  Net investment income (loss) | 3685 | 4965 | 2859 | 11659 | (156146) | (143623) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |  | 2174596 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 8027 | 73978 | 54022 | 23338 | (290703) | (1050480) |
|  Realized gains (losses) | 8027 | 73978 | 54022 | 23338 | 1883893 | (1050480) |
|  Unrealized appreciation (depreciation) during the period | (21124) | 21759 | (97082) | 231713 | 459749 | 4122841 |
|  Net increase (decrease) in net assets from operations | (9412) | 100702 | (40201) | 266710 | 2187496 | 2928738 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  | 2288 | 2314 | 2235 | 2118 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 25739 | (171164) | (34357) | (141741) | (129648) | (137370) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (78175) | (151535) | (413383) | (207828) | (968993) | (1039924) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (379) | (411) | (6982) | (7472) | (2883) | (3042) |
|  Net increase (decrease) in net assets from principal transactions | (52815) | (323110) | (452434) | (354727) | (1099289) | (1178218) |
|  Total increase (decrease) in net assets | (62227) | (222408) | (492635) | (88017) | 1088207 | 1750520 |
|  Net assets at beginning of period | 996261 | 1218669 | 3130486 | 3218503 | 10682506 | 8931986 |
|  Net assets at end of period | $934034 | $996261 | $2637851 | $3130486 | $11770713 | $10682506 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 13032 | 17570 | 57043 | 63730 | 116569 | 130062 |
|  Units issued | 372 | 142 | 1713 | 1603 | 420 | 6360 |
|  Units redeemed | (1103) | (4680) | (9904) | (8290) | (11033) | (19853) |
|  Units, end of period | 12301 | 13032 | 48852 | 57043 | 105956 | 116569 |

---

*See accompanying notes.* 

47 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Science & Technology Trust Series II | <br>Science & Technology Trust Series II | Select Bond Trust Series I | Select Bond Trust Series I | Select Bond Trust Series II | Select Bond Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $(1) | $- | $16581 | $14054 | $1736067 | $1513664 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (157325) | (160717) | (3837) | (3864) | (661581) | (694077) |
|  Net investment income (loss) | (157326) | (160717) | 12744 | 10190 | 1074486 | 819587 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 2527924 |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (415975) | (981237) | (5184) | (8193) | (800870) | (779491) |
|  Realized gains (losses) | 2111949 | (981237) | (5184) | (8193) | (800870) | (779491) |
|  Unrealized appreciation (depreciation) during the period | 93912 | 4405389 | 17143 | 1006 | 2151731 | 37122 |
|  Net increase (decrease) in net assets from operations | 2048535 | 3263435 | 24703 | 3003 | 2425347 | 77218 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 5242 | 750 |  |  | 13456 | 25781 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (209806) | (77521) | 17051 | 30179 | 2259797 | 3302088 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (2085026) | (1076399) | (28923) | (45712) | (5146264) | (5072945) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (28944) | (37945) | (4044) | (3938) | (213957) | (239325) |
|  Net increase (decrease) in net assets from principal transactions | (2318534) | (1191115) | (15916) | (19471) | (3086968) | (1984401) |
|  Total increase (decrease) in net assets | (269999) | 2072320 | 8787 | (16468) | (661621) | (1907183) |
|  Net assets at beginning of period | 11717129 | 9644809 | 395544 | 412012 | 44173626 | 46080809 |
|  Net assets at end of period | $11447130 | $11717129 | $404331 | $395544 | $43512005 | $44173626 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 99246 | 110940 | 27757 | 29111 | 3471831 | 3618431 |
|  Units issued | 2451 | 7121 | 1839 | 2098 | 572423 | 664463 |
|  Units redeemed | (20925) | (18815) | (2928) | (3452) | (807555) | (811063) |
|  Units, end of period | 80772 | 99246 | 26668 | 27757 | 3236699 | 3471831 |

---

*See accompanying notes.* 

48 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Short Term Government Income Trust Series<br>I | Short Term Government Income Trust Series<br>I | Short Term Government Income Trust Series<br>II | Short Term Government Income Trust Series<br>II | Small Cap Core Trust Series II | Small Cap Core Trust Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025<br>(a) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $26718 | $15375 | $29693 | $13085 | $17114 | $11001 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (24031) | (28856) | (30219) | (33520) | (26693) | (30826) |
|  Net investment income (loss) | 2687 | (13481) | (526) | (20435) | (9579) | (19825) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |  | 173186 | 112160 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (21087) | (20326) | 3239 | (37391) | (53071) | (75512) |
|  Realized gains (losses) | (21087) | (20326) | 3239 | (37391) | 120115 | 36648 |
|  Unrealized appreciation (depreciation) during the period | 76626 | 55391 | 55624 | 75607 | (144821) | 71666 |
|  Net increase (decrease) in net assets from operations | 58226 | 21584 | 58337 | 17781 | (34285) | 88489 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 35515 | 325 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (13255) | 215144 | 317510 | (134845) | 39985 | (2047) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (463192) | (177059) | (377940) | (265699) | (91489) | (238335) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (292) | (323) | (3912) | (4626) | (3462) | (3742) |
|  Net increase (decrease) in net assets from principal transactions | (441224) | 38087 | (64342) | (405170) | (54966) | (244124) |
|  Total increase (decrease) in net assets | (382998) | 59671 | (6005) | (387389) | (89251) | (155635) |
|  Net assets at beginning of period | 1847846 | 1788175 | 1803731 | 2191120 | 1922191 | 2077826 |
|  Net assets at end of period | $1464848 | $1847846 | $1797726 | $1803731 | $1832940 | $1922191 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 161463 | 158458 | 164666 | 201525 | 48003 | 53987 |
|  Units issued | 5337 | 24966 | 44242 | 12219 | 1749 | 1467 |
|  Units redeemed | (44055) | (21961) | (50077) | (49078) | (3098) | (7451) |
|  Units, end of period | 122745 | 161463 | 158831 | 164666 | 46654 | 48003 |
|  | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. | (a) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II. |

---

*See accompanying notes.* 

49 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Small Cap Index Trust Series I | Small Cap Index Trust Series I | Small Cap Index Trust Series II | Small Cap Index Trust Series II | Small Cap Opportunities Trust Series I | Small Cap Opportunities Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $2688 | $1303 | $45696 | $13418 | $26391 $| 14673 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (3292) | (3972) | (66133) | (74196) | (37761) | (39624) |
|  Net investment income (loss) | (604) | (2669) | (20437) | (60778) | (11370) | (24951) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 12737 | 6418 | 251126 | 102925 | 216747 | 154811 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (7710) | 4305 | (30556) | (60229) | (15965) | (14738) |
|  Realized gains (losses) | 5027 | 10723 | 220570 | 42696 | 200782 | 140073 |
|  Unrealized appreciation (depreciation) during the period | 14692 | 18402 | 220813 | 377260 | 1980 | 72597 |
|  Net increase (decrease) in net assets from operations | 19115 | 26456 | 420946 | 359178 | 191392 | 187719 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  | 2920 | 2975 | 280 | 300 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (21897) | (5157) | (316980) | 122293 | (32451) | (77791) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (9537) | (32830) | (582482) | (488115) | (109158) | (159410) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (94) | (106) | (14080) | (16921) | (371) | (446) |
|  Net increase (decrease) in net assets from principal transactions | (31528) | (38093) | (910622) | (379768) | (141700) | (237347) |
|  Total increase (decrease) in net assets | (12413) | (11637) | (489676) | (20590) | 49692 | (49628) |
|  Net assets at beginning of period | 242416 | 254053 | 4810431 | 4831021 | 2690949 | 2740577 |
|  Net assets at end of period | $230003 | $242416 | $4320755 | $4810431 | $2740641 | $2690949 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 5237 | 5981 | 104172 | 114398 | 41406 | 45119 |
|  Units issued | 58 | 483 | 2473 | 11309 | 198 | 280 |
|  Units redeemed | (789) | (1227) | (21894) | (21535) | (2400) | (3993) |
|  Units, end of period | 4506 | 5237 | 84751 | 104172 | 39204 | 41406 |

---

*See accompanying notes.* 

50 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Small Cap Opportunities Trust Series II | <br>Small Cap Opportunities Trust Series II | Small Cap Stock Trust Series II | Small Cap Stock Trust Series II | Small Company Value Trust Series I | Small Company Value Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $32607 | $18859 | $- | $- | $8674 | $10061 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (61664) | (77951) | (23861) | (24682) | (25632) | (27777) |
|  Net investment income (loss) | (29057) | (59092) | (23861) | (24682) | (16958) | (17716) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 324608 | 287878 |  |  | 161003 | 70765 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (26526) | (120715) | (64155) | (185496) | (4549) | (110783) |
|  Realized gains (losses) | 298082 | 167163 | (64155) | (185496) | 156454 | (40018) |
|  Unrealized appreciation (depreciation) during the period | (4333) | 206307 | 265038 | 365707 | (48369) | 215613 |
|  Net increase (decrease) in net assets from operations | 264692 | 314378 | 177022 | 155529 | 91127 | 157879 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 9361 | 7320 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (101176) | (753399) | 10445 | (16425) | 22517 | 11093 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (1110151) | (601827) | (91991) | (131316) | (110580) | (223447) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (15728) | (21420) | (1958) | (2101) | (674) | (868) |
|  Net increase (decrease) in net assets from principal transactions | (1217694) | (1369326) | (83504) | (149842) | (88737) | (213222) |
|  Total increase (decrease) in net assets | (953002) | (1054948) | 93518 | 5687 | 2390 | (55343) |
|  Net assets at beginning of period | 4966570 | 6021518 | 1677144 | 1671457 | 1792987 | 1848330 |
|  Net assets at end of period | $4013568 | $4966570 | $1770662 | $1677144 | $1795377 | $1792987 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 80976 | 104672 | 34186 | 37197 | 27906 | 31221 |
|  Units issued | 1615 | 2038 | 327 | 1334 | 343 | 311 |
|  Units redeemed | (21225) | (25734) | (2093) | (4345) | (1763) | (3626) |
|  Units, end of period | 61366 | 80976 | 32420 | 34186 | 26486 | 27906 |

---

*See accompanying notes.* 

51 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Small Company Value Trust Series II | Small Company Value Trust Series II | Strategic Income Opportunities Trust<br>Series I | Strategic Income Opportunities Trust<br>Series I | Strategic Income Opportunities Trust<br>Series II | Strategic Income Opportunities Trust<br>Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $13950 | $18886 | $121088 | $44457 | $234577 | $82585 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (62537) | (70919) | (21763) | (24050) | (47329) | (51043) |
|  Net investment income (loss) | (48587) | (52033) | 99325 | 20407 | 187248 | 31542 |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 397455 | 189413 |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (25090) | (161348) | (10344) | (17188) | (19313) | (32309) |
|  Realized gains (losses) | 372365 | 28065 | (10344) | (17188) | (19313) | (32309) |
|  Unrealized appreciation (depreciation) during the period | (113381) | 392319 | 167 | 22965 | (4140) | 42703 |
|  Net increase (decrease) in net assets from operations | 210397 | 368351 | 89148 | 26184 | 163795 | 41936 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 800 | 840 | 378 | 1538 | 960 | 1979 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 4503 | 111858 | 13417 | 34976 | 89904 | 227673 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (468193) | (817597) | (210645) | (241364) | (466778) | (358689) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (9927) | (10071) | (465) | (607) | (7984) | (9272) |
|  Net increase (decrease) in net assets from principal transactions | (472817) | (714970) | (197315) | (205457) | (383898) | (138309) |
|  Total increase (decrease) in net assets | (262420) | (346619) | (108167) | (179273) | (220103) | (96373) |
|  Net assets at beginning of period | 4368177 | 4714796 | 1629382 | 1808655 | 3266799 | 3363172 |
|  Net assets at end of period | $4105757 | $4368177 | $1521215 | $1629382 | $3046696 | $3266799 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 85290 | 99340 | 66476 | 75009 | 141618 | 147529 |
|  Units issued | 1651 | 4340 | 1789 | 2637 | 7100 | 12529 |
|  Units redeemed | (10867) | (18390) | (9718) | (11170) | (23378) | (18440) |
|  Units, end of period | 76074 | 85290 | 58547 | 66476 | 125340 | 141618 |

---

*See accompanying notes.* 

52 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | <br>Total Bond Market Series Trust NAV | <br>Total Bond Market Series Trust NAV | Total Bond Market Trust Series II | Total Bond Market Trust Series II | Total Stock Market Index Trust Series I | Total Stock Market Index Trust Series I |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $18819 | $15073 | $148517 | $146062 | $36062 | $19343 |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (4879) | (4898) | (69922) | (76715) | (60833) | (59590) |
|  Net investment income (loss) | 13940 | 10175 | 78595 | 69347 | (24771) | (40247) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |  | 82014 | 158610 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | (6222) | (9015) | (281762) | (223346) | 183985 | 123191 |
|  Realized gains (losses) | (6222) | (9015) | (281762) | (223346) | 265999 | 281801 |
|  Unrealized appreciation (depreciation) during the period | 21125 | (710) | 428137 | 109900 | 346722 | 545034 |
|  Net increase (decrease) in net assets from operations | 28843 | 450 | 224970 | (44099) | 587950 | 786588 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments |  |  |  |  | 1320 | 1455 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 25227 | 43480 | 79378 | (96655) | (106035) | (6955) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (37149) | (54691) | (1424847) | (300605) | (358462) | (314764) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (5148) | (4993) | (27729) | (35248) | (1168) | (1259) |
|  Net increase (decrease) in net assets from principal transactions | (17070) | (16204) | (1373198) | (432508) | (464345) | (321523) |
|  Total increase (decrease) in net assets | 11773 | (15754) | (1148228) | (476607) | 123605 | 465065 |
|  Net assets at beginning of period | 502940 | 518694 | 5155727 | 5632334 | 4195859 | 3730794 |
|  Net assets at end of period | $514713 | $502940 | $4007499 | $5155727 | $4319464 | $4195859 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 39247 | 40488 | 441660 | 480244 | 81521 | 88196 |
|  Units issued | 2927 | 3348 | 39066 | 60359 | 831 | 1771 |
|  Units redeemed | (4223) | (4589) | (152200) | (98943) | (9308) | (8446) |
|  Units, end of period | 37951 | 39247 | 328526 | 441660 | 73044 | 81521 |

---

*See accompanying notes.* 

53 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | $— | $— | $— | $— | $— | $— |
|  | Total Stock Market Index Trust Series II | Total Stock Market Index Trust Series II | U.S. Growth Trust - Series I | U.S. Growth Trust - Series I | U.S. Growth Trust - Series II | U.S. Growth Trust - Series II |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025<br>(b) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025<br>(c) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 |
|  Income: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $46022 | $22332 | $- | $- | $- | $- |
|  Expenses: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (108521) | (110888) | (207709) | (195335) | (153452) | (156274) |
|  Net investment income (loss) | (62499) | (88556) | (207709) | (195335) | (153452) | (156274) |
|  Realized gains (losses) on investments: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received | 130101 | 276337 | 1520335 | 704539 | 1352264 | 657071 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 431580 | 365187 | 491806 | 287149 | (90793) | (127801) |
|  Realized gains (losses) | 561681 | 641524 | 2012141 | 991688 | 1261471 | 529270 |
|  Unrealized appreciation (depreciation) during the period | 411209 | 789568 | 713778 | 2565665 | 564575 | 2075944 |
|  Net increase (decrease) in net assets from operations | 910391 | 1342536 | 2518210 | 3362018 | 1672594 | 2448940 |
|  Changes from principal transactions: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 1998 | 2081 | 4935 | 14385 | 980 | 900 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | (44363) | (158099) | (352019) | 4370 | (28109) | (142415) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (858914) | (482667) | (1287474) | (1457090) | (1033470) | (1531684) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (23931) | (24836) | (3383) | (3797) | (22612) | (24455) |
|  Net increase (decrease) in net assets from principal transactions | (925210) | (663521) | (1637941) | (1442132) | (1083211) | (1697654) |
|  Total increase (decrease) in net assets | (14819) | 679015 | 880269 | 1919886 | 589383 | 751286 |
|  Net assets at beginning of period | 6947527 | 6268512 | 14059873 | 12139987 | 9863067 | 9111781 |
|  Net assets at end of period | $6932708 | $6947527 | $14940142 | $14059873 | $10452450 | $9863067 |
|  | 2025 | 2024 | 2025 | 2024 | 2025 | 2024 |
|  Units, beginning of period | 108531 | 118729 | 223871 | 249352 | 108438 | 128125 |
|  Units issued | 2152 | 10672 | 1912 | 7193 | 1565 | 5338 |
|  Units redeemed | (16345) | (20870) | (25564) | (32674) | (13157) | (25025) |
|  Units, end of period | 94338 | 108531 | 200219 | 223871 | 96846 | 108438 |
|  | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. | (b) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I. |
|  | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. | (c) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II. |

---

*See accompanying notes.* 

54 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**STATEMENTS OF OPERATIONS AND CHANGES IN CONTRACT OWNERS' EQUITY** 

**For the years ended December 31,** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | |
|:---|:---|:---|:---|
|  | $— | $— | $|
|  | Ultra Short Term Bond Trust Series II | Ultra Short Term Bond Trust Series II | |
|  | 2025 | 2024 | |
|  Income: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Dividend distributions received | $609089 | $205512 |  |
|  Expenses: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mortality and expense risk and administrative charges | (208119) | (226438) |  |
|  Net investment income (loss) | 400970 | (20926) |  |
|  Realized gains (losses) on investments: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capital gain distributions received |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net realized gain (loss) | 296634 | 187180 |  |
|  Realized gains (losses) | 296634 | 187180 |  |
|  Unrealized appreciation (depreciation) during the period | (367681) | 306866 |  |
|  Net increase (decrease) in net assets from operations | 329923 | 473120 |  |
|  Changes from principal transactions: |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Purchase payments | 50500 | 16200 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers between sub-accounts and the company | 6858864 | 5389577 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Withdrawals | (8923887) | (8937632) |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Annual contract fee | (63183) | (85679) |  |
|  Net increase (decrease) in net assets from principal transactions | (2077706) | (3617534) |  |
|  Total increase (decrease) in net assets | (1747783) | (3144414) |  |
|  Net assets at beginning of period | 13175268 | 16319682 |  |
|  Net assets at end of period | $11427485 | $13175268 |  |
|  | 2025 | 2024 |  |
|  Units, beginning of period | 1155507 | 1469082 |  |
|  Units issued | 972545 | 1163020 |  |
|  Units redeemed | (1153203) | (1476595) |  |
|  Units, end of period | 974849 | 1155507 |  |

---

*See accompanying notes.* 

55 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS** 

**December 31, 2025** 

**1. Organization** 

JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A (the "Account") is a separate account established by John Hancock Life Insurance Company of New York (the "Company"). The Account operates as a Unit Investment Trust under the Investment Company Act of 1940, as amended (the "Act") and is an investment company and accordingly follows the investment company accounting and reporting guidance of the Financial Accounting Standards Board ("FASB") Accounting Standards Codification ("ASC") Topic 946 Financial Services – Investment Companies. The Account consists of 97 active sub-accounts which are exclusively invested in a corresponding portfolio of the John Hancock Variable Insurance Trust (the "Trust"). The Trust is registered under the Act as an open-ended management investment company, commonly known as a mutual fund, which does not transact with the general public. The Account is a funding vehicle for the allocation of net premiums under variable annuity contracts (the "Contracts") issued by the Company.

The Company is a wholly owned subsidiary of John Hancock Life Insurance Company (U.S.A.) ("JHUSA"), which in turn is an indirect, wholly owned subsidiary of the Manufacturers Life Insurance Company which is an indirect, wholly owned subsidiary of Manulife Financial Corporation (""MFC""), a Canadian based publicly traded life insurance company. MFC and its subsidiaries are known collectively as Manulife Financial.

The Company is required to maintain assets in the Account with a total fair value of at least equal to the reserves and other liabilities relating to the variable benefits under all Contracts participating in the Account. These assets may not be charged with liabilities which arise from any other business the Company conducts. However, all obligations under the Contracts are general corporate obligations of the Company.

In addition to the Account, certain contract owners may also allocate funds to the fixed account, which is part of the Company's general account. Because of exemptive and exclusionary provisions, interests in the fixed account have not been registered under the Securities Act of 1933, and the Company's general account has not been registered as an investment company under the Investment Company Act of 1940. Net interfund transfers include transfers between separate and general accounts.

Each sub-account holds shares of a particular series ("Portfolio") of a registered investment company. Sub-accounts that invest in Portfolios of the Trust may offer 4 classes of units to fund Contracts issued by the Company. These classes, Series I, Series II, Series III and Series NAV, represent an interest in the same Trust Portfolio, but in different classes of that Portfolio. Series I, Series II, Series III and Series NAV shares of the Trust Portfolio differ in the level of 12b-1 fees and other expenses assessed against the Portfolio's assets.

As a result of a portfolio change, the following sub-accounts of the Account were renamed as follows:

---

| | | |
|:---|:---|:---|
| **<u>Previous Name</u>** | **<u>New Name</u>** | **<u>Effective Date</u>** |
| Capital Appreciation Trust Series I | U.S. Growth Trust - Series I | 05/01/2025 |
| Capital Appreciation Trust Series II | U.S. Growth Trust - Series II | 05/01/2025 |
| Small Cap Value Trust Series II | Small Cap Core Trust Series II | 04/28/2025 |

---

56 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**2. Significant Accounting Policies** 

***Estimates***

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from reported results using those estimates.

***Valuation of Investments***

Investments made in the Portfolios of the Trust are valued at fair value based on the reported net asset values of such Portfolios. Investment transactions are recorded on the trade date. Income from dividends, and gains from realized gain distributions are recorded on the ex-dividend date. Realized gains and losses on the sales of investments are computed on a first-in, first-out basis.

***Net Assets in Payout (Annuitization) Period***

A portion of net assets is allocated to annuity policies in the payout period. The liability for these policies is calculated using statutory accounting using mortality assumptions and an assumed interest rate. Mortality assumptions are based on the Individual Annuity Mortality Table in effect at the time of annuitization. The assumed interest rate is 3% to 4%, as regulated by the laws of the respective states. The mortality risk is borne entirely by the Company and may result in additional amounts being transferred into the variable annuity account by the Company to cover greater longevity of annuitants than expected. Conversely, if amounts allocated exceed amounts required, transfers may be made to the Company.

***Amounts Receivable/Payable***

Receivables/Payables from/to Portfolios/the Company are due to unsettled contract transactions (net of asset-based charges) and/or subsequent/preceding purchases/sales of the respective Portfolios' shares. The amounts are due from/to either the respective Portfolio and/or the Company for the benefit of contract owners. There are no unsettled policy transactions at December 31, 2025.

57 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**3. Federal Income Taxes** 

The Account does not file separate tax returns. The taxable income of the Account is consolidated with that of the Company within the consolidated federal tax return. Any tax contingencies arising from the taxable income generated by the Account is the responsibility of the Company and the Company holds any and all tax contingencies on its financial statements. The Internal Revenue Service completed the audit of the Company's consolidated federal tax return for tax years 2014-2015 and 2016-2018. The Company's consolidated federal tax return for the years 2019- 2022 are currently under examination by the Internal Revenue Service. The years from 2022 on are also open for examination by the Internal Revenue Service. The Account is not a party to the consolidated tax sharing agreement thus no amount of income taxes or tax contingencies are passed through to the Account. The legal form of the Account is not taxable in any state or foreign jurisdictions.

The income taxes topic of the FASB ASC establishes a minimum threshold for financial statement recognition of the benefit of positions taken, or expected to be taken, in filing tax returns (including whether the Account is taxable in certain jurisdictions). The topic requires the evaluation of tax positions taken or expected to be taken in the course of preparing the Company's tax returns to determine whether tax positions are "more-likely-than-not" of being sustained by the applicable tax authority. Tax positions deemed to meet the more-likely-than-not threshold would be recorded as tax expense or benefit.

The Account complies with the provisions of FASB ASC Topic 740, Income Taxes. As of December 31, 2025, the Account did not have a liability for any uncertain tax positions. The Account recognizes interest and penalties, if any, related to tax liabilities as income tax expense in the Statements of Operations and Changes in Contract Owners' Equity.

**4. Transactions with Affiliates** 

The Company has an administrative services agreement with Manulife Financial, whereby Manulife Financial or its designee, with the consent of the Company, performs certain services on behalf of the Company necessary for the operation of the Account. John Hancock Investment Management Services, LLC ("JHIMS"), a Delaware limited liability company controlled by MFC, serves as investment adviser for the Trust.

John Hancock Distributors, LLC, a registered broker-dealer and wholly owned subsidiary of JHUSA, acts as the principle underwriter of the Contracts pursuant to a distribution agreement with the Company. Contracts are sold by registered representatives of either John Hancock Distributors, LLC or other broker-dealers having distribution agreements with John Hancock Distributors , LLC.

Certain officers of the Account are officers and directors of JHUSA or the Trust.

Contract charges, as described in Note 9, are paid to the Company.

58 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**5. Fair Value Measurements** 

ASC 820 "Fair Value Measurements and Disclosures" provides a single definition of fair value for accounting purposes, establishes a consistent framework for measuring fair value, and expands disclosure requirements about fair value measurements. ASC 820 defines fair value as the value that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit value. An exit value is not a forced liquidation or distressed sale.

Following ASC 820 guidance, the Account has categorized its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Account's valuation techniques. A level is assigned to each fair value measurement based on the lowest level input significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1 – Fair value measurements that reflect unadjusted, quoted prices in active markets for
identical assets and liabilities that the Account has the ability to access at the measurement date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2 – Fair value measurements using inputs other than quoted prices included within
Level 1 that are observable, either directly or indirectly.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3 – Fair value measurements using significant non market observable inputs.

All of the Account's sub-accounts' investments in a Portfolio of the Trust were valued at the reported net asset value of the Portfolio and categorized as Level 1 as of December 31, 2025. The following table presents the Account's assets that are measured at fair value on a recurring basis by fair value hierarchy level under ASC 820, as of December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Level 1** | **Level 2** | **Level 3** | **Total** |
|  Mutual Funds |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp; Affiliated | $1896584866 |  |  | 1896584866 |
|  Total | $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1896584866 |  |  | 1896584866 |

---

Assets owned by the Account are primarily open-ended mutual fund investments issued by the Trust. These are classified within Level 1, as fair values of the underlying funds are based upon reported net asset values ("NAV"), which represent the values at which each sub-account can redeem its investments.

Changes in valuation techniques may result in transfer in or out of an assigned level within the disclosure hierarchy. Transfers between investment levels may occur as the availability of a price source or data used in an investment's valuation changes. Transfers between investment levels are recognized at the beginning of the reporting period. There have been no transfers between any level of fair value measurements during the period ended December 31, 2025.

59 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**6. Purchases and Sales of Investments** 

The cost of purchases including reinvestment of dividend distributions and proceeds from the sales of investments in the Portfolios of the Trust during 2025 were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Sub-Account</u>** | **<u>Purchases</u>** | **<u>Purchases</u>** | **<u>Sales</u>** | **<u>Sales</u>** |
|  500 Index Fund Series I | $— | 1450842 | $— | 1525504 |
|  500 Index Fund Series II |  | 3219964 |  | 4274783 |
|  500 Index Fund Series NAV |  | 218365 |  | 1250282 |
|  Active Bond Trust Series I |  | 32843 |  | 110537 |
|  Active Bond Trust Series II |  | 2400110 |  | 2450116 |
|  American Asset Allocation Trust Series I |  | 621080 |  | 814373 |
|  American Asset Allocation Trust Series II |  | 5520790 |  | 8570238 |
|  American Global Growth Trust Series II |  | 772111 |  | 1896358 |
|  American Global Growth Trust Series III |  | 617 |  | 893 |
|  American Growth Trust Series II |  | 8949240 |  | 16639798 |
|  American Growth Trust Series III |  | 41600 |  | 51434 |
|  American Growth-Income Trust Series I |  | 862995 |  | 1243472 |
|  American Growth-Income Trust Series II |  | 8253710 |  | 11141500 |
|  American Growth-Income Trust Series III |  | 58519 |  | 65697 |
|  American International Trust Series II |  | 404059 |  | 6363148 |
|  American International Trust Series III |  | 2495 |  | 33996 |
|  Blue Chip Growth Trust Series I |  | 4136421 |  | 4638087 |
|  Blue Chip Growth Trust Series II |  | 3039260 |  | 2881827 |
|  Capital Appreciation Value Trust Series II |  | 2323299 |  | 2842232 |
|  Core Bond Trust Series I |  | 658252 |  | 295464 |
|  Core Bond Trust Series II |  | 875689 |  | 847559 |
|  Disciplined Value Emerging Markets Value Trust Series II |  | 164609 |  | 864767 |
|  Disciplined Value International Trust Series I |  | 319378 |  | 384342 |
|  Disciplined Value International Trust Series II |  | 712576 |  | 1045617 |
|  Equity Income Trust Series I |  | 3485256 |  | 2083702 |
|  Equity Income Trust Series II |  | 2516803 |  | 2042522 |
|  Financial Industries Trust Series I |  | 44460 |  | 37641 |
|  Financial Industries Trust Series II |  | 117931 |  | 420606 |
|  Fundamental All Cap Core Trust Series II |  | 696047 |  | 1313833 |
|  Fundamental Large Cap Value Trust Series I |  | 3288061 |  | 2977200 |
|  Fundamental Large Cap Value Trust Series II |  | 2772445 |  | 3999708 |
|  Global Equity Trust Series I |  | 766556 |  | 683703 |
|  Global Equity Trust Series II |  | 428302 |  | 799970 |
|  Health Sciences Trust Series I |  | 399843 |  | 202770 |
|  Health Sciences Trust Series II |  | 847172 |  | 898147 |
|  High Yield Trust Series I |  | 107912 |  | 136239 |
|  High Yield Trust Series II |  | 298236 |  | 584816 |
|  International Equity Index Series I |  | 66446 |  | 108911 |
|  International Equity Index Series II |  | 96917 |  | 865783 |
|  International Equity Index Series NAV |  | 18563 |  | 133940 |
|  International Small Company Trust Series I |  | 78657 |  | 113066 |
|  International Small Company Trust Series II |  | 107959 |  | 518911 |
|  Investment Quality Bond Trust Series I |  | 250954 |  | 162990 |
|  Investment Quality Bond Trust Series II |  | 1407887 |  | 1754644 |
|  Lifestyle Balanced Portfolio Series I |  | 729826 |  | 805431 |
|  Lifestyle Balanced Portfolio Series II |  | 20718973 |  | 38413568 |
|  Lifestyle Conservative Portfolio Series I |  | 132551 |  | 293890 |
|  Lifestyle Conservative Portfolio Series II |  | 2511413 |  | 8214845 |
|  Lifestyle Growth Portfolio Series I |  | 1025912 |  | 1009645 |

---

60 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**6. Purchases and Sales of Investments (continued):** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | | | |
|:---|:---|:---|:---|:---|
| **<u>Sub-Account</u>** | **<u>Purchases</u>** | **<u>Purchases</u>** | **<u>Sales</u>** | **<u>Sales</u>** |
|  Lifestyle Growth Portfolio Series II | $— | 59472691 | $— | 76815611 |
|  Lifestyle Growth Portfolio Series NAV |  | 13281 |  | 7112 |
|  Lifestyle Moderate Portfolio Series I |  | 161223 |  | 298321 |
|  Lifestyle Moderate Portfolio Series II |  | 4047084 |  | 10096303 |
|  Managed Volatility Balanced Portfolio Series I |  | 247740 |  | 692490 |
|  Managed Volatility Balanced Portfolio Series II |  | 7480627 |  | 20171638 |
|  Managed Volatility Conservative Portfolio Series I |  | 19171 |  | 54734 |
|  Managed Volatility Conservative Portfolio Series II |  | 966862 |  | 2921528 |
|  Managed Volatility Growth Portfolio Series I |  | 692682 |  | 316875 |
|  Managed Volatility Growth Portfolio Series II |  | 11717919 |  | 22399247 |
|  Managed Volatility Moderate Portfolio Series I |  | 64465 |  | 139901 |
|  Managed Volatility Moderate Portfolio Series II |  | 2069973 |  | 6673102 |
|  Mid Cap Growth Trust Series I |  | 42011 |  | 552397 |
|  Mid Cap Growth Trust Series II |  | 181585 |  | 688201 |
|  Mid Cap Index Trust Series I |  | 435186 |  | 434000 |
|  Mid Cap Index Trust Series II |  | 813989 |  | 1143463 |
|  Mid Value Trust Series I |  | 283711 |  | 169909 |
|  Mid Value Trust Series II |  | 1361278 |  | 746774 |
|  Money Market Trust Series I |  | 114815 |  | 342266 |
|  Money Market Trust Series II |  | 277377 |  | 743356 |
|  Money Market Trust Series NAV |  | 21835 |  | 36953 |
|  Opportunistic Fixed Income Trust Series I |  | 276078 |  | 103225 |
|  Opportunistic Fixed Income Trust Series II |  | 564216 |  | 689037 |
|  Real Estate Securities Trust Series I |  | 46187 |  | 95317 |
|  Real Estate Securities Trust Series II |  | 131632 |  | 581207 |
|  Science & Technology Trust Series I |  | 2219697 |  | 1300537 |
|  Science & Technology Trust Series II |  | 2847022 |  | 2794958 |
|  Select Bond Trust Series I |  | 43428 |  | 46599 |
|  Select Bond Trust Series II |  | 9322543 |  | 11335026 |
|  Short Term Government Income Trust Series I |  | 87825 |  | 526362 |
|  Short Term Government Income Trust Series II |  | 534326 |  | 599194 |
|  Small Cap Core Trust Series II |  | 256799 |  | 148158 |
|  Small Cap Index Trust Series I |  | 18106 |  | 37500 |
|  Small Cap Index Trust Series II |  | 407671 |  | 1087604 |
|  Small Cap Opportunities Trust Series I |  | 254557 |  | 190881 |
|  Small Cap Opportunities Trust Series II |  | 452884 |  | 1375027 |
|  Small Cap Stock Trust Series II |  | 16560 |  | 123925 |
|  Small Company Value Trust Series I |  | 192275 |  | 136965 |
|  Small Company Value Trust Series II |  | 497108 |  | 621058 |
|  Strategic Income Opportunities Trust Series I |  | 166165 |  | 264154 |
|  Strategic Income Opportunities Trust Series II |  | 404326 |  | 600976 |
|  Total Bond Market Series Trust NAV |  | 57338 |  | 60467 |
|  Total Bond Market Trust Series II |  | 612279 |  | 1906882 |
|  Total Stock Market Index Trust Series I |  | 162159 |  | 569260 |
|  Total Stock Market Index Trust Series II |  | 324306 |  | 1181914 |
|  U.S. Growth Trust - Series I |  | 1643437 |  | 1968751 |
|  U.S. Growth Trust - Series II |  | 1508386 |  | 1392785 |
|  Ultra Short Term Bond Trust Series II |  | 12011080 |  | 13687816 |

---

61 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values** 

A summary of unit values and units outstanding for variable annuity contracts and the expense and income ratios, excluding expenses of the underlying Portfolios, were as follows:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **Sub-account** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value<br>Highest to Lowest (a)** | **Assets<br>(000s)** | **Expense Ratio<br>Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return<br>Highest to Lowest (d)** |
|  500 Index Fund Series I(\*) | 2025 | 296 | $61.53 to $58.75 | $18143 | 1.75 % to 1.40% | 1.07% | 15.89 % to 15.49% |
|  | 2024 | 302 | 53.09 to 50.88 | 15960 | 1.75 to 1.40 | 1.05 | 22.85 to 22.42 |
|  | 2023 | 327 | 43.21 to 41.56 | 14074 | 1.75 to 1.40 | 1.20 | 24.15 to 23.72 |
|  | 2022 | 362 | 34.81 to 33.59 | 12618 | 1.75 to 1.40 | 1.20 | -19.50 to -19.78 |
|  | 2021 | 383 | 43.24 to 41.88 | 16647 | 1.75 to 1.40 | 1.33 | 26.51 to 26.07 |
|  500 Index Fund Series II(\*) | 2025 | 384 | 56.48 to 40.66 | 22608 | 1.85 to 1.00 | 0.86 | 16.11 to 15.12 |
|  | 2024 | 410 | 49.06 to 35.02 | 20880 | 1.85 to 1.00 | 0.86 | 23.11 to 22.06 |
|  | 2023 | 436 | 40.19 to 28.45 | 18127 | 1.85 to 1.00 | 1.09 | 24.39 to 23.34 |
|  | 2022 | 447 | 32.42 to 22.87 | 15063 | 1.90 to 1.00 | 1.00 | -19.32 to -20.04 |
|  | 2021 | 451 | 40.55 to 28.35 | 18986 | 1.90 to 1.00 | 1.12 | 26.76 to 25.63 |
|  500 Index Fund Series NAV(\*) | 2025 | 122 | 67.02 to 56.36 | 7211 | 1.75 to 0.80 | 1.07 | 16.63 to 15.53 |
|  | 2024 | 143 | 57.46 to 48.79 | 7313 | 1.75 to 0.80 | 1.07 | 23.67 to 22.49 |
|  | 2023 | 167 | 46.47 to 39.83 | 6963 | 1.75 to 0.80 | 1.34 | 24.95 to 23.78 |
|  | 2022 | 149 | 37.19 to 32.18 | 5015 | 1.75 to 0.80 | 1.27 | -18.96 to -19.72 |
|  | 2021 | 155 | 45.89 to 40.08 | 6508 | 1.75 to 0.80 | 1.31 | 27.33 to 26.13 |
|  Active Bond Trust Series I(\*) | 2025 | 26 | 21.15 to 19.67 | 538 | 1.75 to 1.40 | 4.40 | 5.89 to 5.52 |
|  | 2024 | 31 | 19.97 to 18.64 | 599 | 1.75 to 1.40 | 3.61 | 0.81 to 0.46 |
|  | 2023 | 36 | 19.81 to 18.55 | 693 | 1.75 to 1.40 | 3.39 | 4.95 to 4.59 |
|  | 2022 | 39 | 18.87 to 17.74 | 742 | 1.75 to 1.40 | 3.22 | -15.04 to -15.34 |
|  | 2021 | 48 | 22.21 to 20.95 | 1058 | 1.75 to 1.40 | 3.12 | -1.95 to -2.29 |
|  Active Bond Trust Series II(\*) | 2025 | 807 | 18.50 to 13.40 | 15699 | 1.85 to 1.15 | 4.35 | 5.96 to 5.22 |
|  | 2024 | 831 | 17.58 to 12.64 | 15355 | 1.85 to 1.15 | 3.57 | 0.89 to 0.18 |
|  | 2023 | 851 | 17.55 to 12.53 | 15633 | 1.85 to 1.15 | 3.35 | 5.00 to 4.27 |
|  | 2022 | 861 | 16.83 to 11.94 | 15121 | 1.85 to 1.15 | 3.04 | -15.00 to -15.59 |
|  | 2021 | 984 | 19.94 to 14.04 | 20399 | 1.85 to 1.15 | 2.95 | -1.91 to -2.59 |
|  American Asset Allocation Trust Series I(\*) | 2025 | 150 | 35.37 to 33.13 | 5241 | 1.75 to 1.40 | 2.14 | 13.79 to 13.39 |
|  | 2024 | 169 | 31.08 to 29.22 | 5197 | 1.75 to 1.40 | 1.77 | 13.99 to 0.00 |
|  | 2023 | 180 | 27.17 to 25.63 | 4828 | 1.75 to 1.40 | 1.85 | 12.32 to 11.93 |
|  | 2022 | 197 | 24.19 to 22.90 | 4716 | 1.75 to 1.40 | 2.29 | -14.95 to -15.25 |
|  | 2021 | 214 | 28.45 to 27.02 | 6031 | 1.75 to 1.40 | 1.59 | 13.11 to 12.72 |
|  American Asset Allocation Trust Series II(\*) | 2025 | 1567 | 35.06 to 31.60 | 52648 | 1.90 to 1.00 | 1.96 | 14.17 to 13.15 |
|  | 2024 | 1792 | 30.71 to 27.93 | 53062 | 1.90 to 1.00 | 1.60 | 14.76 to 13.72 |
|  | 2023 | 2029 | 26.76 to 24.56 | 52592 | 1.90 to 1.00 | 1.75 | 12.55 to 11.55 |
|  | 2022 | 2194 | 23.78 to 22.02 | 50839 | 1.90 to 1.00 | 2.19 | -14.62 to -15.39 |
|  | 2021 | 2414 | 27.85 to 26.02 | 65818 | 1.90 to 1.00 | 1.46 | 13.47 to 12.45 |
|  American Global Growth Trust Series II(\*) | 2025 | 167 | 46.94 to 42.23 | 7462 | 1.85 to 1.00 | 0.89 | 19.88 to 18.86 |
|  | 2024 | 206 | 39.16 to 35.53 | 7765 | 1.85 to 1.00 | 0.98 | 12.01 to 11.06 |
|  | 2023 | 247 | 34.96 to 31.99 | 8330 | 1.85 to 1.00 | 0.42 | 20.81 to 19.79 |
|  | 2022 | 262 | 28.94 to 26.71 | 7551 | 1.85 to 1.00 | 0.42 | -25.83 to -26.45 |
|  | 2021 | 279 | 39.01 to 36.31 | 10777 | 1.85 to 1.00 | 0.00 | 14.77 to 13.79 |
|  American Global Growth Trust Series III(\*) | 2025 | 0 | 57.47 to 57.47 | 6 | 0.80 to 0.80 | 1.60 | 20.58 to 20.58 |
|  | 2024 | 0 | 47.66 to 47.66 | 5 | 0.80 to 0.80 | 1.47 | 12.67 to 12.67 |
|  | 2023 | 0 | 42.30 to 42.30 | 5 | 0.80 to 0.80 | 0.87 | 21.58 to 21.58 |
|  | 2022 | 0 | 34.79 to 34.79 | 5 | 0.80 to 0.80 | 0.70 | -25.37 to -25.37 |
|  | 2021 | 0 | 46.62 to 46.62 | 9 | 0.80 to 0.80 | 0.00 | 15.48 to 15.48 |
|  American Growth Trust Series II(\*) | 2025 | 659 | 120.18 to 82.96 | 78109 | 1.90 to 1.00 | 0.54 | 18.54 to 17.48 |
|  | 2024 | 774 | 102.31 to 69.98 | 77992 | 1.90 to 1.00 | 0.00 | 29.71 to 28.54 |
|  | 2023 | 968 | 79.59 to 53.95 | 75807 | 1.90 to 1.00 | 0.07 | 36.52 to 35.30 |
|  | 2022 | 1177 | 58.83 to 39.52 | 67843 | 1.90 to 1.00 | 1.34 | -30.94 to -31.56 |
|  | 2021 | 1194 | 85.95 to 57.23 | 100218 | 1.90 to 1.00 | 0.32 | 20.28 to 19.20 |
|  American Growth Trust Series III(\*) | 2025 | 4 | 95.60 to 83.59 | 385 | 1.55 to 0.80 | 0.95 | 19.21 to 18.32 |
|  | 2024 | 5 | 80.19 to 70.65 | 358 | 1.55 to 0.80 | 0.07 | 30.54 to 29.56 |
|  | 2023 | 5 | 61.43 to 54.53 | 315 | 1.55 to 0.80 | 0.07 | 37.35 to 36.33 |
|  | 2022 | 7 | 44.72 to 40.00 | 293 | 1.55 to 0.80 | 1.89 | -30.51 to -31.03 |
|  | 2021 | 7 | 64.36 to 57.99 | 413 | 1.55 to 0.80 | 0.74 | 21.03 to 20.12 |
|  American Growth-Income Trust Series I(\*) | 2025 | 82 | 84.84 to 78.36 | 6859 | 1.75 to 1.40 | 1.39 | 16.02 to 15.61 |
|  | 2024 | 96 | 73.12 to 67.78 | 6919 | 1.75 to 1.40 | 0.79 | 21.98 to 21.55 |
|  | 2023 | 111 | 59.95 to 55.76 | 6569 | 1.75 to 1.40 | 1.06 | 23.94 to 23.51 |
|  | 2022 | 117 | 48.37 to 45.15 | 5614 | 1.75 to 1.40 | 2.08 | -17.93 to -18.22 |
|  | 2021 | 133 | 58.94 to 55.21 | 7736 | 1.75 to 1.40 | 0.75 | 21.89 to 21.47 |
|  American Growth-Income Trust Series II(\*) | 2025 | 900 | 74.40 to 57.77 | 67458 | 1.90 to 1.00 | 1.28 | 16.36 to 15.32 |
|  | 2024 | 1033 | 64.52 to 49.65 | 66965 | 1.90 to 1.00 | 0.70 | 22.42 to 21.32 |
|  | 2023 | 1237 | 53.18 to 40.55 | 66001 | 1.90 to 1.00 | 0.95 | 24.28 to 23.17 |
|  | 2022 | 1396 | 43.18 to 32.63 | 60251 | 1.90 to 1.00 | 2.07 | -17.67 to -18.40 |
|  | 2021 | 1572 | 52.92 to 39.64 | 82739 | 1.90 to 1.00 | 0.65 | 22.29 to 21.19 |

---

62 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **Sub-account** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value<br>Highest to Lowest (a)** | **Assets<br>(000s)** | **Expense Ratio<br>Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return<br>Highest to Lowest (d)** |
|  American Growth-Income Trust Series III(\*) | 2025 | 7 | $67.63 to $59.14 | $471 | 1.55 % to 0.80% | 1.83% | 17.16 % to 16.29% |
|  | 2024 | 8 | 57.72 to 50.85 | 454 | 1.55 to 0.80 | 1.15 | 23.17 to 22.24 |
|  | 2023 | 9 | 46.87 to 41.60 | 424 | 1.55 to 0.80 | 1.41 | 25.14 to 24.21 |
|  | 2022 | 11 | 37.45 to 33.49 | 410 | 1.55 to 0.80 | 2.53 | -17.22 to -17.84 |
|  | 2021 | 12 | 45.24 to 40.76 | 538 | 1.55 to 0.80 | 1.10 | 23.14 to 22.22 |
|  American International Trust Series II(\*) | 2025 | 802 | 40.10 to 23.30 | 29616 | 1.90 to 1.00 | 0.72 | 24.83 to 23.72 |
|  | 2024 | 973 | 32.41 to 18.66 | 28936 | 1.90 to 1.00 | 0.64 | 1.58 to 0.66 |
|  | 2023 | 1036 | 32.20 to 18.37 | 30611 | 1.90 to 1.00 | 0.84 | 14.09 to 13.07 |
|  | 2022 | 1109 | 28.48 to 16.10 | 28862 | 1.90 to 1.00 | 2.03 | -21.94 to -22.64 |
|  | 2021 | 1190 | 36.81 to 20.63 | 39888 | 1.90 to 1.00 | 1.74 | -2.94 to -3.81 |
|  American International Trust Series III(\*) | 2025 | 8 | 24.37 to 21.31 | 196 | 1.55 to 0.80 | 1.30 | 25.62 to 24.68 |
|  | 2024 | 10 | 19.40 to 17.09 | 185 | 1.55 to 0.80 | 1.08 | 2.27 to 1.50 |
|  | 2023 | 10 | 18.97 to 16.84 | 189 | 1.55 to 0.80 | 1.40 | 14.84 to 13.99 |
|  | 2022 | 12 | 16.52 to 14.77 | 197 | 1.55 to 0.80 | 2.64 | -21.43 to -22.02 |
|  | 2021 | 12 | 21.02 to 18.94 | 256 | 1.55 to 0.80 | 2.29 | -2.29 to -3.02 |
|  Blue Chip Growth Trust Series I(\*) | 2025 | 187 | 170.92 to 73.76 | 27747 | 1.75 to 1.40 | 0.00 | 16.87 to 16.47 |
|  | 2024 | 219 | 146.25 to 63.33 | 27574 | 1.75 to 1.40 | 0.00 | 33.75 to 33.28 |
|  | 2023 | 243 | 109.34 to 47.52 | 22755 | 1.75 to 1.40 | 0.00 | 47.49 to 46.97 |
|  | 2022 | 255 | 74.14 to 32.33 | 16301 | 1.75 to 1.40 | 0.00 | -38.95 to -39.16 |
|  | 2021 | 269 | 121.43 to 53.14 | 28130 | 1.75 to 1.40 | 0.00 | 15.24 to 14.84 |
|  Blue Chip Growth Trust Series II(\*) | 2025 | 153 | 96.24 to 78.43 | 15677 | 1.90 to 1.00 | 0.00 | 17.09 to 16.04 |
|  | 2024 | 174 | 82.94 to 66.98 | 15349 | 1.90 to 1.00 | 0.00 | 34.00 to 32.79 |
|  | 2023 | 204 | 62.46 to 49.99 | 13462 | 1.90 to 1.00 | 0.00 | 47.77 to 46.46 |
|  | 2022 | 241 | 42.65 to 33.83 | 10775 | 1.90 to 1.00 | 0.00 | -38.82 to -39.37 |
|  | 2021 | 264 | 70.34 to 55.29 | 19392 | 1.90 to 1.00 | 0.00 | 15.47 to 14.44 |
|  Capital Appreciation Value Trust Series II(\*) | 2025 | 355 | 45.03 to 43.90 | 16034 | 1.90 to 1.00 | 1.83 | 10.24 to 9.26 |
|  | 2024 | 406 | 41.22 to 39.82 | 16734 | 1.90 to 1.00 | 0.64 | 11.02 to 10.02 |
|  | 2023 | 455 | 37.46 to 35.87 | 17026 | 1.90 to 1.00 | 1.56 | 16.84 to 15.80 |
|  | 2022 | 487 | 32.35 to 30.70 | 15685 | 1.90 to 1.00 | 0.74 | -12.94 to -13.72 |
|  | 2021 | 516 | 37.50 to 35.26 | 19202 | 1.90 to 1.00 | 0.58 | 16.68 to 15.63 |
|  Core Bond Trust Series I(\*) | 2025 | 262 | 17.98 to 16.72 | 4637 | 1.75 to 1.40 | 4.33 | 5.45 to 5.09 |
|  | 2024 | 249 | 17.05 to 15.92 | 4172 | 1.75 to 1.40 | 3.69 | 0.06 to -0.29 |
|  | 2023 | 250 | 17.04 to 15.96 | 4179 | 1.75 to 1.40 | 2.92 | 4.34 to 3.97 |
|  | 2022 | 244 | 16.33 to 15.35 | 3902 | 1.75 to 1.40 | 2.14 | -14.87 to -15.17 |
|  | 2021 | 262 | 19.18 to 18.10 | 4941 | 1.75 to 1.40 | 1.77 | -3.32 to -3.66 |
|  Core Bond Trust Series II(\*) | 2025 | 288 | 16.04 to 13.05 | 4713 | 1.85 to 1.00 | 4.09 | 5.70 to 4.81 |
|  | 2024 | 294 | 15.30 to 12.35 | 4572 | 1.85 to 1.00 | 3.31 | 0.20 to -0.65 |
|  | 2023 | 359 | 15.40 to 12.32 | 5603 | 1.85 to 1.00 | 2.76 | 4.56 to 3.68 |
|  | 2022 | 375 | 14.86 to 11.79 | 5604 | 1.85 to 1.00 | 1.87 | -14.67 to -15.39 |
|  | 2021 | 451 | 17.56 to 13.81 | 7941 | 1.85 to 1.00 | 1.59 | -3.20 to -4.02 |
|  Disciplined Value Emerging Markets Value Trust Series II(\*) | 2025 | 171 | 17.03 to 15.89 | 2806 | 1.85 to 1.00 | 0.96 | 30.37 to 29.27 |
|  | 2024 | 217 | 13.06 to 12.29 | 2751 | 1.85 to 1.00 | 3.76 | -3.63 to -4.45 |
|  | 2023 | 250 | 13.55 to 12.86 | 3305 | 1.85 to 1.00 | 1.39 | 13.71 to 12.75 |
|  | 2022 | 267 | 11.92 to 11.41 | 3118 | 1.85 to 1.00 | 3.41 | -12.75 to -13.48 |
|  | 2021 | 289 | 13.66 to 13.18 | 3871 | 1.85 to 1.00 | 2.18 | 9.98 to 9.05 |
|  Disciplined Value International Trust Series I(\*) | 2025 | 95 | 35.70 to 32.72 | 3340 | 1.75 to 1.40 | 1.75 | 38.95 to 38.46 |
|  | 2024 | 105 | 25.69 to 23.63 | 2656 | 1.75 to 1.40 | 0.29 | -1.78 to -2.13 |
|  | 2023 | 120 | 26.16 to 24.15 | 3086 | 1.75 to 1.40 | 1.71 | 18.30 to 17.89 |
|  | 2022 | 140 | 22.11 to 20.48 | 3075 | 1.75 to 1.40 | 3.51 | -6.09 to -6.42 |
|  | 2021 | 154 | 23.54 to 21.89 | 3600 | 1.75 to 1.40 | 2.56 | 11.49 to 11.10 |
|  Disciplined Value International Trust Series II(\*) | 2025 | 141 | 35.20 to 26.54 | 5287 | 1.85 to 1.00 | 1.60 | 39.20 to 38.03 |
|  | 2024 | 163 | 25.50 to 19.06 | 4403 | 1.85 to 1.00 | 0.13 | -1.56 to -2.40 |
|  | 2023 | 179 | 26.13 to 19.37 | 4932 | 1.85 to 1.00 | 1.66 | 18.50 to 17.50 |
|  | 2022 | 195 | 22.24 to 16.34 | 4586 | 1.85 to 1.00 | 3.36 | -5.93 to -6.72 |
|  | 2021 | 217 | 23.84 to 17.37 | 5459 | 1.85 to 1.00 | 2.36 | 11.74 to 10.79 |
|  Equity Income Trust Series I(\*) | 2025 | 190 | 108.74 to 56.72 | 18734 | 1.75 to 1.40 | 2.44 | 12.80 to 12.41 |
|  | 2024 | 210 | 96.40 to 50.46 | 18273 | 1.75 to 1.40 | 1.61 | 10.11 to 9.72 |
|  | 2023 | 240 | 87.55 to 45.99 | 18808 | 1.75 to 1.40 | 1.86 | 7.87 to 7.50 |
|  | 2022 | 266 | 81.16 to 42.78 | 19463 | 1.75 to 1.40 | 1.76 | -4.74 to -5.08 |
|  | 2021 | 293 | 85.20 to 45.07 | 22537 | 1.75 to 1.40 | 1.95 | 23.67 to 23.24 |
|  Equity Income Trust Series II(\*) | 2025 | 259 | 45.00 to 38.30 | 12294 | 1.90 to 1.00 | 2.28 | 13.05 to 12.04 |
|  | 2024 | 294 | 40.16 to 33.88 | 12443 | 1.90 to 1.00 | 1.43 | 10.24 to 9.25 |
|  | 2023 | 358 | 36.76 to 30.73 | 13932 | 1.90 to 1.00 | 1.71 | 8.17 to 7.21 |
|  | 2022 | 413 | 34.29 to 28.41 | 15002 | 1.90 to 1.00 | 1.53 | -4.59 to -5.45 |
|  | 2021 | 481 | 36.27 to 29.77 | 18460 | 1.90 to 1.00 | 1.71 | 23.97 to 22.86 |

---

63 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **<u>Sub-account</u>** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value**<br>**Highest to Lowest (a)** | **Assets**<br> **(000s)** | **Expense Ratio**<br>**Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return**<br>**Highest to Lowest (d)** |
|  Financial Industries Trust Series I(\*) | 2025 | 18 | $44.37 to $40.70 | $766 | 1.75 % to 1.40% | 1.19% | 10.44 % to 10.06% |
|  | 2024 | 19 | 40.18 to 36.98 | 720 | 1.75 to 1.40 | 1.06 | 28.41 to 27.96 |
|  | 2023 | 21 | 31.29 to 28.90 | 626 | 1.75 to 1.40 | 1.73 | 3.76 to 3.40 |
|  | 2022 | 21 | 30.15 to 27.95 | 619 | 1.75 to 1.40 | 2.19 | -14.87 to -15.16 |
|  | 2021 | 25 | 35.42 to 32.94 | 865 | 1.75 to 1.40 | 0.86 | 27.90 to 27.45 |
|  Financial Industries Trust Series II(\*) | 2025 | 43 | 41.85 to 41.09 | 1865 | 1.85 to 1.00 | 0.96 | 10.71 to 9.77 |
|  | 2024 | 52 | 38.12 to 37.11 | 2064 | 1.85 to 1.00 | 0.79 | 28.69 to 27.59 |
|  | 2023 | 70 | 29.88 to 28.84 | 2198 | 1.85 to 1.00 | 1.54 | 3.93 to 3.06 |
|  | 2022 | 82 | 28.99 to 27.75 | 2465 | 1.85 to 1.00 | 1.97 | -14.69 to -15.41 |
|  | 2021 | 93 | 34.27 to 32.52 | 3314 | 1.85 to 1.00 | 0.84 | 28.09 to 27.01 |
|  Fundamental All Cap Core Trust Series II(\*) | 2025 | 48 | 86.38 to 39.50 | 4469 | 1.85 to 1.00 | 0.20 | 3.53 to 2.65 |
|  | 2024 | 61 | 84.15 to 38.15 | 5432 | 1.85 to 1.00 | 0.00 | 22.68 to 21.64 |
|  | 2023 | 77 | 69.18 to 31.10 | 5690 | 1.85 to 1.00 | 0.19 | 33.76 to 32.63 |
|  | 2022 | 86 | 52.16 to 23.25 | 4750 | 1.85 to 1.00 | 0.01 | -25.19 to -25.82 |
|  | 2021 | 93 | 71.64 to 31.08 | 6934 | 1.75 to 1.00 | 0.00 | 29.04 to 28.08 |
|  Fundamental Large Cap Value Trust Series I(\*) | 2025 | 348 | 61.61 to 40.74 | 22832 | 1.75 to 1.00 | 1.05 | 14.78 to 13.92 |
|  | 2024 | 389 | 54.08 to 35.49 | 22321 | 1.75 to 1.00 | 0.31 | 15.81 to 14.94 |
|  | 2023 | 439 | 47.05 to 30.65 | 21825 | 1.75 to 1.00 | 1.00 | 22.23 to 21.32 |
|  | 2022 | 475 | 38.79 to 25.08 | 19620 | 1.75 to 1.00 | 1.06 | -8.87 to -9.55 |
|  | 2021 | 516 | 42.88 to 27.52 | 23498 | 1.75 to 1.00 | 0.76 | 28.67 to 27.71 |
|  Fundamental Large Cap Value Trust Series II(\*) | 2025 | 342 | 58.86 to 35.56 | 20065 | 1.85 to 1.00 | 0.83 | 14.56 to 13.59 |
|  | 2024 | 404 | 51.82 to 31.04 | 20925 | 1.85 to 1.00 | 0.14 | 15.57 to 14.58 |
|  | 2023 | 483 | 45.22 to 26.86 | 21733 | 1.85 to 1.00 | 0.82 | 22.00 to 20.97 |
|  | 2022 | 546 | 37.38 to 22.02 | 20230 | 1.85 to 1.00 | 0.86 | -9.04 to -9.81 |
|  | 2021 | 598 | 41.45 to 24.20 | 24499 | 1.85 to 1.00 | 0.57 | 28.43 to 27.34 |
|  Global Equity Trust Series I(\*) | 2025 | 100 | 32.04 to 30.57 | 5947 | 1.75 to 0.80 | 1.23 | 17.19 to 16.08 |
|  | 2024 | 110 | 27.34 to 26.34 | 5606 | 1.75 to 0.80 | 1.15 | 9.59 to 8.54 |
|  | 2023 | 122 | 24.95 to 24.26 | 5722 | 1.75 to 0.80 | 0.78 | 19.14 to 18.02 |
|  | 2022 | 134 | 20.94 to 20.56 | 5286 | 1.75 to 0.80 | 2.68 | -15.51 to -16.31 |
|  | 2021 | 141 | 24.78 to 24.57 | 6607 | 1.75 to 0.80 | 0.00 | 20.34 to 19.20 |
|  Global Equity Trust Series II(\*) | 2025 | 98 | 32.73 to 22.65 | 3359 | 1.90 to 1.00 | 1.01 | 16.74 to 15.69 |
|  | 2024 | 120 | 28.29 to 19.40 | 3560 | 1.90 to 1.00 | 0.98 | 9.17 to 8.19 |
|  | 2023 | 137 | 26.15 to 17.77 | 3744 | 1.90 to 1.00 | 0.60 | 18.62 to 17.57 |
|  | 2022 | 152 | 22.25 to 14.98 | 3555 | 1.90 to 1.00 | 2.43 | -15.85 to -16.61 |
|  | 2021 | 185 | 26.68 to 17.81 | 5151 | 1.90 to 1.00 | 0.00 | 19.81 to 18.73 |
|  Health Sciences Trust Series I(\*) | 2025 | 26 | 126.78 to 116.29 | 3129 | 1.75 to 1.40 | 0.00 | 17.83 to 17.42 |
|  | 2024 | 27 | 107.59 to 99.03 | 2801 | 1.75 to 1.40 | 0.00 | 0.35 to 0.00 |
|  | 2023 | 31 | 107.22 to 99.04 | 3181 | 1.75 to 1.40 | 0.00 | 2.81 to 2.45 |
|  | 2022 | 32 | 104.29 to 96.67 | 3224 | 1.75 to 1.40 | 0.00 | -14.29 to -14.59 |
|  | 2021 | 36 | 121.69 to 113.19 | 4222 | 1.75 to 1.40 | 0.00 | 9.65 to 9.26 |
|  Health Sciences Trust Series II(\*) | 2025 | 46 | 118.85 to 55.54 | 5356 | 1.90 to 1.00 | 0.00 | 18.04 to 16.98 |
|  | 2024 | 54 | 101.60 to 47.05 | 5315 | 1.90 to 1.00 | 0.00 | 0.60 to -0.31 |
|  | 2023 | 64 | 101.92 to 46.77 | 6434 | 1.90 to 1.00 | 0.00 | 2.98 to 2.06 |
|  | 2022 | 73 | 99.85 to 45.42 | 7209 | 1.90 to 1.00 | 0.00 | -14.10 to -14.87 |
|  | 2021 | 83 | 117.30 to 52.87 | 9737 | 1.90 to 1.00 | 0.00 | 9.86 to 8.88 |
|  High Yield Trust Series I(\*) | 2025 | 37 | 28.10 to 19.24 | 1066 | 1.75 to 0.80 | 7.33 | 6.60 to 5.59 |
|  | 2024 | 40 | 26.62 to 18.05 | 1096 | 1.75 to 0.80 | 7.11 | 8.07 to 7.04 |
|  | 2023 | 42 | 24.86 to 16.70 | 1068 | 1.75 to 0.80 | 2.61 | 12.15 to 11.09 |
|  | 2022 | 44 | 22.38 to 14.89 | 1014 | 1.75 to 0.80 | 5.88 | -13.94 to -14.75 |
|  | 2021 | 47 | 26.26 to 17.30 | 1252 | 1.75 to 0.80 | 4.83 | 4.98 to 3.99 |
|  High Yield Trust Series II(\*) | 2025 | 86 | 31.34 to 19.39 | 2477 | 1.85 to 1.00 | 6.71 | 6.18 to 5.28 |
|  | 2024 | 100 | 29.77 to 18.26 | 2758 | 1.85 to 1.00 | 6.48 | 7.62 to 6.71 |
|  | 2023 | 113 | 27.90 to 16.96 | 2919 | 1.85 to 1.00 | 2.28 | 11.58 to 10.64 |
|  | 2022 | 117 | 25.22 to 15.20 | 2761 | 1.85 to 1.00 | 5.33 | -14.31 to -15.03 |
|  | 2021 | 138 | 29.39 to 17.74 | 3812 | 1.90 to 1.00 | 4.63 | 4.62 to 3.68 |
|  International Equity Index Series I(\*) | 2025 | 33 | 25.11 to 23.98 | 835 | 1.75 to 1.40 | 2.23 | 30.66 to 30.20 |
|  | 2024 | 36 | 19.22 to 18.42 | 680 | 1.75 to 1.40 | 1.61 | 3.44 to 3.08 |
|  | 2023 | 34 | 18.58 to 17.87 | 635 | 1.75 to 1.40 | 2.39 | 13.76 to 13.37 |
|  | 2022 | 35 | 16.33 to 15.76 | 575 | 1.75 to 1.40 | 2.80 | -17.42 to -17.71 |
|  | 2021 | 38 | 19.78 to 19.15 | 743 | 1.75 to 1.40 | 2.71 | 6.10 to 5.73 |
|  International Equity Index Series II(\*) | 2025 | 129 | 25.15 to 23.05 | 3099 | 1.85 to 1.00 | 1.91 | 30.95 to 29.84 |
|  | 2024 | 165 | 19.21 to 17.75 | 3047 | 1.85 to 1.00 | 1.30 | 3.57 to 2.68 |
|  | 2023 | 193 | 18.54 to 17.29 | 3449 | 1.85 to 1.00 | 2.24 | 14.03 to 13.07 |
|  | 2022 | 194 | 16.26 to 15.29 | 3073 | 1.85 to 1.00 | 2.55 | -17.22 to -17.92 |
|  | 2021 | 218 | 19.65 to 18.63 | 4183 | 1.85 to 1.00 | 2.35 | 6.26 to 5.36 |

---

64 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **<u>Sub-account</u>** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value**<br>**Highest to Lowest (a)** | **Assets**<br> **(000s)** | **Expense Ratio**<br>**Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return**<br>**Highest to Lowest (d)** |
|  International Equity Index Series NAV(\*) | 2025 | 43 | $20.46 to $18.81 | $848 | 1.85 % to 1.40% | 2.21% | 30.73 % to 30.14% |
|  | 2024 | 50 | 15.65 to 14.45 | 752 | 1.85 to 1.40 | 1.65 | 3.43 to 2.96 |
|  | 2023 | 57 | 15.13 to 14.04 | 829 | 1.85 to 1.40 | 2.45 | 13.82 to 13.31 |
|  | 2022 | 65 | 13.29 to 12.39 | 834 | 1.85 to 1.40 | 2.89 | -17.32 to -17.70 |
|  | 2021 | 68 | 16.08 to 15.05 | 1056 | 1.85 to 1.40 | 2.61 | 6.10 to 5.62 |
|  International Small Company Trust Series I(\*) | 2025 | 41 | 31.87 to 30.12 | 1288 | 1.75 to 1.40 | 2.20 | 33.11 to 32.65 |
|  | 2024 | 44 | 23.94 to 22.71 | 1045 | 1.75 to 1.40 | 2.73 | 1.62 to 1.26 |
|  | 2023 | 45 | 23.56 to 22.42 | 1056 | 1.75 to 1.40 | 2.00 | 11.87 to 11.48 |
|  | 2022 | 47 | 21.06 to 20.11 | 985 | 1.75 to 1.40 | 1.94 | -19.31 to -19.59 |
|  | 2021 | 51 | 26.10 to 25.01 | 1346 | 1.75 to 1.40 | 1.25 | 12.14 to 11.75 |
|  International Small Company Trust Series II(\*) | 2025 | 53 | 29.42 to 28.69 | 1588 | 1.85 to 1.00 | 1.85 | 33.33 to 32.21 |
|  | 2024 | 70 | 22.06 to 21.70 | 1601 | 1.85 to 1.00 | 2.41 | 1.78 to 0.91 |
|  | 2023 | 89 | 21.68 to 21.50 | 1997 | 1.85 to 1.00 | 1.74 | 12.21 to 11.26 |
|  | 2022 | 100 | 19.33 to 19.32 | 2020 | 1.85 to 1.00 | 1.67 | -19.16 to -19.84 |
|  | 2021 | 117 | 24.11 to 23.90 | 2924 | 1.85 to 1.00 | 1.08 | 12.34 to 11.39 |
|  Investment Quality Bond Trust Series I(\*) | 2025 | 46 | 22.53 to 19.17 | 1451 | 1.75 to 0.80 | 4.48 | 6.12 to 5.11 |
|  | 2024 | 45 | 21.44 to 18.06 | 1332 | 1.75 to 0.80 | 3.17 | 1.18 to 0.21 |
|  | 2023 | 55 | 21.39 to 17.85 | 1603 | 1.75 to 0.80 | 1.53 | 5.64 to 4.64 |
|  | 2022 | 58 | 20.44 to 16.90 | 1623 | 1.75 to 0.80 | 3.11 | -15.55 to -16.35 |
|  | 2021 | 62 | 24.44 to 20.01 | 2064 | 1.75 to 0.80 | 1.99 | -2.05 to -2.97 |
|  Investment Quality Bond Trust Series II(\*) | 2025 | 543 | 18.85 to 13.82 | 10284 | 1.85 to 1.00 | 4.37 | 5.61 to 4.71 |
|  | 2024 | 584 | 18.00 to 13.08 | 10417 | 1.85 to 1.00 | 3.21 | 0.80 to -0.06 |
|  | 2023 | 579 | 18.01 to 12.98 | 10290 | 1.85 to 1.00 | 1.37 | 5.22 to 4.33 |
|  | 2022 | 557 | 17.26 to 12.33 | 9472 | 1.85 to 1.00 | 2.82 | -15.90 to -16.61 |
|  | 2021 | 650 | 20.70 to 14.67 | 13283 | 1.85 to 1.00 | 1.81 | -2.44 to -3.26 |
|  Lifestyle Balanced Portfolio Series I(\*) | 2025 | 271 | 23.99 to 21.39 | 6088 | 1.75 to 0.80 | 3.07 | 13.20 to 12.13 |
|  | 2024 | 295 | 21.20 to 19.08 | 5882 | 1.75 to 0.80 | 2.37 | 7.65 to 6.62 |
|  | 2023 | 320 | 19.69 to 17.89 | 5965 | 1.75 to 0.80 | 2.29 | 12.84 to 11.78 |
|  | 2022 | 338 | 17.45 to 16.01 | 5608 | 1.75 to 0.80 | 2.46 | -16.12 to -16.91 |
|  | 2021 | 370 | 20.80 to 19.27 | 7361 | 1.75 to 0.80 | 2.48 | 8.57 to 7.54 |
|  Lifestyle Balanced Portfolio Series II(\*) | 2025 | 10200 | 24.73 to 23.31 | 230099 | 2.00 to 0.35 | 2.57 | 13.41 to 11.56 |
|  | 2024 | 11709 | 21.80 to 20.89 | 235719 | 2.00 to 0.35 | 2.15 | 7.99 to 6.21 |
|  | 2023 | 13148 | 20.19 to 19.67 | 247639 | 2.00 to 0.35 | 2.03 | 13.10 to 11.26 |
|  | 2022 | 14554 | 17.85 to 17.68 | 245069 | 2.00 to 0.35 | 2.27 | -15.89 to -17.27 |
|  | 2021 | 15915 | 21.37 to 21.22 | 321979 | 2.00 to 0.35 | 2.32 | 8.83 to 7.05 |
|  Lifestyle Conservative Portfolio Series I(\*) | 2025 | 107 | 18.09 to 16.13 | 1782 | 1.75 to 0.80 | 3.69 | 9.18 to 8.15 |
|  | 2024 | 120 | 16.57 to 14.92 | 1840 | 1.75 to 0.80 | 2.96 | 3.59 to 2.60 |
|  | 2023 | 134 | 16.00 to 14.54 | 1993 | 1.75 to 0.80 | 2.77 | 8.25 to 7.23 |
|  | 2022 | 141 | 14.78 to 13.56 | 1982 | 1.75 to 0.80 | 2.75 | -15.30 to -16.10 |
|  | 2021 | 153 | 17.45 to 16.16 | 2558 | 1.75 to 0.80 | 3.05 | 2.14 to 1.18 |
|  Lifestyle Conservative Portfolio Series II(\*) | 2025 | 1987 | 18.64 to 16.37 | 33081 | 2.00 to 0.35 | 3.15 | 9.44 to 7.65 |
|  | 2024 | 2378 | 17.03 to 15.20 | 36637 | 2.00 to 0.35 | 2.79 | 3.85 to 2.13 |
|  | 2023 | 2710 | 16.40 to 14.89 | 40659 | 2.00 to 0.35 | 2.48 | 8.52 to 6.75 |
|  | 2022 | 3042 | 15.11 to 13.95 | 42568 | 2.00 to 0.35 | 2.55 | -15.01 to -16.40 |
|  | 2021 | 3298 | 17.78 to 16.68 | 54913 | 2.00 to 0.35 | 2.58 | 2.32 to 0.65 |
|  Lifestyle Growth Portfolio Series I(\*) | 2025 | 380 | 28.76 to 25.64 | 10211 | 1.75 to 0.80 | 2.57 | 15.79 to 14.70 |
|  | 2024 | 415 | 24.83 to 22.35 | 9675 | 1.75 to 0.80 | 2.06 | 10.42 to 9.37 |
|  | 2023 | 466 | 22.49 to 20.44 | 9893 | 1.75 to 0.80 | 1.98 | 16.07 to 14.97 |
|  | 2022 | 497 | 19.38 to 17.78 | 9132 | 1.75 to 0.80 | 2.37 | -16.75 to -17.54 |
|  | 2021 | 530 | 23.28 to 21.56 | 11775 | 1.75 to 0.80 | 2.36 | 13.16 to 12.09 |
|  Lifestyle Growth Portfolio Series II(\*) | 2025 | 19644 | 29.65 to 29.26 | 537739 | 2.00 to 0.35 | 2.16 | 16.10 to 14.21 |
|  | 2024 | 22084 | 25.62 to 25.54 | 525631 | 2.00 to 0.35 | 1.86 | 10.77 to 8.95 |
|  | 2023 | 24961 | 23.51 to 23.05 | 541353 | 2.00 to 0.35 | 1.74 | 16.26 to 14.36 |
|  | 2022 | 27200 | 20.56 to 19.83 | 513128 | 2.00 to 0.35 | 2.13 | -16.53 to -17.90 |
|  | 2021 | 29673 | 25.04 to 23.76 | 678568 | 2.00 to 0.35 | 2.10 | 13.44 to 11.59 |
|  Lifestyle Growth Portfolio Series NAV(\*) | 2025 | 6 | 21.99 to 21.99 | 134 | 1.20 to 1.20 | 2.73 | 15.45 to 15.45 |
|  | 2024 | 6 | 19.05 to 19.05 | 122 | 1.20 to 1.20 | 2.19 | 10.04 to 10.04 |
|  | 2023 | 7 | 17.31 to 17.31 | 116 | 1.20 to 1.20 | 2.05 | 15.58 to 15.58 |
|  | 2022 | 7 | 14.98 to 14.98 | 105 | 1.20 to 1.20 | 2.44 | -16.99 to -16.99 |
|  | 2021 | 7 | 18.05 to 18.05 | 133 | 1.20 to 1.20 | 2.39 | 12.77 to 12.77 |
|  Lifestyle Moderate Portfolio Series I(\*) | 2025 | 82 | 21.30 to 19.45 | 1647 | 1.75 to 1.00 | 3.28 | 11.55 to 10.72 |
|  | 2024 | 93 | 19.52 to 17.57 | 1690 | 1.75 to 0.80 | 2.54 | 6.28 to 5.27 |
|  | 2023 | 115 | 18.37 to 16.69 | 1984 | 1.75 to 0.80 | 2.43 | 11.26 to 10.21 |
|  | 2022 | 124 | 16.51 to 15.15 | 1934 | 1.75 to 0.80 | 2.62 | -15.86 to -16.65 |
|  | 2021 | 135 | 19.62 to 18.17 | 2532 | 1.75 to 0.80 | 2.67 | 6.39 to 5.39 |

---

65 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **<u>Sub-account</u>** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value**<br>**Highest to Lowest (a)** | **Assets**<br> **(000s)** | **Expense Ratio**<br>**Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return**<br>**Highest to Lowest (d)** |
|  Lifestyle Moderate Portfolio Series II(\*) | 2025 | 3146 | $22.51 to $20.88 | $64030 | 2.00 % to 0.35% | 2.78% | 12.09 % to 10.26% |
|  | 2024 | 3594 | 20.08 to 18.94 | 66015 | 2.00 to 0.35 | 2.43 | 6.54 to 4.78 |
|  | 2023 | 4094 | 18.85 to 18.08 | 71295 | 2.00 to 0.35 | 2.17 | 11.52 to 9.70 |
|  | 2022 | 4523 | 16.90 to 16.48 | 71445 | 2.00 to 0.35 | 2.29 | -15.63 to -17.01 |
|  | 2021 | 5166 | 20.03 to 19.86 | 98041 | 2.00 to 0.35 | 2.42 | 6.65 to 4.91 |
|  Managed Volatility Balanced Portfolio Series I(\*) | 2025 | 112 | 27.43 to 25.56 | 3595 | 1.75 to 0.80 | 2.68 | 8.84 to 7.81 |
|  | 2024 | 130 | 25.44 to 23.48 | 3935 | 1.75 to 0.80 | 2.34 | 8.48 to 7.44 |
|  | 2023 | 169 | 23.68 to 21.65 | 4698 | 1.75 to 0.80 | 2.38 | 11.10 to 10.06 |
|  | 2022 | 180 | 21.52 to 19.48 | 4519 | 1.75 to 0.80 | 2.43 | -15.75 to -16.55 |
|  | 2021 | 198 | 25.78 to 23.13 | 5948 | 1.75 to 0.80 | 2.45 | 8.89 to 7.86 |
|  Managed Volatility Balanced Portfolio Series II(\*) | 2025 | 3953 | 28.14 to 25.61 | 104514 | 1.90 to 0.35 | 2.38 | 9.13 to 7.45 |
|  | 2024 | 4657 | 26.19 to 23.47 | 113993 | 1.90 to 0.35 | 2.26 | 8.75 to 7.06 |
|  | 2023 | 5306 | 24.46 to 21.58 | 120217 | 1.90 to 0.35 | 2.10 | 11.40 to 9.69 |
|  | 2022 | 6036 | 22.30 to 19.37 | 124655 | 1.90 to 0.35 | 2.23 | -15.51 to -16.81 |
|  | 2021 | 6676 | 26.81 to 22.93 | 165504 | 1.90 to 0.35 | 2.26 | 9.16 to 7.48 |
|  Managed Volatility Conservative Portfolio Series I(\*) | 2025 | 19 | 23.39 to 20.52 | 521 | 1.75 to 0.80 | 3.69 | 7.97 to 6.95 |
|  | 2024 | 20 | 21.87 to 19.00 | 532 | 1.75 to 0.80 | 3.12 | 2.77 to 1.79 |
|  | 2023 | 28 | 21.48 to 18.49 | 754 | 1.75 to 0.80 | 2.93 | 4.63 to 3.64 |
|  | 2022 | 32 | 20.73 to 17.67 | 849 | 1.75 to 0.80 | 2.55 | -15.48 to -16.28 |
|  | 2021 | 38 | 24.76 to 20.91 | 1210 | 1.75 to 0.80 | 2.99 | 2.65 to 1.68 |
|  Managed Volatility Conservative Portfolio Series II(\*) | 2025 | 982 | 21.08 to 20.62 | 19038 | 1.90 to 0.35 | 3.28 | 8.25 to 6.59 |
|  | 2024 | 1102 | 19.47 to 19.35 | 20017 | 1.90 to 0.35 | 2.87 | 3.07 to 1.47 |
|  | 2023 | 1323 | 19.07 to 18.89 | 23484 | 1.90 to 0.35 | 2.70 | 4.84 to 3.23 |
|  | 2022 | 1490 | 18.47 to 18.02 | 25635 | 1.90 to 0.35 | 2.49 | -15.23 to -16.53 |
|  | 2021 | 1663 | 22.13 to 21.26 | 34213 | 1.90 to 0.35 | 2.75 | 2.95 to 1.36 |
|  Managed Volatility Growth Portfolio Series I(\*) | 2025 | 112 | 26.78 to 26.75 | 3838 | 1.75 to 0.80 | 2.42 | 9.93 to 8.89 |
|  | 2024 | 109 | 24.59 to 24.34 | 3380 | 1.75 to 0.80 | 2.08 | 11.05 to 9.99 |
|  | 2023 | 113 | 22.36 to 21.91 | 3183 | 1.75 to 0.80 | 1.99 | 12.78 to 11.72 |
|  | 2022 | 122 | 20.01 to 19.43 | 3001 | 1.75 to 0.80 | 2.30 | -15.54 to -16.33 |
|  | 2021 | 133 | 23.92 to 23.00 | 3850 | 1.75 to 0.80 | 2.21 | 11.92 to 10.87 |
|  Managed Volatility Growth Portfolio Series II(\*) | 2025 | 4605 | 26.62 to 21.19 | 131519 | 2.00 to 0.35 | 1.94 | 10.18 to 8.38 |
|  | 2024 | 5292 | 24.16 to 19.55 | 138999 | 2.00 to 0.35 | 1.79 | 11.30 to 9.47 |
|  | 2023 | 6078 | 21.71 to 17.86 | 144896 | 2.00 to 0.35 | 1.73 | 13.15 to 11.30 |
|  | 2022 | 6894 | 19.19 to 16.05 | 146707 | 2.00 to 0.35 | 2.06 | -15.32 to -16.71 |
|  | 2021 | 7440 | 22.66 to 19.26 | 189439 | 2.00 to 0.35 | 1.96 | 12.18 to 10.35 |
|  Managed Volatility Moderate Portfolio Series I(\*) | 2025 | 34 | 27.66 to 25.47 | 1257 | 1.75 to 0.80 | 3.13 | 8.38 to 7.36 |
|  | 2024 | 37 | 25.77 to 23.50 | 1289 | 1.75 to 0.80 | 2.20 | 7.30 to 6.27 |
|  | 2023 | 56 | 24.25 to 21.90 | 1771 | 1.75 to 0.80 | 2.56 | 9.77 to 8.73 |
|  | 2022 | 74 | 22.30 to 19.95 | 2034 | 1.75 to 0.80 | 2.57 | -15.55 to -16.35 |
|  | 2021 | 78 | 26.66 to 23.63 | 2589 | 1.75 to 0.80 | 2.68 | 7.04 to 6.02 |
|  Managed Volatility Moderate Portfolio Series II(\*) | 2025 | 1519 | 26.39 to 25.84 | 36832 | 1.90 to 0.35 | 2.72 | 8.68 to 7.01 |
|  | 2024 | 1766 | 24.66 to 23.77 | 40009 | 1.90 to 0.35 | 2.48 | 7.44 to 5.77 |
|  | 2023 | 2051 | 23.32 to 22.13 | 43629 | 1.90 to 0.35 | 2.28 | 10.16 to 8.47 |
|  | 2022 | 2337 | 21.50 to 20.09 | 45764 | 1.90 to 0.35 | 2.33 | -15.39 to -16.69 |
|  | 2021 | 2656 | 25.81 to 23.74 | 61983 | 1.90 to 0.35 | 2.47 | 7.38 to 5.73 |
|  Mid Cap Growth Trust Series I(\*) | 2025 | 93 | 68.61 to 56.04 | 6579 | 1.75 to 0.80 | 0.00 | 5.27 to 4.27 |
|  | 2024 | 99 | 65.80 to 53.24 | 6693 | 1.75 to 0.80 | 0.00 | 24.14 to 22.96 |
|  | 2023 | 109 | 53.52 to 42.88 | 6001 | 1.75 to 0.80 | 0.00 | 17.76 to 16.66 |
|  | 2022 | 118 | 45.88 to 36.42 | 5523 | 1.75 to 0.80 | 0.00 | -35.16 to -35.78 |
|  | 2021 | 127 | 71.43 to 56.16 | 9210 | 1.75 to 0.80 | 0.00 | 2.71 to 1.74 |
|  Mid Cap Growth Trust Series II(\*) | 2025 | 89 | 78.57 to 50.38 | 7246 | 1.90 to 1.00 | 0.00 | 4.88 to 3.95 |
|  | 2024 | 94 | 75.59 to 48.04 | 7339 | 1.90 to 1.00 | 0.00 | 23.49 to 22.37 |
|  | 2023 | 135 | 61.77 to 38.90 | 8744 | 1.90 to 1.00 | 0.00 | 17.45 to 16.40 |
|  | 2022 | 157 | 53.06 to 33.12 | 8748 | 1.90 to 1.00 | 0.00 | -35.42 to -36.00 |
|  | 2021 | 162 | 82.91 to 51.28 | 14000 | 1.90 to 1.00 | 0.00 | 2.27 to 1.36 |
|  Mid Cap Index Trust Series I(\*) | 2025 | 52 | 69.20 to 62.20 | 3862 | 1.75 to 0.80 | 1.21 | 6.13 to 5.12 |
|  | 2024 | 56 | 65.82 to 58.61 | 3933 | 1.75 to 0.80 | 1.01 | 12.45 to 11.38 |
|  | 2023 | 66 | 59.10 to 52.12 | 4159 | 1.75 to 0.80 | 1.07 | 15.09 to 14.00 |
|  | 2022 | 75 | 51.84 to 45.29 | 4151 | 1.75 to 0.80 | 1.11 | -14.12 to -14.93 |
|  | 2021 | 78 | 60.94 to 52.74 | 5066 | 1.75 to 0.80 | 0.88 | 23.22 to 22.06 |
|  Mid Cap Index Trust Series II(\*) | 2025 | 120 | 60.63 to 40.91 | 7498 | 1.85 to 1.00 | 1.02 | 5.74 to 4.85 |
|  | 2024 | 133 | 57.83 to 38.69 | 7973 | 1.85 to 1.00 | 0.87 | 12.00 to 11.04 |
|  | 2023 | 152 | 52.08 to 34.55 | 8151 | 1.85 to 1.00 | 0.88 | 14.58 to 13.61 |
|  | 2022 | 168 | 45.84 to 30.15 | 7977 | 1.85 to 1.00 | 0.90 | -14.44 to -15.17 |
|  | 2021 | 191 | 54.03 to 35.24 | 10557 | 1.85 to 1.00 | 0.66 | 22.72 to 21.69 |

---

66 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **<u>Sub-account</u>** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value**<br>**Highest to Lowest (a)** | **Assets**<br> **(000s)** | **Expense Ratio**<br>**Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return**<br>**Highest to Lowest (d)** |
|  Mid Value Trust Series I(\*) | 2025 | 23 | $62.83 to $58.44 | $1417 | 1.75 % to 1.40% | 1.15% | 4.38 % to 4.01% |
|  | 2024 | 25 | 60.19 to 56.19 | 1489 | 1.75 to 1.40 | 0.34 | 14.62 to 14.21 |
|  | 2023 | 30 | 52.52 to 49.20 | 1534 | 1.75 to 1.40 | 1.12 | 16.87 to 16.47 |
|  | 2022 | 32 | 44.94 to 42.24 | 1408 | 1.75 to 1.40 | 0.84 | -5.64 to -5.96 |
|  | 2021 | 38 | 47.62 to 44.92 | 1769 | 1.75 to 1.40 | 0.95 | 22.61 to 22.18 |
|  Mid Value Trust Series II(\*) | 2025 | 117 | 55.40 to 26.47 | 6902 | 1.85 to 1.35 | 0.97 | 4.24 to 3.72 |
|  | 2024 | 127 | 53.42 to 25.40 | 7199 | 1.85 to 1.35 | 0.18 | 14.57 to 14.00 |
|  | 2023 | 142 | 46.86 to 22.17 | 7031 | 1.85 to 1.35 | 0.94 | 16.66 to 16.08 |
|  | 2022 | 161 | 40.37 to 19.00 | 6859 | 1.85 to 1.35 | 0.71 | -5.80 to -6.27 |
|  | 2021 | 160 | 43.06 to 20.17 | 7234 | 1.85 to 1.35 | 0.79 | 22.43 to 21.82 |
|  Money Market Trust Series I(\*) | 2025 | 66 | 12.87 to 12.09 | 1038 | 1.75 to 1.00 | 3.96 | 2.98 to 2.21 |
|  | 2024 | 81 | 12.50 to 11.83 | 1265 | 1.75 to 1.00 | 4.88 | 3.93 to 3.15 |
|  | 2023 | 94 | 12.03 to 11.47 | 1388 | 1.75 to 1.00 | 4.65 | 3.73 to 2.95 |
|  | 2022 | 99 | 11.59 to 11.14 | 1438 | 1.75 to 1.00 | 1.30 | 0.28 to -0.46 |
|  | 2021 | 104 | 11.56 to 11.19 | 1500 | 1.75 to 1.00 | 0.00 | -0.99 to -1.73 |
|  Money Market Trust Series II(\*) | 2025 | 320 | 13.08 to 11.08 | 3874 | 1.85 to 1.00 | 3.75 | 2.78 to 1.91 |
|  | 2024 | 368 | 12.73 to 10.88 | 4340 | 1.85 to 1.00 | 4.68 | 3.72 to 2.84 |
|  | 2023 | 437 | 12.27 to 10.58 | 4975 | 1.85 to 1.00 | 4.44 | 3.52 to 2.65 |
|  | 2022 | 530 | 11.85 to 10.30 | 5856 | 1.85 to 1.00 | 1.02 | 0.07 to -0.77 |
|  | 2021 | 607 | 11.84 to 10.38 | 6724 | 1.85 to 1.00 | 0.00 | -0.99 to -1.83 |
|  Money Market Trust Series NAV(\*) | 2025 | 22 | 13.27 to 12.83 | 287 | 1.75 to 1.40 | 4.00 | 2.62 to 2.27 |
|  | 2024 | 24 | 12.94 to 12.55 | 302 | 1.75 to 1.40 | 4.92 | 3.56 to 3.20 |
|  | 2023 | 26 | 12.49 to 12.16 | 323 | 1.75 to 1.40 | 4.70 | 3.37 to 3.01 |
|  | 2022 | 31 | 12.08 to 11.80 | 367 | 1.75 to 1.40 | 1.24 | -0.06 to -0.41 |
|  | 2021 | 44 | 12.09 to 11.85 | 530 | 1.75 to 1.40 | 0.00 | -1.39 to -1.73 |
|  Opportunistic Fixed Income Trust Series I(\*) | 2025 | 30 | 41.69 to 24.98 | 1212 | 1.75 to 1.40 | 6.27 | 7.98 to 7.61 |
|  | 2024 | 27 | 38.61 to 23.21 | 1009 | 1.75 to 1.40 | 3.16 | -1.71 to -2.06 |
|  | 2023 | 30 | 39.29 to 23.70 | 1135 | 1.75 to 1.40 | 2.44 | 6.73 to 6.36 |
|  | 2022 | 29 | 36.81 to 22.28 | 1022 | 1.75 to 1.40 | 2.68 | -12.35 to -12.66 |
|  | 2021 | 31 | 42.00 to 25.51 | 1251 | 1.75 to 1.40 | 2.70 | -3.38 to -3.72 |
|  Opportunistic Fixed Income Trust Series II(\*) | 2025 | 199 | 21.94 to 13.52 | 4157 | 1.90 to 1.00 | 6.00 | 8.11 to 7.15 |
|  | 2024 | 214 | 20.48 to 12.51 | 4165 | 1.90 to 1.00 | 3.07 | -1.40 to -2.30 |
|  | 2023 | 236 | 20.96 to 12.69 | 4679 | 1.90 to 1.00 | 2.47 | 6.90 to 5.94 |
|  | 2022 | 253 | 19.78 to 11.87 | 4763 | 1.90 to 1.00 | 2.44 | -12.15 to -12.93 |
|  | 2021 | 285 | 22.72 to 13.51 | 6160 | 1.90 to 1.00 | 2.61 | -3.23 to -4.10 |
|  Real Estate Securities Trust Series I(\*) | 2025 | 12 | 77.30 to 69.46 | 934 | 1.75 to 1.40 | 1.85 | -0.77 to -1.12 |
|  | 2024 | 13 | 77.90 to 70.25 | 996 | 1.75 to 1.40 | 1.94 | 9.16 to 8.77 |
|  | 2023 | 18 | 71.36 to 64.58 | 1219 | 1.75 to 1.40 | 2.09 | 11.45 to 11.06 |
|  | 2022 | 19 | 64.03 to 58.15 | 1215 | 1.75 to 1.40 | 1.08 | -29.50 to -29.75 |
|  | 2021 | 20 | 90.83 to 82.78 | 1775 | 1.75 to 1.40 | 1.48 | 44.75 to 44.24 |
|  Real Estate Securities Trust Series II(\*) | 2025 | 49 | 55.19 to 26.24 | 2638 | 1.85 to 1.00 | 1.63 | -0.60 to -1.44 |
|  | 2024 | 57 | 56.00 to 26.39 | 3130 | 1.85 to 1.00 | 1.93 | 9.39 to 8.45 |
|  | 2023 | 64 | 51.64 to 24.13 | 3219 | 1.85 to 1.00 | 1.92 | 11.68 to 10.74 |
|  | 2022 | 71 | 46.63 to 21.61 | 3255 | 1.85 to 1.00 | 0.81 | -29.35 to -29.95 |
|  | 2021 | 96 | 66.57 to 30.58 | 6259 | 1.85 to 1.00 | 1.24 | 45.01 to 43.78 |
|  Science & Technology Trust Series I(\*) | 2025 | 106 | 144.18 to 47.42 | 11771 | 1.75 to 1.40 | 0.00 | 21.87 to 21.44 |
|  | 2024 | 117 | 118.31 to 39.05 | 10683 | 1.75 to 1.40 | 0.00 | 35.97 to 35.49 |
|  | 2023 | 130 | 87.01 to 28.82 | 8932 | 1.75 to 1.40 | 0.00 | 52.54 to 52.01 |
|  | 2022 | 135 | 57.04 to 18.96 | 6114 | 1.75 to 1.40 | 0.00 | -36.57 to -36.79 |
|  | 2021 | 138 | 89.93 to 29.99 | 9875 | 1.75 to 1.40 | 0.00 | 7.02 to 6.65 |
|  Science & Technology Trust Series II(\*) | 2025 | 81 | 136.89 to 114.54 | 11447 | 1.90 to 1.00 | 0.00 | 22.06 to 20.97 |
|  | 2024 | 99 | 113.16 to 93.84 | 11717 | 1.90 to 1.00 | 0.00 | 36.20 to 34.97 |
|  | 2023 | 111 | 83.84 to 68.90 | 9645 | 1.90 to 1.00 | 0.00 | 52.84 to 51.47 |
|  | 2022 | 121 | 55.35 to 45.08 | 6901 | 1.90 to 1.00 | 0.00 | -36.40 to -36.97 |
|  | 2021 | 141 | 87.81 to 70.88 | 12813 | 1.90 to 1.00 | 0.00 | 7.23 to 6.27 |
|  Select Bond Trust Series I(\*) | 2025 | 27 | 15.53 to 13.96 | 404 | 1.55 to 0.80 | 4.17 | 6.61 to 5.82 |
|  | 2024 | 28 | 14.56 to 13.19 | 396 | 1.55 to 0.80 | 3.51 | 1.01 to 0.25 |
|  | 2023 | 29 | 14.42 to 13.16 | 412 | 1.55 to 0.80 | 3.18 | 5.25 to 4.47 |
|  | 2022 | 33 | 13.70 to 12.60 | 443 | 1.55 to 0.80 | 2.90 | -14.88 to -15.52 |
|  | 2021 | 36 | 16.09 to 14.91 | 571 | 1.55 to 0.80 | 2.84 | -1.98 to -2.72 |
|  Select Bond Trust Series II(\*) | 2025 | 3237 | 13.84 to 12.25 | 43512 | 2.00 to 1.00 | 3.99 | 6.29 to 5.24 |
|  | 2024 | 3472 | 13.02 to 11.64 | 44174 | 2.00 to 1.00 | 3.34 | 0.54 to -0.46 |
|  | 2023 | 3618 | 12.95 to 11.70 | 46081 | 2.00 to 1.00 | 3.04 | 4.83 to 3.79 |
|  | 2022 | 3710 | 12.35 to 11.27 | 45406 | 2.00 to 1.00 | 2.74 | -15.23 to -16.07 |
|  | 2021 | 3830 | 14.57 to 13.43 | 55384 | 2.00 to 1.00 | 2.59 | -2.37 to -3.35 |

---

67 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **<u>Sub-account</u>** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value**<br>**Highest to Lowest (a)** | **Assets**<br> **(000s)** | **Expense Ratio**<br>**Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return**<br>**Highest to Lowest (d)** |
|  Short Term Government Income Trust Series I(\*) | 2025 | 123 | $12.10 to $11.45 | $1465 | 1.75 % to 1.40% | 1.68% | 3.67 % to 3.31% |
|  | 2024 | 161 | 11.67 to 11.09 | 1848 | 1.75 to 1.40 | 0.83 | 1.22 to 0.87 |
|  | 2023 | 158 | 11.53 to 10.99 | 1788 | 1.75 to 1.40 | 1.59 | 2.47 to 2.12 |
|  | 2022 | 169 | 11.25 to 10.76 | 1883 | 1.75 to 1.40 | 1.45 | -7.78 to -8.10 |
|  | 2021 | 176 | 12.20 to 11.71 | 2114 | 1.75 to 1.40 | 1.70 | -2.96 to -3.29 |
|  Short Term Government Income Trust Series II(\*) | 2025 | 159 | 12.14 to 10.92 | 1798 | 1.85 to 1.00 | 1.58 | 3.91 to 3.03 |
|  | 2024 | 165 | 11.68 to 10.60 | 1804 | 1.85 to 1.00 | 0.64 | 1.45 to 0.59 |
|  | 2023 | 202 | 11.51 to 10.54 | 2191 | 1.85 to 1.00 | 1.33 | 2.60 to 1.74 |
|  | 2022 | 244 | 11.22 to 10.36 | 2607 | 1.85 to 1.00 | 1.23 | -7.60 to -8.38 |
|  | 2021 | 359 | 12.15 to 11.31 | 4168 | 1.85 to 1.00 | 1.42 | -2.76 to -3.58 |
|  Small Cap Core Trust Series II(\*) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 (e) | 47 | 38.82 to 27.96 | 1833 | 1.85 to 1.00 | 0.96 | -1.12 to -1.95 |
|  | 2024 | 48 | 39.59 to 28.27 | 1922 | 1.85 to 1.00 | 0.54 | 4.68 to 3.78 |
|  | 2023 | 54 | 38.15 to 27.01 | 2078 | 1.85 to 1.00 | 0.21 | 12.72 to 11.76 |
|  | 2022 | 56 | 34.13 to 23.96 | 1945 | 1.85 to 1.00 | 0.66 | -11.38 to -12.12 |
|  | 2021 | 61 | 38.84 to 27.04 | 2407 | 1.85 to 1.00 | 0.33 | 24.72 to 23.66 |
|  Small Cap Index Trust Series I(\*) | 2025 | 5 | 52.15 to 49.21 | 230 | 1.75 to 1.40 | 1.23 | 10.69 to 10.30 |
|  | 2024 | 5 | 47.12 to 44.61 | 242 | 1.75 to 1.40 | 0.49 | 9.29 to 8.90 |
|  | 2023 | 6 | 43.11 to 40.97 | 254 | 1.75 to 1.40 | 1.24 | 14.88 to 14.48 |
|  | 2022 | 6 | 37.53 to 35.78 | 218 | 1.75 to 1.40 | 1.01 | -21.75 to -22.03 |
|  | 2021 | 6 | 47.96 to 45.89 | 274 | 1.75 to 1.40 | 0.60 | 12.90 to 12.50 |
|  Small Cap Index Trust Series II(\*) | 2025 | 85 | 47.35 to 24.56 | 4321 | 1.85 to 1.15 | 1.08 | 10.84 to 10.07 |
|  | 2024 | 104 | 43.02 to 22.43 | 4810 | 1.85 to 1.00 | 0.28 | 9.49 to 8.56 |
|  | 2023 | 114 | 39.63 to 20.49 | 4831 | 1.85 to 1.00 | 1.03 | 15.07 to 14.10 |
|  | 2022 | 117 | 34.73 to 17.80 | 4298 | 1.85 to 1.00 | 0.79 | -21.60 to -22.26 |
|  | 2021 | 130 | 44.68 to 22.71 | 6132 | 1.85 to 1.00 | 0.38 | 13.11 to 12.16 |
|  Small Cap Opportunities Trust Series I(\*) | 2025 | 39 | 70.63 to 65.24 | 2741 | 1.75 to 1.40 | 1.01 | 7.67 to 7.29 |
|  | 2024 | 41 | 65.60 to 60.81 | 2691 | 1.75 to 1.40 | 0.54 | 7.06 to 6.68 |
|  | 2023 | 45 | 61.28 to 57.00 | 2741 | 1.75 to 1.40 | 0.40 | 16.41 to 16.01 |
|  | 2022 | 46 | 52.64 to 49.13 | 2412 | 1.75 to 1.40 | 0.50 | -11.31 to -11.62 |
|  | 2021 | 49 | 59.35 to 55.60 | 2885 | 1.75 to 1.40 | 0.48 | 29.28 to 28.82 |
|  Small Cap Opportunities Trust Series II(\*) | 2025 | 61 | 61.19 to 39.02 | 4014 | 1.85 to 1.00 | 0.78 | 7.86 to 6.94 |
|  | 2024 | 81 | 57.21 to 36.18 | 4967 | 1.85 to 1.00 | 0.36 | 7.29 to 6.37 |
|  | 2023 | 105 | 53.79 to 33.72 | 6022 | 1.85 to 1.00 | 0.22 | 16.66 to 15.67 |
|  | 2022 | 116 | 46.50 to 28.90 | 5767 | 1.85 to 1.00 | 0.31 | -11.14 to -11.89 |
|  | 2021 | 123 | 52.77 to 32.53 | 6871 | 1.85 to 1.00 | 0.31 | 29.55 to 28.45 |
|  Small Cap Stock Trust Series II(\*) | 2025 | 32 | 53.18 to 40.77 | 1771 | 1.90 to 1.00 | 0.00 | 11.38 to 10.38 |
|  | 2024 | 34 | 48.18 to 36.60 | 1677 | 1.90 to 1.00 | 0.00 | 10.17 to 9.18 |
|  | 2023 | 37 | 44.13 to 33.22 | 1671 | 1.90 to 1.00 | 0.00 | 14.74 to 13.71 |
|  | 2022 | 56 | 38.80 to 28.96 | 2178 | 1.90 to 1.00 | 0.00 | -31.94 to -32.55 |
|  | 2021 | 61 | 57.53 to 42.54 | 3494 | 1.90 to 1.00 | 0.00 | 0.05 to -0.85 |
|  Small Company Value Trust Series I(\*) | 2025 | 26 | 68.34 to 67.24 | 1795 | 1.75 to 1.40 | 0.51 | 5.63 to 5.26 |
|  | 2024 | 28 | 64.70 to 63.88 | 1793 | 1.75 to 1.40 | 0.54 | 8.65 to 8.27 |
|  | 2023 | 31 | 59.55 to 59.00 | 1848 | 1.75 to 1.40 | 0.27 | 11.91 to 11.52 |
|  | 2022 | 33 | 53.21 to 52.91 | 1764 | 1.75 to 1.40 | 0.00 | -19.86 to -20.14 |
|  | 2021 | 37 | 66.40 to 66.25 | 2454 | 1.75 to 1.40 | 0.31 | 21.00 to 20.57 |
|  Small Company Value Trust Series II(\*) | 2025 | 76 | 49.64 to 32.41 | 4106 | 1.85 to 1.00 | 0.34 | 5.94 to 5.04 |
|  | 2024 | 85 | 47.26 to 30.59 | 4368 | 1.85 to 1.00 | 0.41 | 8.78 to 7.85 |
|  | 2023 | 99 | 43.82 to 28.13 | 4715 | 1.85 to 1.00 | 0.09 | 12.25 to 11.31 |
|  | 2022 | 111 | 39.37 to 25.06 | 4741 | 1.85 to 1.00 | 0.00 | -19.75 to -20.43 |
|  | 2021 | 131 | 49.48 to 31.22 | 7007 | 1.85 to 1.00 | 0.13 | 21.29 to 20.27 |
|  Strategic Income Opportunities Trust Series I(\*) | 2025 | 59 | 26.11 to 24.21 | 1521 | 1.75 to 1.40 | 7.93 | 6.02 to 5.65 |
|  | 2024 | 66 | 24.63 to 22.91 | 1629 | 1.75 to 1.40 | 2.65 | 1.66 to 1.30 |
|  | 2023 | 75 | 24.23 to 22.62 | 1809 | 1.75 to 1.40 | 3.42 | 5.88 to 5.51 |
|  | 2022 | 80 | 22.88 to 21.44 | 1840 | 1.75 to 1.40 | 3.44 | -11.31 to -11.62 |
|  | 2021 | 86 | 25.80 to 24.25 | 2243 | 1.75 to 1.40 | 3.34 | -0.50 to -0.85 |
|  Strategic Income Opportunities Trust Series II(\*) | 2025 | 125 | 22.97 to 16.33 | 3047 | 1.85 to 1.00 | 7.70 | 6.15 to 5.25 |
|  | 2024 | 142 | 21.82 to 15.38 | 3267 | 1.85 to 1.00 | 2.53 | 1.88 to 1.01 |
|  | 2023 | 148 | 21.61 to 15.10 | 3363 | 1.85 to 1.00 | 3.22 | 6.17 to 5.27 |
|  | 2022 | 158 | 20.52 to 14.22 | 3432 | 1.85 to 1.00 | 3.12 | -11.19 to -11.94 |
|  | 2021 | 182 | 23.31 to 16.01 | 4487 | 1.85 to 1.00 | 3.07 | -0.30 to -1.15 |
|  Total Bond Market Series Trust NAV(\*) | 2025 | 38 | 13.87 to 12.56 | 515 | 1.55 to 0.80 | 3.72 | 6.06 to 5.27 |
|  | 2024 | 39 | 13.08 to 11.93 | 503 | 1.55 to 0.80 | 2.97 | 0.33 to -0.43 |
|  | 2023 | 40 | 13.03 to 11.99 | 519 | 1.55 to 0.80 | 2.72 | 4.45 to 3.67 |
|  | 2022 | 44 | 12.48 to 11.56 | 546 | 1.55 to 0.80 | 2.58 | -14.05 to -14.69 |
|  | 2021 | 49 | 14.52 to 13.55 | 701 | 1.55 to 0.80 | 2.34 | -2.64 to -3.37 |

---

68 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **At December 31,** | **At December 31,** | **At December 31,** | **At December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** | **For the years and periods ended December 31,** |
| **<u>Sub-account</u>** | **Year** | **Units**<br> **(000s)** | **Unit Fair Value**<br>**Highest to Lowest (a)** | **Assets**<br> **(000s)** | **Expense Ratio**<br>**Highest to Lowest (b)** | **Investment**<br>**Income Ratio (c)** | **Total Return**<br>**Highest to Lowest (d)** |
|  Total Bond Market Trust Series II(\*) | 2025 | 329 | $13.02 to $11.60 | $4007 | 1.90 % to 1.00% | 3.17% | 5.61 % to 4.66% |
|  | 2024 | 442 | 12.33 to 11.09 | 5156 | 1.90 to 1.00 | 2.83 | -0.21 to -1.11 |
|  | 2023 | 480 | 12.35 to 11.21 | 5632 | 1.90 to 1.00 | 2.57 | 3.98 to 3.05 |
|  | 2022 | 430 | 11.88 to 10.88 | 4889 | 1.90 to 1.00 | 2.57 | -14.44 to -15.20 |
|  | 2021 | 444 | 13.88 to 12.83 | 5935 | 1.90 to 1.00 | 2.41 | -3.07 to -3.94 |
|  Total Stock Market Index Trust Series I(\*) | 2025 | 73 | 59.83 to 56.36 | 4319 | 1.75 to 1.40 | 0.87 | 15.01 to 14.61 |
|  | 2024 | 82 | 52.02 to 49.17 | 4196 | 1.75 to 1.40 | 0.48 | 21.75 to 21.32 |
|  | 2023 | 88 | 42.72 to 40.53 | 3731 | 1.75 to 1.40 | 1.05 | 23.79 to 23.36 |
|  | 2022 | 97 | 34.51 to 32.86 | 3353 | 1.75 to 1.40 | 1.06 | -21.51 to -21.79 |
|  | 2021 | 102 | 43.97 to 42.01 | 4461 | 1.75 to 1.40 | 1.07 | 22.72 to 22.29 |
|  Total Stock Market Index Trust Series II(\*) | 2025 | 94 | 69.57 to 36.67 | 6933 | 1.85 to 1.35 | 0.68 | 14.87 to 14.29 |
|  | 2024 | 109 | 60.87 to 31.92 | 6948 | 1.85 to 1.35 | 0.32 | 21.56 to 20.95 |
|  | 2023 | 119 | 50.33 to 26.26 | 6269 | 1.85 to 1.35 | 0.89 | 23.58 to 22.96 |
|  | 2022 | 125 | 40.93 to 21.25 | 5370 | 1.85 to 1.35 | 0.86 | -21.61 to -22.00 |
|  | 2021 | 133 | 52.47 to 27.11 | 7275 | 1.85 to 1.35 | 0.90 | 22.53 to 21.92 |
|  U.S. Growth Trust - Series I(\*) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 (f) | 200 | 75.61 to 69.23 | 14940 | 1.75 to 1.40 | 0.00 | 18.92 to 18.51 |
|  | 2024 | 224 | 63.58 to 58.42 | 14060 | 1.75 to 1.40 | 0.00 | 28.98 to 28.52 |
|  | 2023 | 249 | 49.29 to 45.45 | 12140 | 1.75 to 1.40 | 0.00 | 50.73 to 50.21 |
|  | 2022 | 275 | 32.70 to 30.26 | 8939 | 1.75 to 1.40 | 0.00 | -38.56 to -38.78 |
|  | 2021 | 297 | 53.23 to 49.43 | 15701 | 1.75 to 1.40 | 0.00 | 14.14 to 13.74 |
|  U.S. Growth Trust - Series II(\*) | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 (g) | 97 | 103.33 to 88.08 | 10452 | 1.85 to 1.00 | 0.00 | 19.35 to 18.34 |
|  | 2024 | 108 | 87.32 to 73.80 | 9863 | 1.85 to 1.00 | 0.00 | 29.23 to 28.13 |
|  | 2023 | 128 | 68.15 to 57.10 | 9112 | 1.85 to 1.00 | 0.00 | 51.00 to 49.73 |
|  | 2022 | 145 | 45.51 to 37.82 | 6843 | 1.85 to 1.00 | 0.00 | -38.50 to -39.02 |
|  | 2021 | 159 | 74.63 to 61.49 | 12341 | 1.85 to 1.00 | 0.00 | 14.49 to 13.52 |
|  Ultra Short Term Bond Trust Series II(\*) | 2025 | 975 | 14.01 to 11.05 | 11427 | 2.00 to 0.35 | 4.49 | 3.65 to 1.96 |
|  | 2024 | 1156 | 12.57 to 10.84 | 13175 | 2.00 to 1.00 | 1.38 | 3.73 to 2.69 |
|  | 2023 | 1469 | 12.12 to 10.55 | 16320 | 2.00 to 1.00 | 2.53 | 3.37 to 2.35 |
|  | 2022 | 1784 | 11.73 to 10.31 | 19266 | 2.00 to 1.00 | 1.40 | -2.03 to -3.00 |
|  | 2021 | 1440 | 11.97 to 10.63 | 15993 | 2.00 to 1.00 | 1.58 | -1.65 to -2.63 |

---

69 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**7. Unit Values (continued):** 

(\*) Sub-account that invests in affiliated Trust.

&nbsp;&nbsp;&nbsp;&nbsp;(a) As the unit fair value is presented as a range of minimum to maximum values, based on the product grouping representing the minimum and maximum expense ratio amounts, some individual contract unit values are not within the ranges presented.

&nbsp;&nbsp;&nbsp;&nbsp;(b) These ratios represent the annualized contract expenses of the separate account, consisting primarily of the items known as "Revenue from underlying fund (12b-1, ST A, Other)" and "Revenue from Sub-account" (formerly referred to as the administrative maintenance charges and sales and service fees (AMC and SSF)). The ratios include only those expenses that result in a direct reduction to unit values. Charges made directly to unitholder accounts through the redemption of units and expenses of the underlying fund are excluded.

&nbsp;&nbsp;&nbsp;&nbsp;(c) These ratios represent the distributions from net investment income received by the sub-account from the underlying Portfolio, net of management fees assessed by the portfolio manager, divided by the average net assets. These ratios exclude those expenses, such as mortality and expense charges, that are assessed against policyholder accounts either through the reductions in the unit values or the redemptions of units. T he recognition of investment income by the sub-account is affected by the timing of the declaration of dividends by the underlying Portfolio in which the sub-accounts invest.

&nbsp;&nbsp;&nbsp;&nbsp;(d) These ratios, represent the total return for the periods indicated, including changes in the value of the underlying Portfolio, and expenses assessed through the reduction of unit values. These ratios do not include any expenses assessed through the redemption of units. Investment options indicated in footnote 1 with a date notation, if any, denote the effective date of that investment option in the vari able account. The total return is calculated for the period indicated or from the effective date through the end of the reporting period. As the total return is presented as a range of minimum to maximum values, based on the product grouping representing the minimum and maximum expense ratio amounts, some individual contract total returns are not within the ranges presented.

&nbsp;&nbsp;&nbsp;&nbsp;(e) Renamed on April 28, 2025. Previously known as Small Cap Value Trust Series II.

&nbsp;&nbsp;&nbsp;&nbsp;(f) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series I.

&nbsp;&nbsp;&nbsp;&nbsp;(g) Renamed on May 1, 2025. Previously known as Capital Appreciation Trust Series II.

70 of 71

------

##### [**Table of Contents**](#toc)
**JOHN HANCOCK LIFE INSURANCE CO OF NEW YORK SEPARATE ACCOUNT A** 

**NOTES TO FINANCIAL STATEMENTS (CONTINUED)** 

**December 31, 2025** 

**8. Diversification Requirements** 

The Internal Revenue Service has issued regulations under Section 817(h) of the Internal Revenue Code ("the Code"). Under the provisions of Section 817(h) of the Code, a Contract will not be treated as a variable annuity contract for federal tax purposes for any period for which the investments of the Account on which the contract is based are not adequately diversified. The Code provides that the "adequately diversified" requirement may be met if the underlying investments satisfy either a statutory safe harbor test or diversification requirement set forth in regulations issued by the Secretary of the Treasury. The Company believes that the Account satisfies the current requirements of the regulations, and the Account will continue to meet such requirements.

**9. Contract Charges** 

The expense ratio represents the contract expenses of the Account for the period indicated and includes only those expenses that are charged through a reduction of the unit value. Included in this category are mortality and expense charges, and the cost of any riders the policy holder has elected. These fees range between 0.35% and 2.00% of net assets of the sub-account depending on the type of contract. Annual contract charges of up to $30 per policy are made through redemption of units.

**10. Operating Segments** 

An operating segment is defined as a component of a public entity that engages in business activities from which it may recognize revenues and incur expenses, has operating results that are regularly reviewed by the public entity's chief operating decision maker (CODM) to make decisions about resources to be allocated to the segment and assess its performance, and has discrete financial information available. The CODM is the Head of US Insurance. The subaccount represents a single operating segment, as the CODM monitors the operating results of the subaccount and as a whole, the subaccount's long-term strategic asset allocation is pre-determined based on a defined investment strategy. The net increase (decrease) in net assets from operations, which is used by the CODM to assess the segment's performance is consistent with that presented within the subaccount's financial statements. Segment assets are reflected on the accompanying Statement of Assets and Liabilities as "total assets" and significant segment expenses are listed on the accompanying Statement of Operations.

71 of 71